data_1a91_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a91 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.87 -36.76 85.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.282 1.433 . . . . 0.0 109.412 168.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -74.63 -47.83 29.87 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.392 1.477 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.33 -25.91 50.61 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 126.811 2.044 . . . . 0.0 113.221 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.58 -43.76 46.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.563 1.145 . . . . 0.0 110.71 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -67.02 -30.41 70.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 124.666 1.186 . . . . 0.0 110.185 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.85 -36.6 70.19 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.058 0.943 . . . . 0.0 110.957 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.53 -50.57 51.07 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 126.487 1.915 . . . . 0.0 108.165 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 mt -71.05 -28.42 64.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.931 1.292 . . . . 0.0 112.613 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -54.12 16.22 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.482 0.713 . . . . 0.0 110.823 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -18.74 62.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.075 0.55 . . . . 0.0 111.255 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.52 42.02 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.299 1.44 . . . . 0.0 110.077 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.53 63.87 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.802 2.041 . . . . 0.0 113.993 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.65 -22.92 24.41 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 119.197 0.908 . . . . 0.0 109.909 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.16 -30.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.9 mmt -76.87 -77.11 0.15 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 124.183 0.993 . . . . 0.0 108.439 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -81.29 -5.5 57.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.69 -52.05 32.02 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 165.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.43 -58.09 7.43 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 111.788 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.57 -47.51 19.25 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -24.81 51.6 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pp -81.89 -32.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 CA-C-N 119.086 0.857 . . . . 0.0 111.562 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.17 -35.44 88.51 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 125.081 1.324 . . . . 0.0 111.181 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.22 60.58 Favored 'General case' 0 CA--C 1.486 -1.497 0 C-N-CA 128.334 2.654 . . . . 0.0 109.992 166.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.04 90.65 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 123.712 0.805 . . . . 0.0 112.068 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.3 -21.97 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.41 -32.08 9.06 Favored Glycine 0 CA--C 1.472 -2.605 0 CA-C-N 119.922 1.237 . . . . 0.0 112.3 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.4 mt -58.9 -36.98 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.15 -51.19 7.0 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 96.0 mt -66.31 -66.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 C-N-CA 124.316 1.046 . . . . 0.0 112.515 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.69 -58.47 6.21 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 126.021 1.728 . . . . 0.0 109.404 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.19 -16.6 62.58 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 119.221 0.919 . . . . 0.0 113.963 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.74 -43.52 14.57 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 118.861 1.331 . . . . 0.0 110.491 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.14 -32.85 56.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.515 1.526 . . . . 0.0 111.082 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 124.971 1.309 . . . . 0.0 111.014 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tp -76.46 -21.05 56.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.499 0.59 . . . . 0.0 111.814 172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -80.75 2.9 24.18 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.701 -1.25 . . . . 0.0 110.385 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.9 -31.9 7.11 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 164.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.93 -22.22 53.63 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.688 1.195 . . . . 0.0 112.705 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.14 63.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.873 1.669 . . . . 0.0 112.484 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.15 -25.37 47.3 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.364 1.065 . . . . 0.0 110.58 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -83.7 176.73 3.5 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 125.673 1.589 . . . . 0.0 106.993 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.32 153.49 50.74 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 123.787 2.388 . . . . 0.0 107.274 165.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -87.38 38.65 0.83 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.237 0.615 . . . . 0.0 109.757 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.64 -73.06 0.58 Allowed 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.82 -55.74 1.88 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 115.603 -2.142 . . . . 0.0 110.778 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -85.3 9.45 4.12 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 125.637 3.049 . . . . 0.0 111.71 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.53 -30.68 47.16 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -33.63 58.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.332 1.053 . . . . 0.0 111.43 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.23 -31.7 66.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.115 -0.991 . . . . 0.0 110.316 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.39 -55.52 32.57 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.992 -1.004 . . . . 0.0 108.947 169.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -44.74 -36.47 3.19 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.423 1.489 . . . . 0.0 112.678 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.357 52.7 m-85 -78.03 -37.5 46.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 pt -75.55 -25.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.752 -1.217 . . . . 0.0 109.089 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.9 -38.59 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 130.042 3.337 . . . . 0.0 111.494 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.4 ttm -53.43 -33.67 54.91 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.707 1.603 . . . . 0.0 111.198 167.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.4 -41.44 25.51 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 116.349 -0.387 . . . . 0.0 113.821 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.1 mt -66.02 -32.12 73.41 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 118.233 1.016 . . . . 0.0 112.371 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -77.1 -24.93 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 125.652 1.581 . . . . 0.0 111.246 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.51 -39.96 85.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.373 0.669 . . . . 0.0 111.161 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.11 24.89 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 123.654 0.782 . . . . 0.0 112.812 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -48.36 73.96 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.03 -7.75 9.18 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 CA-C-N 124.234 2.548 . . . . 0.0 108.485 -170.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.08 -29.97 13.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.068 1.747 . . . . 0.0 108.606 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.21 -30.73 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 108.926 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.23 -28.76 38.5 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.537 1.135 . . . . 0.0 110.898 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.58 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.42 -18.69 77.6 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.23 -37.07 54.0 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 126.928 2.091 . . . . 0.0 110.111 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.63 58.49 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.9 -28.41 49.82 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.783 1.633 . . . . 0.0 110.596 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.06 -35.28 37.29 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.177 0.591 . . . . 0.0 110.801 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.14 -32.14 46.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 124.124 0.969 . . . . 0.0 109.122 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.8 ttt -75.5 -28.46 59.16 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.422 0.689 . . . . 0.0 110.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.33 -35.92 82.45 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.437 1.895 . . . . 0.0 109.422 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.813 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -177.012 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.99 -44.44 92.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.682 1.193 . . . . 0.0 110.031 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -82.01 -31.2 31.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.438 1.095 . . . . 0.0 110.958 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.44 -34.01 66.42 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.327 1.851 . . . . 0.0 111.632 168.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.54 -38.21 59.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.655 1.182 . . . . 0.0 111.404 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.83 -25.87 63.96 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.353 1.061 . . . . 0.0 110.153 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.08 -41.41 67.35 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.234 0.614 . . . . 0.0 110.128 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.93 -22.87 45.16 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.79 -45.36 64.81 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.113 1.365 . . . . 0.0 110.228 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -45.38 70.15 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.906 1.683 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.54 -35.23 75.51 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 126.291 1.836 . . . . 0.0 111.361 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.58 -52.97 62.91 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.735 1.214 . . . . 0.0 111.544 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.99 -36.04 74.22 Favored 'General case' 0 CA--C 1.484 -1.595 0 C-N-CA 125.544 1.538 . . . . 0.0 114.189 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.1 -22.16 25.57 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 119.532 1.06 . . . . 0.0 109.819 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -83.96 -27.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 125.05 1.34 . . . . 0.0 107.524 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.8 ttm -82.13 -71.62 0.48 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.335 0.654 . . . . 0.0 109.931 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -5.62 58.02 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.445 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.6 -54.98 7.89 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.45 -53.25 51.21 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.669 1.188 . . . . 0.0 111.134 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -48.97 16.16 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.91 64.89 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.79 -33.85 12.33 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 CA-C-N 118.651 0.66 . . . . 0.0 111.7 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.84 -38.34 95.99 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 124.65 1.119 . . . . 0.0 110.504 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.02 -68.84 0.16 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 127.845 2.458 . . . . 0.0 108.736 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.61 64.95 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -163.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -71.05 -45.23 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 125.275 1.43 . . . . 0.0 110.826 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.94 43.56 Favored Glycine 0 CA--C 1.465 -3.037 0 CA-C-N 120.246 1.385 . . . . 0.0 115.026 -174.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.98 -10.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 118.423 1.111 . . . . 0.0 110.721 171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -51.15 7.33 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.49 -71.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.065 0 C-N-CA 123.915 0.886 . . . . 0.0 111.892 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -38.18 89.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.782 2.833 . . . . 0.0 111.775 -174.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.64 -20.34 71.53 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.88 -38.08 20.7 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.98 -18.88 49.18 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.387 1.475 . . . . 0.0 110.801 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -67.72 -42.03 82.58 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.93 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.0 -8.44 56.96 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-N 119.572 1.078 . . . . 0.0 111.567 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.26 -39.35 68.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 119.771 -1.831 . . . . 0.0 108.655 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -42.73 80.07 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 125.048 1.309 . . . . 0.0 111.082 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.48 62.91 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.206 1.402 . . . . 0.0 112.966 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.27 -52.29 19.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.991 1.316 . . . . 0.0 111.246 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -19.06 36.94 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 122.831 0.452 . . . . 0.0 111.434 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.11 169.53 18.13 Favored Pre-proline 0 C--N 1.355 0.825 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.86 148.54 52.09 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 CA-C-N 123.989 2.46 . . . . 0.0 107.798 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -87.31 43.92 1.14 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.521 0.728 . . . . 0.0 109.203 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.56 -77.75 0.44 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.411 1.085 . . . . 0.0 108.33 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.03 -56.92 1.54 Allowed Pre-proline 0 N--CA 1.435 -1.192 0 CA-C-O 116.118 -1.896 . . . . 0.0 110.916 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -81.69 7.31 5.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-N 124.75 2.732 . . . . 0.0 111.721 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.68 -34.75 34.5 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 121.229 1.832 . . . . 0.0 107.821 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -37.73 73.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.737 1.215 . . . . 0.0 107.831 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -22.85 60.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 121.074 -1.016 . . . . 0.0 112.688 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -63.01 -46.67 86.52 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 120.369 -1.457 . . . . 0.0 111.411 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -66.17 -50.76 62.81 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -43.74 -31.33 0.78 Allowed 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 128.275 2.63 . . . . 0.0 112.724 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.72 -53.27 8.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.17 -24.48 35.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 121.097 1.771 . . . . 0.0 111.515 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.73 -40.21 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 C-N-CA 130.808 3.643 . . . . 0.0 112.031 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.1 ttm -55.0 -28.26 50.63 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.058 1.343 . . . . 0.0 111.602 167.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -7.4 52.97 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 122.045 -0.409 . . . . 0.0 113.946 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -81.65 -35.72 29.64 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.62 1.21 . . . . 0.0 109.066 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -77.11 -20.3 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 C-N-CA 126.361 1.864 . . . . 0.0 111.338 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.99 -44.13 70.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.923 1.689 . . . . 0.0 110.41 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.55 -25.73 24.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 123.785 0.834 . . . . 0.0 112.662 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.268 0.3 OUTLIER -49.47 -52.7 47.52 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.63 -9.6 8.96 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 CA-C-N 123.773 2.383 . . . . 0.0 108.332 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -87.01 -45.61 10.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 127.009 2.124 . . . . 0.0 105.817 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.18 -32.54 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 109.628 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.49 -27.77 51.98 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.794 0.838 . . . . 0.0 111.086 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.69 -28.84 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.03 -19.88 76.69 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 119.087 0.858 . . . . 0.0 111.611 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.29 -35.33 48.05 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 127.753 2.421 . . . . 0.0 109.892 172.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.17 -32.59 62.77 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 mt -78.48 -23.33 46.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.438 1.895 . . . . 0.0 110.796 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -43.81 21.39 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.506 1.122 . . . . 0.0 110.295 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.1 -25.99 18.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 125.761 1.624 . . . . 0.0 109.162 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.8 ttm -76.63 -31.02 57.12 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 109.66 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -33.95 73.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.132 1.373 . . . . 0.0 109.575 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.775 0 C-N-CA 123.766 0.826 . . . . 0.0 111.559 -174.676 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.03 -27.99 65.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.061 0.944 . . . . 0.0 110.135 170.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -90.49 -32.47 16.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.729 1.212 . . . . 0.0 109.829 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.53 -34.83 67.41 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.228 1.811 . . . . 0.0 111.498 165.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.91 -37.48 58.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.613 1.165 . . . . 0.0 110.709 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.9 mtt -65.95 -30.91 71.56 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.799 1.24 . . . . 0.0 110.295 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.02 -36.9 69.82 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.784 0.834 . . . . 0.0 110.835 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.81 -28.41 36.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.71 1.204 . . . . 0.0 110.487 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 mt -79.68 -27.11 40.81 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.024 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.4 -43.11 74.11 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.829 0.852 . . . . 0.0 109.193 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.3 -23.7 66.42 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.476 1.511 . . . . 0.0 111.708 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -55.59 17.1 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.732 1.213 . . . . 0.0 110.304 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.14 -17.37 26.28 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.247 1.819 . . . . 0.0 114.234 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.37 -29.94 24.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.174 -1.579 . . . . 0.0 109.533 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.5 t -80.51 -37.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 125.774 1.63 . . . . 0.0 108.642 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.2 mmt -80.45 -51.18 9.12 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.924 1.29 . . . . 0.0 111.247 -172.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 34.7 mtm -80.77 -24.96 38.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.5 -48.08 77.28 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.24 -45.07 89.78 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 125.264 1.426 . . . . 0.0 112.458 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.22 2.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.55 -22.72 35.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.81 -33.82 12.29 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 CA-C-N 120.13 1.332 . . . . 0.0 111.589 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.45 -36.71 93.52 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.64 -67.48 0.28 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.611 1.964 . . . . 0.0 108.926 164.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.79 68.53 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.465 1.506 . . . . 0.0 114.554 -160.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.0 -51.97 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 C-N-CA 124.753 1.221 . . . . 0.0 109.122 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -37.49 29.17 Favored Glycine 0 CA--C 1.465 -3.074 0 C-N-CA 119.186 -1.483 . . . . 0.0 115.542 -171.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 pt -76.4 -9.48 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 118.682 1.241 . . . . 0.0 110.885 173.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 -51.22 7.53 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 165.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.496 HG21 ' HZ2' ' A' ' 34' ' ' LYS . 96.0 mt -65.44 -71.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 123.882 0.873 . . . . 0.0 111.909 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -38.88 91.55 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 129.245 3.018 . . . . 0.0 111.792 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.33 -19.74 68.46 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -37.82 20.14 Favored Glycine 0 C--N 1.361 1.932 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HZ2' HG21 ' A' ' 30' ' ' ILE . 58.0 mttp -79.97 -17.31 53.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.485 1.514 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -34.22 71.57 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.66 0.784 . . . . 0.0 110.802 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.4 -19.45 58.1 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-O 121.141 0.496 . . . . 0.0 112.051 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -75.16 -20.37 59.4 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.0 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.38 -24.64 67.71 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 125.071 1.32 . . . . 0.0 110.844 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.02 -26.82 54.19 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 118.9 1.35 . . . . 0.0 111.604 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -57.16 4.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.707 1.603 . . . . 0.0 112.144 -167.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -28.06 39.6 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.128 0.571 . . . . 0.0 111.303 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -84.13 173.46 7.27 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 125.586 1.554 . . . . 0.0 106.921 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.61 150.74 57.49 Favored 'Trans proline' 0 CA--C 1.5 -1.215 0 CA-C-N 123.946 2.445 . . . . 0.0 107.437 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.27 35.88 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.608 0.763 . . . . 0.0 109.592 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.43 -70.96 0.68 Allowed 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.84 -59.47 1.17 Allowed Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-O 116.103 -1.903 . . . . 0.0 110.483 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.3 1.86 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 124.796 2.749 . . . . 0.0 112.695 -167.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.02 -27.69 21.87 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 121.241 1.837 . . . . 0.0 107.819 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -37.47 69.95 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -24.86 61.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.044 -1.035 . . . . 0.0 112.084 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.5 m -63.09 -46.17 88.66 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.761 1.224 . . . . 0.0 112.046 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -64.47 -49.95 69.38 Favored 'General case' 0 CA--C 1.469 -2.151 0 C-N-CA 123.752 0.821 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -45.86 -33.67 3.32 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 126.538 1.935 . . . . 0.0 112.604 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.314 4.0 m-85 -77.28 -39.09 49.34 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.0 pt -74.16 -24.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 CA-C-N 121.283 1.856 . . . . 0.0 109.98 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.9 -37.26 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 C-N-CA 131.509 3.924 . . . . 0.0 111.441 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.13 -32.94 62.47 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.201 1.0 . . . . 0.0 111.563 162.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.86 -9.34 74.51 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 123.447 0.546 . . . . 0.0 112.989 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.79 -16.8 49.76 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.933 0.893 . . . . 0.0 109.655 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.5 -30.03 19.04 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.91 -16.15 58.45 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.908 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 65' ' ' MET . . . -86.09 -24.07 26.44 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 110.997 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -50.19 68.41 Favored Pre-proline 0 C--N 1.35 0.63 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.44 0.87 9.66 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.335 2.69 . . . . 0.0 108.913 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 62' ' ' ALA . 2.7 ttt -67.99 -59.08 3.54 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.05 -38.17 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.684 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.886 -164.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.24 63.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.376 0.535 . . . . 0.0 111.562 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.8 -27.76 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.01 77.66 Favored Glycine 0 C--N 1.36 1.891 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.841 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.33 48.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.046 2.938 . . . . 0.0 110.869 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.68 -33.69 66.89 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.47 -22.24 51.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.36 1.464 . . . . 0.0 112.233 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.26 -36.59 34.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.619 0.645 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.4 -30.38 48.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.881 1.272 . . . . 0.0 109.242 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.1 tpt -76.67 -34.68 58.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.235 0.614 . . . . 0.0 110.261 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.03 -36.69 82.33 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 126.746 2.018 . . . . 0.0 109.712 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.854 0 C-N-CA 124.007 0.923 . . . . 0.0 111.724 -174.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.452 ' H1 ' ' H ' ' A' ' 4' ' ' LEU . 67.4 mtt . . . . . 0 CA--C 1.482 -1.656 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -70.59 -26.77 63.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.192 0.997 . . . . 0.0 109.721 167.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -88.91 -34.95 16.76 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.625 1.17 . . . . 0.0 109.602 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.452 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 28.2 tp -56.49 -30.88 63.5 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.562 1.945 . . . . 0.0 112.005 166.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -78.32 -35.26 47.95 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.834 1.253 . . . . 0.0 111.261 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -26.26 61.74 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.18 0.992 . . . . 0.0 109.573 172.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.1 -34.95 69.04 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 123.944 0.898 . . . . 0.0 110.058 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -70.13 -46.95 63.69 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.987 1.715 . . . . 0.0 109.126 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.06 -39.67 95.42 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.791 1.636 . . . . 0.0 112.451 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -48.96 59.11 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.104 0.962 . . . . 0.0 110.432 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.3 mtp -71.37 -17.37 62.42 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.178 0.991 . . . . 0.0 111.997 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -51.7 57.32 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.606 1.163 . . . . 0.0 110.071 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -20.83 56.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.025 2.13 . . . . 0.0 114.372 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.35 -31.34 24.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 120.062 -1.649 . . . . 0.0 110.0 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -80.84 -41.61 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 125.774 1.629 . . . . 0.0 108.526 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -77.51 -45.23 26.13 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.952 1.301 . . . . 0.0 110.788 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.2 mtp -81.01 -20.31 42.05 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.925 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.2 -38.17 54.45 Favored Glycine 0 C--N 1.356 1.639 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.68 -55.91 22.54 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.085 1.354 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.71 -46.75 24.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -164.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' SD ' ' A' ' 65' ' ' MET . . . -56.23 -27.45 54.96 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.18 -32.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 121.158 -0.964 . . . . 0.0 108.788 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -32.35 78.34 Favored Glycine 0 C--N 1.36 1.9 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.94 -66.67 0.44 Allowed 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.201 1.4 . . . . 0.0 109.645 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.68 -32.61 59.64 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.626 1.97 . . . . 0.0 115.017 -166.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.4 mt -70.02 -50.63 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 C-N-CA 124.424 1.089 . . . . 0.0 109.553 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.06 -41.28 32.57 Favored Glycine 0 CA--C 1.463 -3.181 0 C-N-CA 119.672 -1.252 . . . . 0.0 115.202 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 pt -75.82 -9.27 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.814 1.307 . . . . 0.0 109.727 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.66 -48.92 8.39 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 166.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.72 -75.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.059 0 CA-C-N 117.942 0.871 . . . . 0.0 112.162 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.55 -41.79 92.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 C-N-CA 129.556 3.142 . . . . 0.0 112.447 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.39 -16.79 70.45 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.12 -44.08 12.39 Favored Glycine 0 C--N 1.363 2.033 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.72 -27.26 61.1 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.288 1.435 . . . . 0.0 110.611 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.21 82.38 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.581 1.152 . . . . 0.0 111.553 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.25 -17.78 59.32 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 118.792 0.724 . . . . 0.0 112.102 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.51 -27.74 64.41 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.964 -1.71 . . . . 0.0 109.997 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.32 -37.28 36.99 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.36 -17.1 61.32 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.451 1.501 . . . . 0.0 113.831 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.58 -54.92 8.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.901 1.681 . . . . 0.0 111.254 -171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.79 -20.09 36.47 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.906 0.882 . . . . 0.0 111.116 -175.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.99 168.46 22.7 Favored Pre-proline 0 C--N 1.355 0.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.93 149.12 58.89 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 CA-C-N 122.476 1.92 . . . . 0.0 107.666 170.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.43 40.21 0.91 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.467 0.707 . . . . 0.0 109.575 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -93.67 -76.52 0.47 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 124.696 1.199 . . . . 0.0 109.101 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.84 -49.84 3.38 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 115.408 -2.234 . . . . 0.0 111.087 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -82.94 11.03 3.39 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 125.932 3.154 . . . . 0.0 111.111 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.56 -29.29 41.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -30.34 56.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.611 0.765 . . . . 0.0 112.123 -177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.71 -40.98 65.72 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.2 -0.938 . . . . 0.0 111.765 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.8 m -63.1 -38.54 91.59 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.605 1.562 . . . . 0.0 113.603 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -62.77 -54.35 40.43 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 124.355 1.062 . . . . 0.0 109.655 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -47.63 -31.25 4.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 126.908 2.083 . . . . 0.0 112.577 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.305 6.1 m-30 -77.19 -45.46 26.56 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -71.76 -18.97 20.02 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 121.306 1.866 . . . . 0.0 110.836 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.0 -42.88 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 130.329 3.452 . . . . 0.0 110.732 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ttt -55.19 -27.14 43.82 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.784 1.234 . . . . 0.0 111.743 162.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.52 -24.25 65.78 Favored Glycine 0 C--N 1.356 1.67 0 C-N-CA 124.739 1.162 . . . . 0.0 112.337 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.0 -21.71 36.93 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.145 1.378 . . . . 0.0 110.426 174.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.62 -28.11 17.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 124.908 1.283 . . . . 0.0 108.319 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -77.78 -29.76 51.05 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.062 0.945 . . . . 0.0 110.089 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 -14.65 42.76 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.083 1.353 . . . . 0.0 112.31 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.277 0.3 OUTLIER -49.94 -52.21 54.41 Favored Pre-proline 0 C--N 1.354 0.782 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 172.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.33 -13.21 12.48 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 123.707 2.36 . . . . 0.0 108.33 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.57 -51.21 45.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.35 2.26 . . . . 0.0 107.281 175.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.91 -39.15 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.178 -164.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.22 58.66 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 119.316 0.962 . . . . 0.0 111.588 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.94 -30.41 10.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.76 -18.27 75.66 Favored Glycine 0 C--N 1.359 1.82 0 CA-C-N 118.842 0.747 . . . . 0.0 111.425 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -35.67 59.72 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 127.778 2.431 . . . . 0.0 110.66 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.66 -41.26 24.7 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.62 -39.23 84.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.772 1.629 . . . . 0.0 112.128 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -80.18 -30.71 38.81 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 117.935 0.334 . . . . 0.0 111.425 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -71.02 -33.05 50.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.306 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 60.4 mtt -75.33 -31.75 60.68 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.297 0.639 . . . . 0.0 110.364 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.391 1.876 . . . . 0.0 109.751 172.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.847 0 C-N-CA 124.512 1.125 . . . . 0.0 112.807 -174.724 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 CA--C 1.483 -1.597 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.14 -27.21 65.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.323 1.049 . . . . 0.0 110.196 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -87.13 -41.31 13.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.293 1.037 . . . . 0.0 108.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.8 tp -56.11 -29.98 61.41 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 127.277 2.231 . . . . 0.0 112.608 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -72.66 -46.85 51.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.461 1.104 . . . . 0.0 110.877 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.12 -25.08 62.43 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.338 1.455 . . . . 0.0 109.739 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.05 -43.87 64.23 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.754 0.821 . . . . 0.0 110.418 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.7 tp -72.11 -48.57 42.9 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 110.585 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.54 -41.89 92.56 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.241 1.016 . . . . 0.0 112.759 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -51.17 37.43 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.389 1.075 . . . . 0.0 110.328 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.71 -19.31 62.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.63 -53.27 43.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.35 1.06 . . . . 0.0 110.173 170.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.79 -15.31 11.7 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.624 2.369 . . . . 0.0 114.453 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.85 -26.45 18.49 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 120.783 -1.198 . . . . 0.0 109.756 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.62 -34.17 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.084 1.353 . . . . 0.0 108.362 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.8 mtt -76.73 -65.72 0.9 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.738 1.615 . . . . 0.0 108.779 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.0 mtm -80.75 -18.96 46.04 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.39 -43.28 97.02 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -64.76 0.8 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.145 0.978 . . . . 0.0 110.588 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.64 -52.69 8.59 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -169.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.97 44.41 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.1 -38.29 16.58 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 CA-C-N 120.291 1.405 . . . . 0.0 111.81 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.19 -38.52 95.76 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.51 -70.28 0.1 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.947 2.499 . . . . 0.0 109.32 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.63 72.44 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 114.15 -158.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.11 -47.23 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 C-N-CA 124.96 1.304 . . . . 0.0 109.908 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 -37.8 27.18 Favored Glycine 0 CA--C 1.465 -3.072 0 CA-C-N 120.218 1.372 . . . . 0.0 115.508 -173.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.1 -9.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 118.583 1.192 . . . . 0.0 110.408 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.32 -51.01 7.75 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 166.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.6 -71.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.994 0.918 . . . . 0.0 112.212 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.47 -39.85 92.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 129.211 3.004 . . . . 0.0 112.622 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.85 -19.1 66.22 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.97 -33.44 26.76 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HB2' ' HZ3' ' A' ' 34' ' ' LYS . 4.8 ttmp? -71.5 -35.7 70.84 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.716 2.006 . . . . 0.0 109.042 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.45 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 125.77 1.628 . . . . 0.0 111.429 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -16.46 59.72 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.73 -26.45 62.48 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 120.006 -1.684 . . . . 0.0 110.199 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.5 -28.9 46.13 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -31.03 56.13 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.82 -50.91 25.47 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.519 1.128 . . . . 0.0 113.915 -163.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -38.43 66.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.231 1.012 . . . . 0.0 111.785 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.79 172.27 9.28 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.73 157.89 57.23 Favored 'Trans proline' 0 CA--C 1.496 -1.375 0 CA-C-N 124.585 2.673 . . . . 0.0 109.891 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.12 38.19 0.8 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.407 1.083 . . . . 0.0 110.063 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.17 -74.06 0.54 Allowed 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 123.723 0.809 . . . . 0.0 109.002 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.79 -54.15 2.27 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 115.834 -2.031 . . . . 0.0 110.967 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.31 -5.26 14.22 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 125.122 2.865 . . . . 0.0 111.676 -168.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.97 -33.59 70.6 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 119.914 1.234 . . . . 0.0 108.742 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.33 68.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.52 1.128 . . . . 0.0 110.729 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -72.39 -28.88 63.28 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.713 -1.242 . . . . 0.0 112.95 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.6 m -62.95 -45.52 92.07 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.291 1.436 . . . . 0.0 112.381 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -59.81 -55.12 38.2 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 123.698 0.799 . . . . 0.0 109.331 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -43.86 -35.56 2.0 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 127.566 2.346 . . . . 0.0 112.904 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.27 8.0 m-85 -76.95 -49.46 15.47 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.9 pt -67.75 -24.51 30.96 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-N 121.023 1.738 . . . . 0.0 111.172 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.5 t -74.78 -40.58 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 C-N-CA 130.058 3.343 . . . . 0.0 112.065 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 50.0 ttp -51.5 -35.86 42.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.95 0.9 . . . . 0.0 111.309 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -11.82 62.87 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.56 -22.44 37.8 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.394 1.097 . . . . 0.0 109.28 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.76 -30.35 18.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 126.82 2.048 . . . . 0.0 108.749 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.13 -41.3 74.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.849 1.259 . . . . 0.0 111.082 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.61 31.7 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.695 0.798 . . . . 0.0 111.917 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -49.23 71.74 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.67 -11.5 10.34 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 CA-C-N 124.418 2.614 . . . . 0.0 107.986 -168.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -34.76 14.91 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 126.002 1.721 . . . . 0.0 108.021 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.49 -23.46 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 C-N-CA 123.357 0.663 . . . . 0.0 111.219 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -31.68 24.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.552 1.141 . . . . 0.0 110.101 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.37 -26.37 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.04 -16.51 79.72 Favored Glycine 0 CA--C 1.489 -1.537 0 C-N-CA 124.855 1.217 . . . . 0.0 110.728 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.73 -32.66 31.48 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 125.942 1.697 . . . . 0.0 109.311 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.16 -46.64 15.32 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.64 -39.71 94.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 126.446 1.899 . . . . 0.0 112.83 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -79.89 -28.87 39.84 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.06 -32.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 CA-C-N 118.753 0.706 . . . . 0.0 109.216 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.2 mmt -78.04 -19.78 53.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.275 0.63 . . . . 0.0 111.441 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.13 -37.82 53.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.297 1.439 . . . . 0.0 108.537 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.867 -169.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.483 -1.634 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.74 -36.61 82.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.735 1.214 . . . . 0.0 110.278 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.276 1.031 . . . . 0.0 110.804 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.77 -35.84 69.13 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 112.026 164.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -36.19 44.77 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 124.661 1.184 . . . . 0.0 110.133 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.95 -33.19 75.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.704 1.602 . . . . 0.0 109.748 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.01 -35.44 69.42 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.349 1.06 . . . . 0.0 110.096 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.5 -49.4 33.19 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 125.432 1.493 . . . . 0.0 109.852 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.9 -34.17 71.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.843 0.857 . . . . 0.0 112.024 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.63 -50.48 62.85 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.511 0.596 . . . . 0.0 111.273 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.6 mtp -72.73 -13.48 61.34 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.066 0.546 . . . . 0.0 112.215 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.32 12.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.727 1.211 . . . . 0.0 110.035 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.61 54.78 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.735 2.014 . . . . 0.0 114.33 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 -22.72 20.26 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 120.711 -1.243 . . . . 0.0 110.48 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.94 -33.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.7 tpp -79.61 -62.71 1.6 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 109.806 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mtm -81.31 -23.56 37.78 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.35 99.16 Favored Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.19 -67.98 0.39 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.94 -57.05 4.0 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.01 -27.84 54.75 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -31.73 10.24 Favored 'Isoleucine or valine' 0 C--N 1.369 1.42 0 CA-C-N 120.481 1.491 . . . . 0.0 111.638 172.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.05 76.23 Favored Glycine 0 C--N 1.363 2.044 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -73.2 0.08 Allowed 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 127.912 2.485 . . . . 0.0 108.65 167.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.59 30.89 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -167.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.6 mm -71.0 -50.31 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.187 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 -40.48 49.16 Favored Glycine 0 CA--C 1.46 -3.36 0 CA-C-N 120.087 1.312 . . . . 0.0 114.585 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 pt -75.87 -8.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 119.026 1.413 . . . . 0.0 110.703 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.92 -50.51 7.75 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -65.41 -70.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.144 0 CA-C-N 117.617 0.709 . . . . 0.0 112.278 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.81 -46.02 91.34 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 129.398 3.079 . . . . 0.0 111.506 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.09 -19.49 79.78 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 119.435 1.016 . . . . 0.0 111.996 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.57 14.64 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -74.23 -27.0 60.57 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.01 1.724 . . . . 0.0 110.693 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -43.73 91.17 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.45 1.5 . . . . 0.0 112.091 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -10.64 59.56 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -70.14 -34.53 73.17 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.035 -1.666 . . . . 0.0 110.434 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.43 -35.19 48.33 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.15 62.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.652 1.581 . . . . 0.0 113.729 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -48.42 47.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.31 1.444 . . . . 0.0 113.594 -169.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -37.23 63.91 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.159 0.984 . . . . 0.0 111.324 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -84.47 174.67 5.51 Favored Pre-proline 0 C--N 1.353 0.757 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.98 153.5 57.95 Favored 'Trans proline' 0 CA--C 1.5 -1.2 0 CA-C-N 125.435 2.977 . . . . 0.0 109.158 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -87.25 44.43 1.18 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.095 0.958 . . . . 0.0 108.551 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -93.77 -75.47 0.5 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 124.713 1.205 . . . . 0.0 108.255 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.84 -54.04 2.27 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 115.777 -2.058 . . . . 0.0 111.116 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.05 -1.75 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 CA-C-N 125.24 2.907 . . . . 0.0 111.429 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 tp -77.98 -26.85 48.94 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 120.049 1.295 . . . . 0.0 108.86 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.16 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.87 0.868 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.258 0.8 OUTLIER -72.41 -27.65 62.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 120.65 -1.281 . . . . 0.0 112.984 173.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -62.9 -44.52 95.88 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 112.962 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -59.28 -51.11 71.35 Favored 'General case' 0 CA--C 1.474 -1.959 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.44 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -41.89 -37.66 1.35 Allowed 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.853 2.461 . . . . 0.0 113.566 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.12 -46.26 24.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.81 -21.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 120.889 1.677 . . . . 0.0 110.924 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.02 -40.67 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 C-N-CA 130.9 3.68 . . . . 0.0 112.019 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.8 ttp -53.17 -31.83 44.73 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.387 1.075 . . . . 0.0 111.544 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.04 -3.92 51.33 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.186 0.435 . . . . 0.0 114.186 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.87 -38.05 25.98 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.5 -21.17 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 127.264 2.226 . . . . 0.0 110.289 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.05 -42.36 72.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.963 1.705 . . . . 0.0 110.628 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.48 -20.67 27.74 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.408 1.083 . . . . 0.0 112.729 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.276 0.3 OUTLIER -49.62 -52.27 52.06 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.45 -5.37 9.23 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 CA-C-N 123.748 2.374 . . . . 0.0 107.82 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.4 mmt -92.48 -41.27 10.38 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 126.701 2.0 . . . . 0.0 106.184 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -29.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 C-N-CA 124.392 1.077 . . . . 0.0 109.848 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.87 -29.88 56.02 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 124.031 0.932 . . . . 0.0 111.584 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.04 -31.88 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.06 -18.71 80.14 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.324 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -36.88 38.47 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 127.964 2.506 . . . . 0.0 110.559 174.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.86 -38.84 85.62 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.16 -23.31 61.27 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.544 1.538 . . . . 0.0 111.716 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -79.99 -35.21 37.81 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.847 0.859 . . . . 0.0 110.68 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.64 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 124.293 1.037 . . . . 0.0 109.538 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.4 mtp -77.96 -25.48 48.24 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.627 0.771 . . . . 0.0 111.268 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -36.99 78.54 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.95 1.7 . . . . 0.0 108.516 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.818 0 C-N-CA 124.322 1.049 . . . . 0.0 111.556 -174.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.34 -41.27 98.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.091 1.356 . . . . 0.0 110.074 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -78.26 -44.6 25.07 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.945 1.298 . . . . 0.0 110.631 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.63 -23.7 43.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.105 2.162 . . . . 0.0 113.029 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.97 -43.85 42.63 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.302 1.041 . . . . 0.0 110.945 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.2 mtm -69.57 -27.22 64.94 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.88 1.272 . . . . 0.0 110.219 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.86 -37.03 70.28 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.691 0.797 . . . . 0.0 110.131 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.9 tp -77.81 -31.72 51.9 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.233 1.413 . . . . 0.0 110.128 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.08 -45.08 82.52 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 0.0 111.256 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -69.34 -41.7 76.29 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.467 0.707 . . . . 0.0 111.637 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.9 ttm -61.9 -32.79 73.2 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.099 1.36 . . . . 0.0 111.149 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.54 -60.17 3.91 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.194 1.397 . . . . 0.0 110.786 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.01 58.69 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.718 1.607 . . . . 0.0 114.416 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.34 -33.28 18.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.469 -1.394 . . . . 0.0 110.3 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.11 -33.76 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 125.312 1.445 . . . . 0.0 108.393 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.53 -53.23 6.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.576 1.15 . . . . 0.0 110.041 -170.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.1 mtm -80.65 -23.69 39.5 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.92 90.55 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.36 -51.61 62.45 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.966 1.307 . . . . 0.0 112.29 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.05 13.99 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -170.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.15 57.77 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.87 -32.77 11.46 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 CA-C-N 119.156 0.889 . . . . 0.0 111.928 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.84 91.49 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.16 61.26 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 128.752 2.821 . . . . 0.0 110.831 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.62 82.07 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.906 0.882 . . . . 0.0 113.194 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.01 -37.61 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 C-N-CA 126.183 1.793 . . . . 0.0 110.052 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -33.71 32.54 Favored Glycine 0 CA--C 1.478 -2.227 0 CA-C-N 119.875 1.216 . . . . 0.0 113.682 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.6 -30.28 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.58 9.11 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.21 -73.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.139 0 C-N-CA 123.773 0.829 . . . . 0.0 112.543 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.68 -45.52 82.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.964 2.506 . . . . 0.0 111.335 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.27 -17.03 80.27 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.29 -36.56 30.48 Favored Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -74.98 -35.47 62.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.528 1.931 . . . . 0.0 108.883 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -34.66 76.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.657 1.183 . . . . 0.0 111.218 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -13.43 60.15 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 122.89 0.476 . . . . 0.0 112.149 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.53 -39.59 85.06 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 119.902 -1.748 . . . . 0.0 109.803 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.92 -26.77 66.01 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.9 59.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.924 1.289 . . . . 0.0 112.948 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.23 8.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.521 1.528 . . . . 0.0 111.639 -171.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -29.55 51.4 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 111.205 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -84.04 167.44 27.78 Favored Pre-proline 0 N--CA 1.441 -0.894 0 C-N-CA 125.193 1.397 . . . . 0.0 107.277 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.06 155.01 62.32 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 CA-C-N 123.538 2.299 . . . . 0.0 108.275 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.11 42.03 1.01 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.33 0.652 . . . . 0.0 110.066 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -93.5 -79.16 0.41 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.992 0.917 . . . . 0.0 108.7 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.79 -52.48 2.7 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-O 115.615 -2.136 . . . . 0.0 111.864 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.68 2.79 8.3 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 125.57 3.025 . . . . 0.0 110.858 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 -27.01 35.25 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 172.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -72.04 -36.48 69.64 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.798 0.839 . . . . 0.0 110.837 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -32.56 66.59 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.179 -0.951 . . . . 0.0 112.131 173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -62.79 -42.53 99.75 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.92 1.288 . . . . 0.0 113.109 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 11.6 pt20 -63.87 -45.05 91.14 Favored 'General case' 0 CA--C 1.464 -2.347 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -52.76 -30.8 34.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.889 1.276 . . . . 0.0 112.297 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 10.3 m-30 -78.15 -28.55 48.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 121.364 3.839 . . . . 0.0 121.364 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.79 -29.12 25.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 121.251 1.841 . . . . 0.0 108.597 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.81 -35.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 1 C-N-CA 132.645 4.378 . . . . 0.0 111.794 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.4 ttt -55.05 -33.21 62.51 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.724 1.21 . . . . 0.0 110.919 164.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -38.26 33.53 Favored Glycine 0 N--CA 1.433 -1.526 0 O-C-N 121.888 -0.508 . . . . 0.0 114.045 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.5 -35.07 76.99 Favored 'General case' 0 CA--C 1.508 -0.673 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.08 -25.73 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 C-N-CA 126.267 1.827 . . . . 0.0 110.93 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.53 -37.04 71.19 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.631 0.772 . . . . 0.0 111.681 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.71 -20.81 27.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.484 1.113 . . . . 0.0 112.882 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -45.9 78.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.14 -7.49 8.05 Favored 'Trans proline' 0 CA--C 1.494 -1.479 0 CA-C-N 124.189 2.532 . . . . 0.0 107.318 -168.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -91.4 -40.43 11.44 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 125.54 1.536 . . . . 0.0 107.77 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 tp -77.74 -30.58 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.15 57.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.162 0.985 . . . . 0.0 111.313 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -77.96 -28.67 15.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 CA-C-N 118.298 0.499 . . . . 0.0 109.947 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.94 -21.92 70.08 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -34.9 62.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.604 2.362 . . . . 0.0 110.462 170.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.43 -35.61 63.19 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.2 mt -73.74 -25.86 60.39 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 110.876 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -39.88 29.11 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.671 1.188 . . . . 0.0 110.814 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 -26.15 20.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.891 1.277 . . . . 0.0 109.247 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.18 57.48 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.61 0.764 . . . . 0.0 109.344 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.57 -33.68 69.28 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.798 1.239 . . . . 0.0 109.425 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 0.798 0 C-N-CA 123.733 0.813 . . . . 0.0 111.96 -173.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.466 ' H1 ' ' H ' ' A' ' 4' ' ' LEU . 66.1 mtt . . . . . 0 CA--C 1.478 -1.801 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -36.62 82.76 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.35 1.06 . . . . 0.0 108.345 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.04 -48.85 16.75 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 125.254 1.422 . . . . 0.0 111.672 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.466 ' H ' ' H1 ' ' A' ' 1' ' ' MET 0.264 1.8 pp -56.78 -27.95 60.52 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.973 1.309 . . . . 0.0 113.099 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.88 -45.22 44.36 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.96 1.304 . . . . 0.0 110.837 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 81.8 mtp -64.07 -31.58 72.83 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.36 1.464 . . . . 0.0 110.282 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.98 -38.71 69.67 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.097 0.959 . . . . 0.0 110.701 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.46 -36.14 58.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 125.136 1.375 . . . . 0.0 110.181 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.31 -27.29 42.16 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.87 0.868 . . . . 0.0 111.852 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.41 -44.76 70.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 123.14 0.576 . . . . 0.0 109.913 168.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm -63.72 -25.78 68.35 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 111.712 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -59.14 4.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.061 1.345 . . . . 0.0 110.503 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.39 -9.61 2.5 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 126.428 1.891 . . . . 0.0 114.742 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.03 -28.26 14.71 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 120.865 -1.147 . . . . 0.0 109.153 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.24 -27.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.709 0.804 . . . . 0.0 109.334 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -59.99 2.56 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.638 1.575 . . . . 0.0 108.701 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.6 mtm -80.9 -22.81 39.44 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.921 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.8 -40.84 75.03 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.35 -51.03 65.37 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.105 0.962 . . . . 0.0 111.715 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.02 -51.86 10.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.25 -25.69 48.74 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.88 -33.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 119.828 1.195 . . . . 0.0 110.907 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.8 -38.27 95.68 Favored Glycine 0 C--N 1.355 1.619 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -64.64 0.81 Allowed 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.266 1.826 . . . . 0.0 109.659 165.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.04 73.31 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.712 1.205 . . . . 0.0 113.964 -159.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.81 -47.11 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 C-N-CA 124.908 1.283 . . . . 0.0 109.54 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.9 27.76 Favored Glycine 0 CA--C 1.462 -3.235 0 C-N-CA 119.235 -1.46 . . . . 0.0 115.455 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -73.68 -10.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 118.924 1.362 . . . . 0.0 109.842 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.6 -50.27 8.25 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 167.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.73 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 123.493 0.717 . . . . 0.0 112.42 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.69 -44.29 86.64 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 129.417 3.087 . . . . 0.0 112.138 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.56 -18.33 68.73 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.7 -38.45 20.29 Favored Glycine 0 C--N 1.364 2.115 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 125.939 1.695 . . . . 0.0 109.925 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -39.3 85.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 124.456 1.102 . . . . 0.0 111.604 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -10.18 59.21 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.71 -43.04 80.97 Favored 'General case' 0 C--N 1.362 1.114 0 O-C-N 119.995 -1.691 . . . . 0.0 109.625 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.67 -27.11 65.76 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.04 60.77 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.662 1.185 . . . . 0.0 112.914 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.63 -56.4 5.91 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 125.198 1.399 . . . . 0.0 111.559 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -28.32 40.25 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 111.467 -173.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -84.02 164.78 42.47 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.94 155.2 62.48 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 CA-C-N 123.294 2.212 . . . . 0.0 108.38 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -87.21 45.02 1.22 Allowed 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.734 0.647 . . . . 0.0 109.455 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -79.19 0.41 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.058 0.943 . . . . 0.0 108.718 173.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.31 -54.26 2.5 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-O 115.766 -2.064 . . . . 0.0 111.587 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.66 0.19 10.21 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 CA-C-N 125.32 2.936 . . . . 0.0 111.001 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.6 -35.71 57.95 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -42.2 84.2 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.744 1.218 . . . . 0.0 110.956 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.01 -31.6 66.36 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.859 -1.15 . . . . 0.0 112.596 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -62.87 -45.09 94.2 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 124.735 1.214 . . . . 0.0 112.738 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.94 -54.29 48.8 Favored 'General case' 0 CA--C 1.461 -2.469 0 CA-C-O 116.819 -1.562 . . . . 0.0 109.322 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -44.91 -38.41 4.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 128.572 2.749 . . . . 0.0 113.039 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -76.95 -35.78 57.0 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -75.83 -29.09 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 C-N-CA 126.224 1.809 . . . . 0.0 109.382 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.15 -35.97 36.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 C-N-CA 125.307 1.443 . . . . 0.0 110.043 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.04 -33.86 63.03 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.979 0.911 . . . . 0.0 111.31 165.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.14 -20.54 62.6 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 124.053 0.835 . . . . 0.0 112.709 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -82.12 -26.95 33.1 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.644 1.978 . . . . 0.0 109.502 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.4 -27.24 17.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 125.731 1.612 . . . . 0.0 108.621 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.84 -24.92 58.68 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.034 0.933 . . . . 0.0 110.461 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.56 31.83 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.844 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -50.31 -58.97 8.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 171.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.82 -13.29 13.12 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.915 2.41 . . . . 0.0 108.913 -169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -59.44 3.2 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 127.353 2.261 . . . . 0.0 106.076 174.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -31.34 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.736 -164.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -28.77 47.76 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 118.984 0.811 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.37 -28.51 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.61 -15.4 79.67 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -39.94 62.21 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 126.712 2.005 . . . . 0.0 110.311 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.85 -35.06 46.4 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.75 -26.66 50.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.148 1.379 . . . . 0.0 112.17 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -80.31 -32.68 37.94 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 118.762 0.71 . . . . 0.0 110.17 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.51 -30.59 49.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 123.999 0.92 . . . . 0.0 109.667 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -37.21 66.54 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.546 0.739 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.31 -32.56 73.32 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 127.028 2.131 . . . . 0.0 110.314 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.871 0 C-N-CA 123.97 0.908 . . . . 0.0 111.781 -176.633 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.41 -31.2 71.25 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.847 1.259 . . . . 0.0 109.711 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -76.38 -50.52 13.99 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.326 1.45 . . . . 0.0 109.678 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.62 -20.48 21.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.039 2.535 . . . . 0.0 113.249 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.45 -40.46 50.48 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.626 1.17 . . . . 0.0 111.358 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -26.16 61.48 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 124.29 1.036 . . . . 0.0 109.351 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.94 -35.02 69.49 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.594 0.757 . . . . 0.0 110.166 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.99 -48.05 55.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.5 1.52 . . . . 0.0 109.271 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.18 -37.3 86.99 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.239 1.016 . . . . 0.0 113.083 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.62 44.02 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.283 1.033 . . . . 0.0 110.267 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.6 mtp -74.98 -14.38 60.62 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.753 0.821 . . . . 0.0 111.977 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.61 -51.74 57.32 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.965 1.306 . . . . 0.0 109.616 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.92 64.24 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.706 2.002 . . . . 0.0 113.385 170.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.73 -29.31 32.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 119.709 -1.87 . . . . 0.0 110.218 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -79.89 -40.17 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 C-N-CA 125.686 1.595 . . . . 0.0 108.662 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.5 ttm -84.53 -43.04 14.9 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.579 0.752 . . . . 0.0 111.431 -168.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.2 mtp -80.16 -28.59 38.81 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.28 -41.88 91.15 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.31 -44.12 92.56 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.673 1.189 . . . . 0.0 111.322 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.23 7.15 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.27 -28.54 58.99 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.68 -31.86 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.6 74.3 Favored Glycine 0 C--N 1.361 1.935 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.05 -74.01 0.07 Allowed 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.965 1.306 . . . . 0.0 109.312 164.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.55 69.79 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.762 1.625 . . . . 0.0 114.774 -161.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.7 mm -71.07 -45.43 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 124.869 1.267 . . . . 0.0 110.495 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.82 -41.18 29.1 Favored Glycine 0 CA--C 1.461 -3.314 0 CA-C-N 120.348 1.431 . . . . 0.0 114.494 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.02 -5.88 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 118.823 1.311 . . . . 0.0 110.323 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.95 -50.06 6.63 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.509 HG22 ' HZ2' ' A' ' 34' ' ' LYS . 98.8 mt -65.59 -71.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.042 0.937 . . . . 0.0 111.997 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.43 -30.96 71.82 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 129.425 3.09 . . . . 0.0 112.601 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.14 -19.13 47.68 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 119.113 0.87 . . . . 0.0 110.956 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.12 -36.29 9.09 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 118.329 1.064 . . . . 0.0 110.608 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HZ2' HG22 ' A' ' 30' ' ' ILE . 60.4 mttp -79.96 -20.42 45.63 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.208 1.403 . . . . 0.0 109.559 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -42.13 98.7 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.757 1.223 . . . . 0.0 111.188 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -10.81 59.7 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 123.353 0.661 . . . . 0.0 111.829 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -71.87 -36.8 70.2 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 120.185 -1.572 . . . . 0.0 109.268 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.22 -33.72 56.29 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.46 71.84 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.163 1.385 . . . . 0.0 113.066 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.76 -41.26 68.62 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.251 1.42 . . . . 0.0 112.636 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -75.92 -36.99 59.21 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.546 1.138 . . . . 0.0 111.453 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -84.44 176.42 3.74 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.97 155.41 52.96 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 CA-C-N 125.622 3.044 . . . . 0.0 109.542 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -87.09 54.3 3.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 169.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 tp -93.68 -75.8 0.49 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 125.498 1.519 . . . . 0.0 107.436 172.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.1 -54.26 2.08 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 115.567 -2.159 . . . . 0.0 108.885 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 43.76 1.02 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 CA-C-N 125.129 2.867 . . . . 0.0 110.498 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 tt -90.1 -46.55 8.4 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 152.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -34.75 65.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.999 1.719 . . . . 0.0 111.935 -175.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -42.96 64.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.922 0.868 . . . . 0.0 109.757 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -62.89 -37.61 87.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.236 2.214 . . . . 0.0 113.693 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 4.5 pt20 -66.42 -50.3 63.88 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.42 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -48.98 -28.93 4.25 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 126.704 2.002 . . . . 0.0 112.691 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.289 2.5 m-85 -77.09 -41.71 41.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 119.349 3.092 . . . . 0.0 119.349 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 pt -72.31 -23.24 21.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 CA-C-N 121.675 2.034 . . . . 0.0 110.357 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.85 -35.42 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 C-N-CA 131.438 3.895 . . . . 0.0 111.607 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 38.1 ttp -55.36 -34.76 64.56 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.858 0.863 . . . . 0.0 111.257 162.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -12.87 80.65 Favored Glycine 0 C--N 1.353 1.486 0 C-N-CA 124.042 0.829 . . . . 0.0 112.701 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.82 -17.75 46.4 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.147 0.979 . . . . 0.0 110.433 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.6 -24.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 124.314 1.046 . . . . 0.0 108.628 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.97 -13.3 59.93 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.903 0.881 . . . . 0.0 111.305 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.22 -19.48 29.92 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.994 1.318 . . . . 0.0 111.834 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.321 0.3 OUTLIER -50.16 -58.77 8.6 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.22 -5.71 12.83 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.006 2.47 . . . . 0.0 108.828 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.63 -54.33 6.81 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -30.45 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.636 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.66 -29.38 40.87 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 119.124 0.874 . . . . 0.0 111.028 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.8 t -82.66 -29.78 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.26 80.03 Favored Glycine 0 C--N 1.359 1.83 0 CA-C-N 118.89 0.768 . . . . 0.0 111.432 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.84 68.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.34 1.856 . . . . 0.0 110.988 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.03 -42.66 28.96 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.21 -36.62 83.53 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 127.402 2.281 . . . . 0.0 112.616 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -79.91 -33.02 40.16 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.014 0.126 . . . . 0.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.25 -30.25 45.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.876 0 C-N-CA 124.095 0.958 . . . . 0.0 109.742 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.2 ttt -72.93 -31.69 64.79 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.71 -0.619 . . . . 0.0 110.397 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -71.75 -30.76 65.94 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 126.178 1.791 . . . . 0.0 110.124 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.661 -174.251 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.529 ' H1 ' ' H ' ' A' ' 4' ' ' LEU . 1.8 mpt? . . . . . 0 CA--C 1.481 -1.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.16 -30.54 67.72 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.69 1.196 . . . . 0.0 108.348 164.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.03 -49.05 40.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.424 1.49 . . . . 0.0 110.501 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.529 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 90.2 mt -56.35 -28.64 59.7 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.89 -44.11 50.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.524 1.13 . . . . 0.0 110.786 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -25.03 61.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.363 1.465 . . . . 0.0 109.947 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.06 -43.03 65.52 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.031 0.932 . . . . 0.0 110.201 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.29 -35.31 71.26 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.318 1.447 . . . . 0.0 109.879 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -67.79 -40.91 83.9 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.258 1.823 . . . . 0.0 112.684 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -48.73 60.3 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.221 1.409 . . . . 0.0 108.84 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.0 mtt -68.51 -16.43 63.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.425 1.09 . . . . 0.0 112.076 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.09 62.43 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.398 1.079 . . . . 0.0 109.929 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.44 70.49 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 125.113 1.365 . . . . 0.0 113.509 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.83 -20.5 35.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.719 1.145 . . . . 0.0 110.421 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.64 -26.54 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 125.408 1.483 . . . . 0.0 107.767 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 mmt -81.35 -68.76 0.66 Allowed 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.68 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -16.58 53.38 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.81 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.44 -51.79 40.11 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.46 -61.98 1.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.291 0.636 . . . . 0.0 110.925 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -41.47 39.68 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.88 66.96 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.46 -31.3 9.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.66 -32.05 74.1 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.32 -63.89 1.11 Allowed 'General case' 0 CA--C 1.493 -1.222 0 C-N-CA 125.014 1.325 . . . . 0.0 110.169 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.41 -41.67 4.34 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 126.879 2.072 . . . . 0.0 115.258 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.75 -53.68 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 125.592 1.557 . . . . 0.0 111.487 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.67 67.4 Favored Glycine 0 CA--C 1.49 -1.508 0 CA-C-N 120.143 1.338 . . . . 0.0 114.988 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.22 -27.89 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -48.56 10.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.74 -76.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 124.32 1.048 . . . . 0.0 112.484 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.17 -36.76 83.96 Favored 'General case' 0 CA--C 1.493 -1.236 0 C-N-CA 126.45 1.9 . . . . 0.0 113.385 -170.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -21.01 64.18 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.11 -34.92 31.89 Favored Glycine 0 C--N 1.362 2.003 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -73.33 -31.13 63.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 126.763 2.025 . . . . 0.0 109.654 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -38.17 84.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.729 1.211 . . . . 0.0 111.176 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.28 -13.97 60.14 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.923 -0.485 . . . . 0.0 111.946 175.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -67.12 -38.38 85.5 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 119.777 -1.827 . . . . 0.0 110.333 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.53 -36.4 58.88 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.21 62.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.241 1.417 . . . . 0.0 113.859 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.57 -53.69 12.94 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.679 1.591 . . . . 0.0 111.392 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -23.54 41.09 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.84 0.856 . . . . 0.0 111.16 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.23 167.33 31.22 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.97 153.35 63.39 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.342 2.028 . . . . 0.0 108.078 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.26 42.86 1.06 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.254 0.622 . . . . 0.0 109.951 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.1 tp -93.28 -79.42 0.4 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.096 0.958 . . . . 0.0 108.656 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.78 -53.53 2.43 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-O 115.783 -2.056 . . . . 0.0 111.223 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.15 3.68 7.63 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 125.262 2.915 . . . . 0.0 110.933 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.09 -28.6 48.72 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -36.92 66.17 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.19 0.996 . . . . 0.0 110.917 -177.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.67 66.74 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.326 -0.859 . . . . 0.0 112.201 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -62.91 -43.63 98.28 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.804 1.242 . . . . 0.0 112.809 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 9.3 pt20 -63.97 -49.07 73.94 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 124.179 0.992 . . . . 0.0 109.869 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -49.63 -31.97 11.99 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.928 1.691 . . . . 0.0 112.28 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 5.3 m-30 -77.76 -34.59 52.31 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 121.163 3.764 . . . . 0.0 121.163 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 pt -76.79 -23.79 15.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 CA-C-N 120.95 1.705 . . . . 0.0 109.197 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.3 t -75.13 -40.37 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 1 C-N-CA 131.827 4.051 . . . . 0.0 112.114 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.8 ttt -55.17 -31.47 61.39 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.164 1.386 . . . . 0.0 110.597 165.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.17 -22.54 37.73 Favored Glycine 0 N--CA 1.426 -2.003 0 C-N-CA 124.254 0.931 . . . . 0.0 114.041 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.15 -40.57 27.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.614 1.566 . . . . 0.0 107.678 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.85 -18.93 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 C-N-CA 126.901 2.081 . . . . 0.0 111.382 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.46 -41.59 69.22 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.718 1.207 . . . . 0.0 110.141 173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.32 21.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.641 0.776 . . . . 0.0 112.351 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -48.7 72.85 Favored Pre-proline 0 CA--C 1.507 -0.709 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -85.21 0.28 8.82 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 124.33 2.582 . . . . 0.0 107.366 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.92 -39.52 10.63 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.718 1.207 . . . . 0.0 108.093 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.64 -31.78 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -26.89 57.53 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 118.653 0.661 . . . . 0.0 111.297 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.84 -26.33 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.77 -18.44 79.64 Favored Glycine 0 C--N 1.357 1.741 0 CA-C-N 119.082 0.856 . . . . 0.0 111.156 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -35.56 30.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 128.537 2.735 . . . . 0.0 109.205 175.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.07 -28.72 63.86 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -79.09 -29.09 43.12 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.043 1.737 . . . . 0.0 109.878 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.17 -35.5 36.41 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 124.017 0.927 . . . . 0.0 111.772 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.36 -26.71 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 C-N-CA 125.405 1.482 . . . . 0.0 108.716 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.8 tpt -74.27 -28.8 61.37 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.43 -29.0 59.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.677 1.591 . . . . 0.0 109.576 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 123.569 0.748 . . . . 0.0 111.284 -177.852 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.87 -36.76 85.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.282 1.433 . . . . 0.0 109.412 168.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -74.63 -47.83 29.87 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.392 1.477 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.33 -25.91 50.61 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 126.811 2.044 . . . . 0.0 113.221 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.58 -43.76 46.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.563 1.145 . . . . 0.0 110.71 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -67.02 -30.41 70.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 124.666 1.186 . . . . 0.0 110.185 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.85 -36.6 70.19 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.058 0.943 . . . . 0.0 110.957 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.53 -50.57 51.07 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 126.487 1.915 . . . . 0.0 108.165 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 mt -71.05 -28.42 64.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.931 1.292 . . . . 0.0 112.613 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -54.12 16.22 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.482 0.713 . . . . 0.0 110.823 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -18.74 62.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.075 0.55 . . . . 0.0 111.255 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.52 42.02 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.299 1.44 . . . . 0.0 110.077 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.53 63.87 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.802 2.041 . . . . 0.0 113.993 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.65 -22.92 24.41 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 119.197 0.908 . . . . 0.0 109.909 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.16 -30.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.9 mmt -76.87 -77.11 0.15 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 124.183 0.993 . . . . 0.0 108.439 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -81.29 -5.5 57.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.69 -52.05 32.02 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 165.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.43 -58.09 7.43 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 111.788 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.57 -47.51 19.25 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -24.81 51.6 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pp -81.89 -32.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 CA-C-N 119.086 0.857 . . . . 0.0 111.562 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.17 -35.44 88.51 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 125.081 1.324 . . . . 0.0 111.181 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.22 60.58 Favored 'General case' 0 CA--C 1.486 -1.497 0 C-N-CA 128.334 2.654 . . . . 0.0 109.992 166.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.04 90.65 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 123.712 0.805 . . . . 0.0 112.068 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.3 -21.97 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.41 -32.08 9.06 Favored Glycine 0 CA--C 1.472 -2.605 0 CA-C-N 119.922 1.237 . . . . 0.0 112.3 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.4 mt -58.9 -36.98 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.15 -51.19 7.0 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 96.0 mt -66.31 -66.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 C-N-CA 124.316 1.046 . . . . 0.0 112.515 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.69 -58.47 6.21 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 126.021 1.728 . . . . 0.0 109.404 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.19 -16.6 62.58 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 119.221 0.919 . . . . 0.0 113.963 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.74 -43.52 14.57 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 118.861 1.331 . . . . 0.0 110.491 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.14 -32.85 56.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.515 1.526 . . . . 0.0 111.082 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 124.971 1.309 . . . . 0.0 111.014 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tp -76.46 -21.05 56.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.499 0.59 . . . . 0.0 111.814 172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -80.75 2.9 24.18 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.701 -1.25 . . . . 0.0 110.385 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.9 -31.9 7.11 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 164.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.93 -22.22 53.63 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.688 1.195 . . . . 0.0 112.705 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.14 63.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.873 1.669 . . . . 0.0 112.484 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.15 -25.37 47.3 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.364 1.065 . . . . 0.0 110.58 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -83.7 176.73 3.5 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 125.673 1.589 . . . . 0.0 106.993 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.32 153.49 50.74 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 123.787 2.388 . . . . 0.0 107.274 165.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -87.38 38.65 0.83 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.237 0.615 . . . . 0.0 109.757 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.64 -73.06 0.58 Allowed 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.82 -55.74 1.88 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 115.603 -2.142 . . . . 0.0 110.778 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -85.3 9.45 4.12 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 125.637 3.049 . . . . 0.0 111.71 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.53 -30.68 47.16 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -33.63 58.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.332 1.053 . . . . 0.0 111.43 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.23 -31.7 66.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.115 -0.991 . . . . 0.0 110.316 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.39 -55.52 32.57 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.992 -1.004 . . . . 0.0 108.947 169.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -44.74 -36.47 3.19 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.423 1.489 . . . . 0.0 112.678 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.357 52.7 m-85 -78.03 -37.5 46.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 pt -75.55 -25.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.752 -1.217 . . . . 0.0 109.089 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.9 -38.59 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 130.042 3.337 . . . . 0.0 111.494 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.4 ttm -53.43 -33.67 54.91 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.707 1.603 . . . . 0.0 111.198 167.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.4 -41.44 25.51 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 116.349 -0.387 . . . . 0.0 113.821 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.1 mt -66.02 -32.12 73.41 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 118.233 1.016 . . . . 0.0 112.371 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -77.1 -24.93 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 125.652 1.581 . . . . 0.0 111.246 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.51 -39.96 85.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.373 0.669 . . . . 0.0 111.161 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.11 24.89 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 123.654 0.782 . . . . 0.0 112.812 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -48.36 73.96 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.03 -7.75 9.18 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 CA-C-N 124.234 2.548 . . . . 0.0 108.485 -170.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -96.08 -29.97 13.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.068 1.747 . . . . 0.0 108.606 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.21 -30.73 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 108.926 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.23 -28.76 38.5 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.537 1.135 . . . . 0.0 110.898 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.58 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.42 -18.69 77.6 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.23 -37.07 54.0 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 126.928 2.091 . . . . 0.0 110.111 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.63 58.49 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.9 -28.41 49.82 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.783 1.633 . . . . 0.0 110.596 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.06 -35.28 37.29 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.177 0.591 . . . . 0.0 110.801 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.14 -32.14 46.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 124.124 0.969 . . . . 0.0 109.122 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.8 ttt -75.5 -28.46 59.16 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.422 0.689 . . . . 0.0 110.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.33 -35.92 82.45 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.437 1.895 . . . . 0.0 109.422 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.24 60.98 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -83.42 -45.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.877 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.595 0 C-N-CA 124.143 0.977 . . . . 0.0 112.465 -176.525 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.99 -44.44 92.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.682 1.193 . . . . 0.0 110.031 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -82.01 -31.2 31.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.438 1.095 . . . . 0.0 110.958 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.44 -34.01 66.42 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.327 1.851 . . . . 0.0 111.632 168.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.54 -38.21 59.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.655 1.182 . . . . 0.0 111.404 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.83 -25.87 63.96 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.353 1.061 . . . . 0.0 110.153 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.08 -41.41 67.35 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.234 0.614 . . . . 0.0 110.128 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.93 -22.87 45.16 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.79 -45.36 64.81 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.113 1.365 . . . . 0.0 110.228 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -45.38 70.15 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.906 1.683 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.54 -35.23 75.51 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 126.291 1.836 . . . . 0.0 111.361 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.58 -52.97 62.91 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.735 1.214 . . . . 0.0 111.544 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.99 -36.04 74.22 Favored 'General case' 0 CA--C 1.484 -1.595 0 C-N-CA 125.544 1.538 . . . . 0.0 114.189 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.1 -22.16 25.57 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 119.532 1.06 . . . . 0.0 109.819 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -83.96 -27.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 125.05 1.34 . . . . 0.0 107.524 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.8 ttm -82.13 -71.62 0.48 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.335 0.654 . . . . 0.0 109.931 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -5.62 58.02 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.445 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.6 -54.98 7.89 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.45 -53.25 51.21 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.669 1.188 . . . . 0.0 111.134 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -48.97 16.16 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.91 64.89 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.79 -33.85 12.33 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 CA-C-N 118.651 0.66 . . . . 0.0 111.7 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.84 -38.34 95.99 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 124.65 1.119 . . . . 0.0 110.504 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.02 -68.84 0.16 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 127.845 2.458 . . . . 0.0 108.736 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.61 64.95 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -163.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -71.05 -45.23 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 125.275 1.43 . . . . 0.0 110.826 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.94 43.56 Favored Glycine 0 CA--C 1.465 -3.037 0 CA-C-N 120.246 1.385 . . . . 0.0 115.026 -174.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.98 -10.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 118.423 1.111 . . . . 0.0 110.721 171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -51.15 7.33 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.49 -71.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.065 0 C-N-CA 123.915 0.886 . . . . 0.0 111.892 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -38.18 89.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.782 2.833 . . . . 0.0 111.775 -174.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.64 -20.34 71.53 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.88 -38.08 20.7 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.98 -18.88 49.18 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.387 1.475 . . . . 0.0 110.801 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -67.72 -42.03 82.58 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.93 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.0 -8.44 56.96 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-N 119.572 1.078 . . . . 0.0 111.567 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.26 -39.35 68.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 119.771 -1.831 . . . . 0.0 108.655 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -42.73 80.07 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 125.048 1.309 . . . . 0.0 111.082 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.48 62.91 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.206 1.402 . . . . 0.0 112.966 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.27 -52.29 19.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.991 1.316 . . . . 0.0 111.246 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -19.06 36.94 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 122.831 0.452 . . . . 0.0 111.434 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.11 169.53 18.13 Favored Pre-proline 0 C--N 1.355 0.825 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.86 148.54 52.09 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 CA-C-N 123.989 2.46 . . . . 0.0 107.798 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -87.31 43.92 1.14 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.521 0.728 . . . . 0.0 109.203 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.56 -77.75 0.44 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.411 1.085 . . . . 0.0 108.33 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.03 -56.92 1.54 Allowed Pre-proline 0 N--CA 1.435 -1.192 0 CA-C-O 116.118 -1.896 . . . . 0.0 110.916 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -81.69 7.31 5.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-N 124.75 2.732 . . . . 0.0 111.721 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.68 -34.75 34.5 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 121.229 1.832 . . . . 0.0 107.821 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -37.73 73.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.737 1.215 . . . . 0.0 107.831 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -22.85 60.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 121.074 -1.016 . . . . 0.0 112.688 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -63.01 -46.67 86.52 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 120.369 -1.457 . . . . 0.0 111.411 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -66.17 -50.76 62.81 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -43.74 -31.33 0.78 Allowed 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 128.275 2.63 . . . . 0.0 112.724 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.72 -53.27 8.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.17 -24.48 35.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 121.097 1.771 . . . . 0.0 111.515 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.73 -40.21 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 C-N-CA 130.808 3.643 . . . . 0.0 112.031 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.1 ttm -55.0 -28.26 50.63 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.058 1.343 . . . . 0.0 111.602 167.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -7.4 52.97 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 122.045 -0.409 . . . . 0.0 113.946 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -81.65 -35.72 29.64 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.62 1.21 . . . . 0.0 109.066 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -77.11 -20.3 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 C-N-CA 126.361 1.864 . . . . 0.0 111.338 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.99 -44.13 70.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.923 1.689 . . . . 0.0 110.41 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.55 -25.73 24.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 123.785 0.834 . . . . 0.0 112.662 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.268 0.3 OUTLIER -49.47 -52.7 47.52 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.63 -9.6 8.96 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 CA-C-N 123.773 2.383 . . . . 0.0 108.332 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -87.01 -45.61 10.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 127.009 2.124 . . . . 0.0 105.817 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.18 -32.54 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 109.628 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.49 -27.77 51.98 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.794 0.838 . . . . 0.0 111.086 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.69 -28.84 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.03 -19.88 76.69 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 119.087 0.858 . . . . 0.0 111.611 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.29 -35.33 48.05 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 127.753 2.421 . . . . 0.0 109.892 172.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.17 -32.59 62.77 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 mt -78.48 -23.33 46.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.438 1.895 . . . . 0.0 110.796 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -43.81 21.39 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.506 1.122 . . . . 0.0 110.295 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.1 -25.99 18.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 125.761 1.624 . . . . 0.0 109.162 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.8 ttm -76.63 -31.02 57.12 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 109.66 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -33.95 73.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.132 1.373 . . . . 0.0 109.575 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.66 -22.1 57.06 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.766 0.826 . . . . 0.0 111.559 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.0 t -91.38 -49.31 13.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.686 0 CA-C-O 117.158 -1.401 . . . . 0.0 112.071 -177.018 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.03 -27.99 65.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.061 0.944 . . . . 0.0 110.135 170.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -90.49 -32.47 16.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.729 1.212 . . . . 0.0 109.829 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.53 -34.83 67.41 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.228 1.811 . . . . 0.0 111.498 165.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.91 -37.48 58.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.613 1.165 . . . . 0.0 110.709 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.9 mtt -65.95 -30.91 71.56 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.799 1.24 . . . . 0.0 110.295 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.02 -36.9 69.82 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.784 0.834 . . . . 0.0 110.835 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.81 -28.41 36.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.71 1.204 . . . . 0.0 110.487 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 mt -79.68 -27.11 40.81 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.024 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.4 -43.11 74.11 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.829 0.852 . . . . 0.0 109.193 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.3 -23.7 66.42 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.476 1.511 . . . . 0.0 111.708 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -55.59 17.1 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.732 1.213 . . . . 0.0 110.304 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.14 -17.37 26.28 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.247 1.819 . . . . 0.0 114.234 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.37 -29.94 24.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.174 -1.579 . . . . 0.0 109.533 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.5 t -80.51 -37.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 125.774 1.63 . . . . 0.0 108.642 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.2 mmt -80.45 -51.18 9.12 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.924 1.29 . . . . 0.0 111.247 -172.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 34.7 mtm -80.77 -24.96 38.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.5 -48.08 77.28 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.24 -45.07 89.78 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 125.264 1.426 . . . . 0.0 112.458 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.22 2.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.55 -22.72 35.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.81 -33.82 12.29 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 CA-C-N 120.13 1.332 . . . . 0.0 111.589 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.45 -36.71 93.52 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.64 -67.48 0.28 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.611 1.964 . . . . 0.0 108.926 164.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.79 68.53 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.465 1.506 . . . . 0.0 114.554 -160.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.0 -51.97 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 C-N-CA 124.753 1.221 . . . . 0.0 109.122 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -37.49 29.17 Favored Glycine 0 CA--C 1.465 -3.074 0 C-N-CA 119.186 -1.483 . . . . 0.0 115.542 -171.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 pt -76.4 -9.48 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 118.682 1.241 . . . . 0.0 110.885 173.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 -51.22 7.53 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 165.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.496 HG21 ' HZ2' ' A' ' 34' ' ' LYS . 96.0 mt -65.44 -71.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 123.882 0.873 . . . . 0.0 111.909 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -38.88 91.55 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 129.245 3.018 . . . . 0.0 111.792 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.33 -19.74 68.46 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -37.82 20.14 Favored Glycine 0 C--N 1.361 1.932 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HZ2' HG21 ' A' ' 30' ' ' ILE . 58.0 mttp -79.97 -17.31 53.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.485 1.514 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -34.22 71.57 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.66 0.784 . . . . 0.0 110.802 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.4 -19.45 58.1 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-O 121.141 0.496 . . . . 0.0 112.051 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -75.16 -20.37 59.4 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.0 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.38 -24.64 67.71 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 125.071 1.32 . . . . 0.0 110.844 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.02 -26.82 54.19 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 118.9 1.35 . . . . 0.0 111.604 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -57.16 4.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.707 1.603 . . . . 0.0 112.144 -167.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -28.06 39.6 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.128 0.571 . . . . 0.0 111.303 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -84.13 173.46 7.27 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 125.586 1.554 . . . . 0.0 106.921 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.61 150.74 57.49 Favored 'Trans proline' 0 CA--C 1.5 -1.215 0 CA-C-N 123.946 2.445 . . . . 0.0 107.437 168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.27 35.88 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.608 0.763 . . . . 0.0 109.592 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.43 -70.96 0.68 Allowed 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.84 -59.47 1.17 Allowed Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-O 116.103 -1.903 . . . . 0.0 110.483 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.3 1.86 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 124.796 2.749 . . . . 0.0 112.695 -167.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.02 -27.69 21.87 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 121.241 1.837 . . . . 0.0 107.819 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -37.47 69.95 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -24.86 61.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.044 -1.035 . . . . 0.0 112.084 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.5 m -63.09 -46.17 88.66 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.761 1.224 . . . . 0.0 112.046 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -64.47 -49.95 69.38 Favored 'General case' 0 CA--C 1.469 -2.151 0 C-N-CA 123.752 0.821 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -45.86 -33.67 3.32 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 126.538 1.935 . . . . 0.0 112.604 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.314 4.0 m-85 -77.28 -39.09 49.34 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.0 pt -74.16 -24.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 CA-C-N 121.283 1.856 . . . . 0.0 109.98 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.9 -37.26 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 C-N-CA 131.509 3.924 . . . . 0.0 111.441 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.13 -32.94 62.47 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.201 1.0 . . . . 0.0 111.563 162.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.86 -9.34 74.51 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 123.447 0.546 . . . . 0.0 112.989 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.79 -16.8 49.76 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.933 0.893 . . . . 0.0 109.655 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.5 -30.03 19.04 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.91 -16.15 58.45 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.908 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 65' ' ' MET . . . -86.09 -24.07 26.44 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 110.997 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -50.19 68.41 Favored Pre-proline 0 C--N 1.35 0.63 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.44 0.87 9.66 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.335 2.69 . . . . 0.0 108.913 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 62' ' ' ALA . 2.7 ttt -67.99 -59.08 3.54 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.05 -38.17 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.684 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.886 -164.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.24 63.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.376 0.535 . . . . 0.0 111.562 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.8 -27.76 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.01 77.66 Favored Glycine 0 C--N 1.36 1.891 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.841 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.33 48.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.046 2.938 . . . . 0.0 110.869 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.68 -33.69 66.89 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.47 -22.24 51.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.36 1.464 . . . . 0.0 112.233 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.26 -36.59 34.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.619 0.645 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.4 -30.38 48.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.881 1.272 . . . . 0.0 109.242 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.1 tpt -76.67 -34.68 58.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.235 0.614 . . . . 0.0 110.261 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.03 -36.69 82.33 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 126.746 2.018 . . . . 0.0 109.712 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.4 -22.7 61.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.007 0.923 . . . . 0.0 111.724 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.68 -77.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.645 0 CA-C-O 117.605 -1.188 . . . . 0.0 109.73 -175.29 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' H1 ' ' H ' ' A' ' 4' ' ' LEU . 67.4 mtt . . . . . 0 CA--C 1.482 -1.656 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -70.59 -26.77 63.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.192 0.997 . . . . 0.0 109.721 167.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -88.91 -34.95 16.76 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.625 1.17 . . . . 0.0 109.602 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 28.2 tp -56.49 -30.88 63.5 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.562 1.945 . . . . 0.0 112.005 166.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -78.32 -35.26 47.95 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.834 1.253 . . . . 0.0 111.261 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -26.26 61.74 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.18 0.992 . . . . 0.0 109.573 172.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.1 -34.95 69.04 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 123.944 0.898 . . . . 0.0 110.058 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -70.13 -46.95 63.69 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.987 1.715 . . . . 0.0 109.126 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.06 -39.67 95.42 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.791 1.636 . . . . 0.0 112.451 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -48.96 59.11 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.104 0.962 . . . . 0.0 110.432 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.3 mtp -71.37 -17.37 62.42 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.178 0.991 . . . . 0.0 111.997 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -51.7 57.32 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.606 1.163 . . . . 0.0 110.071 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -20.83 56.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.025 2.13 . . . . 0.0 114.372 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.35 -31.34 24.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 120.062 -1.649 . . . . 0.0 110.0 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -80.84 -41.61 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 125.774 1.629 . . . . 0.0 108.526 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -77.51 -45.23 26.13 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.952 1.301 . . . . 0.0 110.788 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.2 mtp -81.01 -20.31 42.05 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.925 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.2 -38.17 54.45 Favored Glycine 0 C--N 1.356 1.639 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.68 -55.91 22.54 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.085 1.354 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.71 -46.75 24.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -164.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' SD ' ' A' ' 65' ' ' MET . . . -56.23 -27.45 54.96 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.18 -32.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 121.158 -0.964 . . . . 0.0 108.788 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -32.35 78.34 Favored Glycine 0 C--N 1.36 1.9 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.94 -66.67 0.44 Allowed 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.201 1.4 . . . . 0.0 109.645 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.68 -32.61 59.64 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.626 1.97 . . . . 0.0 115.017 -166.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.4 mt -70.02 -50.63 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 C-N-CA 124.424 1.089 . . . . 0.0 109.553 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.06 -41.28 32.57 Favored Glycine 0 CA--C 1.463 -3.181 0 C-N-CA 119.672 -1.252 . . . . 0.0 115.202 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 pt -75.82 -9.27 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.814 1.307 . . . . 0.0 109.727 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.66 -48.92 8.39 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 166.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.72 -75.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.059 0 CA-C-N 117.942 0.871 . . . . 0.0 112.162 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.55 -41.79 92.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 C-N-CA 129.556 3.142 . . . . 0.0 112.447 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.39 -16.79 70.45 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.12 -44.08 12.39 Favored Glycine 0 C--N 1.363 2.033 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.72 -27.26 61.1 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.288 1.435 . . . . 0.0 110.611 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.21 82.38 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.581 1.152 . . . . 0.0 111.553 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.25 -17.78 59.32 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 118.792 0.724 . . . . 0.0 112.102 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.51 -27.74 64.41 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.964 -1.71 . . . . 0.0 109.997 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.32 -37.28 36.99 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.36 -17.1 61.32 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.451 1.501 . . . . 0.0 113.831 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.58 -54.92 8.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.901 1.681 . . . . 0.0 111.254 -171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.79 -20.09 36.47 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.906 0.882 . . . . 0.0 111.116 -175.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.99 168.46 22.7 Favored Pre-proline 0 C--N 1.355 0.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.93 149.12 58.89 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 CA-C-N 122.476 1.92 . . . . 0.0 107.666 170.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.43 40.21 0.91 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.467 0.707 . . . . 0.0 109.575 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -93.67 -76.52 0.47 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 124.696 1.199 . . . . 0.0 109.101 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.84 -49.84 3.38 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 115.408 -2.234 . . . . 0.0 111.087 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -82.94 11.03 3.39 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 125.932 3.154 . . . . 0.0 111.111 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.56 -29.29 41.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -30.34 56.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.611 0.765 . . . . 0.0 112.123 -177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.71 -40.98 65.72 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.2 -0.938 . . . . 0.0 111.765 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.8 m -63.1 -38.54 91.59 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.605 1.562 . . . . 0.0 113.603 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -62.77 -54.35 40.43 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 124.355 1.062 . . . . 0.0 109.655 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -47.63 -31.25 4.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 126.908 2.083 . . . . 0.0 112.577 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.305 6.1 m-30 -77.19 -45.46 26.56 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -71.76 -18.97 20.02 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 121.306 1.866 . . . . 0.0 110.836 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.0 -42.88 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 130.329 3.452 . . . . 0.0 110.732 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ttt -55.19 -27.14 43.82 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.784 1.234 . . . . 0.0 111.743 162.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.52 -24.25 65.78 Favored Glycine 0 C--N 1.356 1.67 0 C-N-CA 124.739 1.162 . . . . 0.0 112.337 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.0 -21.71 36.93 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.145 1.378 . . . . 0.0 110.426 174.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.62 -28.11 17.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 124.908 1.283 . . . . 0.0 108.319 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -77.78 -29.76 51.05 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.062 0.945 . . . . 0.0 110.089 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 -14.65 42.76 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.083 1.353 . . . . 0.0 112.31 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.277 0.3 OUTLIER -49.94 -52.21 54.41 Favored Pre-proline 0 C--N 1.354 0.782 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 172.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.33 -13.21 12.48 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 123.707 2.36 . . . . 0.0 108.33 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.57 -51.21 45.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.35 2.26 . . . . 0.0 107.281 175.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.91 -39.15 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.178 -164.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.22 58.66 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 119.316 0.962 . . . . 0.0 111.588 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.94 -30.41 10.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.76 -18.27 75.66 Favored Glycine 0 C--N 1.359 1.82 0 CA-C-N 118.842 0.747 . . . . 0.0 111.425 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -35.67 59.72 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 127.778 2.431 . . . . 0.0 110.66 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.66 -41.26 24.7 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.62 -39.23 84.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.772 1.629 . . . . 0.0 112.128 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -80.18 -30.71 38.81 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 117.935 0.334 . . . . 0.0 111.425 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -71.02 -33.05 50.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.306 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 60.4 mtt -75.33 -31.75 60.68 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.297 0.639 . . . . 0.0 110.364 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.391 1.876 . . . . 0.0 109.751 172.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.31 -17.61 60.23 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.512 1.125 . . . . 0.0 112.807 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.52 -75.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.613 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.658 -176.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 CA--C 1.483 -1.597 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.14 -27.21 65.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.323 1.049 . . . . 0.0 110.196 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -87.13 -41.31 13.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.293 1.037 . . . . 0.0 108.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.8 tp -56.11 -29.98 61.41 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 127.277 2.231 . . . . 0.0 112.608 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -72.66 -46.85 51.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.461 1.104 . . . . 0.0 110.877 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.12 -25.08 62.43 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.338 1.455 . . . . 0.0 109.739 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.05 -43.87 64.23 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.754 0.821 . . . . 0.0 110.418 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.7 tp -72.11 -48.57 42.9 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 110.585 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.54 -41.89 92.56 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.241 1.016 . . . . 0.0 112.759 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -51.17 37.43 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.389 1.075 . . . . 0.0 110.328 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.71 -19.31 62.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.63 -53.27 43.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.35 1.06 . . . . 0.0 110.173 170.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.79 -15.31 11.7 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.624 2.369 . . . . 0.0 114.453 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.85 -26.45 18.49 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 120.783 -1.198 . . . . 0.0 109.756 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.62 -34.17 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.084 1.353 . . . . 0.0 108.362 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.8 mtt -76.73 -65.72 0.9 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.738 1.615 . . . . 0.0 108.779 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.0 mtm -80.75 -18.96 46.04 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.39 -43.28 97.02 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -64.76 0.8 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.145 0.978 . . . . 0.0 110.588 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.64 -52.69 8.59 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -169.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.97 44.41 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.1 -38.29 16.58 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 CA-C-N 120.291 1.405 . . . . 0.0 111.81 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.19 -38.52 95.76 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.51 -70.28 0.1 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.947 2.499 . . . . 0.0 109.32 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.63 72.44 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 114.15 -158.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.11 -47.23 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 C-N-CA 124.96 1.304 . . . . 0.0 109.908 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 -37.8 27.18 Favored Glycine 0 CA--C 1.465 -3.072 0 CA-C-N 120.218 1.372 . . . . 0.0 115.508 -173.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.1 -9.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 118.583 1.192 . . . . 0.0 110.408 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.32 -51.01 7.75 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 166.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.6 -71.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.994 0.918 . . . . 0.0 112.212 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.47 -39.85 92.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 129.211 3.004 . . . . 0.0 112.622 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.85 -19.1 66.22 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.97 -33.44 26.76 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HB2' ' HZ3' ' A' ' 34' ' ' LYS . 4.8 ttmp? -71.5 -35.7 70.84 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.716 2.006 . . . . 0.0 109.042 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.45 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 125.77 1.628 . . . . 0.0 111.429 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -16.46 59.72 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.73 -26.45 62.48 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 120.006 -1.684 . . . . 0.0 110.199 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.5 -28.9 46.13 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -31.03 56.13 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.82 -50.91 25.47 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.519 1.128 . . . . 0.0 113.915 -163.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -38.43 66.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.231 1.012 . . . . 0.0 111.785 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.79 172.27 9.28 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.73 157.89 57.23 Favored 'Trans proline' 0 CA--C 1.496 -1.375 0 CA-C-N 124.585 2.673 . . . . 0.0 109.891 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.12 38.19 0.8 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.407 1.083 . . . . 0.0 110.063 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.17 -74.06 0.54 Allowed 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 123.723 0.809 . . . . 0.0 109.002 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.79 -54.15 2.27 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 115.834 -2.031 . . . . 0.0 110.967 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.31 -5.26 14.22 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 125.122 2.865 . . . . 0.0 111.676 -168.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.97 -33.59 70.6 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 119.914 1.234 . . . . 0.0 108.742 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.33 68.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.52 1.128 . . . . 0.0 110.729 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -72.39 -28.88 63.28 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.713 -1.242 . . . . 0.0 112.95 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.6 m -62.95 -45.52 92.07 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.291 1.436 . . . . 0.0 112.381 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -59.81 -55.12 38.2 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 123.698 0.799 . . . . 0.0 109.331 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -43.86 -35.56 2.0 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 127.566 2.346 . . . . 0.0 112.904 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.27 8.0 m-85 -76.95 -49.46 15.47 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.9 pt -67.75 -24.51 30.96 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-N 121.023 1.738 . . . . 0.0 111.172 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.5 t -74.78 -40.58 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 C-N-CA 130.058 3.343 . . . . 0.0 112.065 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 50.0 ttp -51.5 -35.86 42.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.95 0.9 . . . . 0.0 111.309 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -11.82 62.87 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.56 -22.44 37.8 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.394 1.097 . . . . 0.0 109.28 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.76 -30.35 18.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 126.82 2.048 . . . . 0.0 108.749 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.13 -41.3 74.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.849 1.259 . . . . 0.0 111.082 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.61 31.7 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.695 0.798 . . . . 0.0 111.917 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -49.23 71.74 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.67 -11.5 10.34 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 CA-C-N 124.418 2.614 . . . . 0.0 107.986 -168.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -34.76 14.91 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 126.002 1.721 . . . . 0.0 108.021 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.49 -23.46 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 C-N-CA 123.357 0.663 . . . . 0.0 111.219 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -31.68 24.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.552 1.141 . . . . 0.0 110.101 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.37 -26.37 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.04 -16.51 79.72 Favored Glycine 0 CA--C 1.489 -1.537 0 C-N-CA 124.855 1.217 . . . . 0.0 110.728 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.73 -32.66 31.48 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 125.942 1.697 . . . . 0.0 109.311 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.16 -46.64 15.32 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.64 -39.71 94.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 126.446 1.899 . . . . 0.0 112.83 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -79.89 -28.87 39.84 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.06 -32.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 CA-C-N 118.753 0.706 . . . . 0.0 109.216 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.2 mmt -78.04 -19.78 53.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.275 0.63 . . . . 0.0 111.441 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.13 -37.82 53.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.297 1.439 . . . . 0.0 108.537 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.63 -18.96 46.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.867 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 p -83.23 -53.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -169.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.624 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.483 -1.634 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.74 -36.61 82.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.735 1.214 . . . . 0.0 110.278 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.276 1.031 . . . . 0.0 110.804 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.77 -35.84 69.13 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 112.026 164.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -36.19 44.77 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 124.661 1.184 . . . . 0.0 110.133 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.95 -33.19 75.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.704 1.602 . . . . 0.0 109.748 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.01 -35.44 69.42 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.349 1.06 . . . . 0.0 110.096 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.5 -49.4 33.19 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 125.432 1.493 . . . . 0.0 109.852 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.9 -34.17 71.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.843 0.857 . . . . 0.0 112.024 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.63 -50.48 62.85 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.511 0.596 . . . . 0.0 111.273 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.6 mtp -72.73 -13.48 61.34 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.066 0.546 . . . . 0.0 112.215 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.32 12.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.727 1.211 . . . . 0.0 110.035 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.61 54.78 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.735 2.014 . . . . 0.0 114.33 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 -22.72 20.26 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 120.711 -1.243 . . . . 0.0 110.48 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.94 -33.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.7 tpp -79.61 -62.71 1.6 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 109.806 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mtm -81.31 -23.56 37.78 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.35 99.16 Favored Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.19 -67.98 0.39 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.94 -57.05 4.0 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.01 -27.84 54.75 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -31.73 10.24 Favored 'Isoleucine or valine' 0 C--N 1.369 1.42 0 CA-C-N 120.481 1.491 . . . . 0.0 111.638 172.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.05 76.23 Favored Glycine 0 C--N 1.363 2.044 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -73.2 0.08 Allowed 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 127.912 2.485 . . . . 0.0 108.65 167.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.59 30.89 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -167.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.6 mm -71.0 -50.31 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.187 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 -40.48 49.16 Favored Glycine 0 CA--C 1.46 -3.36 0 CA-C-N 120.087 1.312 . . . . 0.0 114.585 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 pt -75.87 -8.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 119.026 1.413 . . . . 0.0 110.703 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.92 -50.51 7.75 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -65.41 -70.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.144 0 CA-C-N 117.617 0.709 . . . . 0.0 112.278 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.81 -46.02 91.34 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 129.398 3.079 . . . . 0.0 111.506 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.09 -19.49 79.78 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 119.435 1.016 . . . . 0.0 111.996 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.57 14.64 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -74.23 -27.0 60.57 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.01 1.724 . . . . 0.0 110.693 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -43.73 91.17 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.45 1.5 . . . . 0.0 112.091 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -10.64 59.56 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -70.14 -34.53 73.17 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.035 -1.666 . . . . 0.0 110.434 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.43 -35.19 48.33 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.15 62.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.652 1.581 . . . . 0.0 113.729 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -48.42 47.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.31 1.444 . . . . 0.0 113.594 -169.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -37.23 63.91 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.159 0.984 . . . . 0.0 111.324 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -84.47 174.67 5.51 Favored Pre-proline 0 C--N 1.353 0.757 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.98 153.5 57.95 Favored 'Trans proline' 0 CA--C 1.5 -1.2 0 CA-C-N 125.435 2.977 . . . . 0.0 109.158 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -87.25 44.43 1.18 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.095 0.958 . . . . 0.0 108.551 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -93.77 -75.47 0.5 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 124.713 1.205 . . . . 0.0 108.255 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.84 -54.04 2.27 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 115.777 -2.058 . . . . 0.0 111.116 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.05 -1.75 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 CA-C-N 125.24 2.907 . . . . 0.0 111.429 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 tp -77.98 -26.85 48.94 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 120.049 1.295 . . . . 0.0 108.86 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.16 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.87 0.868 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.258 0.8 OUTLIER -72.41 -27.65 62.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 120.65 -1.281 . . . . 0.0 112.984 173.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -62.9 -44.52 95.88 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 112.962 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -59.28 -51.11 71.35 Favored 'General case' 0 CA--C 1.474 -1.959 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.44 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -41.89 -37.66 1.35 Allowed 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.853 2.461 . . . . 0.0 113.566 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.12 -46.26 24.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.81 -21.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 120.889 1.677 . . . . 0.0 110.924 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.02 -40.67 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 C-N-CA 130.9 3.68 . . . . 0.0 112.019 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.8 ttp -53.17 -31.83 44.73 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.387 1.075 . . . . 0.0 111.544 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.04 -3.92 51.33 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.186 0.435 . . . . 0.0 114.186 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.87 -38.05 25.98 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.5 -21.17 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 127.264 2.226 . . . . 0.0 110.289 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.05 -42.36 72.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.963 1.705 . . . . 0.0 110.628 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.48 -20.67 27.74 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.408 1.083 . . . . 0.0 112.729 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.276 0.3 OUTLIER -49.62 -52.27 52.06 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.45 -5.37 9.23 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 CA-C-N 123.748 2.374 . . . . 0.0 107.82 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.4 mmt -92.48 -41.27 10.38 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 126.701 2.0 . . . . 0.0 106.184 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -29.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 C-N-CA 124.392 1.077 . . . . 0.0 109.848 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.87 -29.88 56.02 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 124.031 0.932 . . . . 0.0 111.584 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.04 -31.88 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.06 -18.71 80.14 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.324 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -36.88 38.47 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 127.964 2.506 . . . . 0.0 110.559 174.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.86 -38.84 85.62 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.16 -23.31 61.27 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.544 1.538 . . . . 0.0 111.716 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -79.99 -35.21 37.81 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.847 0.859 . . . . 0.0 110.68 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.64 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 124.293 1.037 . . . . 0.0 109.538 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.4 mtp -77.96 -25.48 48.24 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.627 0.771 . . . . 0.0 111.268 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -36.99 78.54 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.95 1.7 . . . . 0.0 108.516 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.69 62.71 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.322 1.049 . . . . 0.0 111.556 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -87.56 -85.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.603 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.046 -178.271 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.34 -41.27 98.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.091 1.356 . . . . 0.0 110.074 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -78.26 -44.6 25.07 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.945 1.298 . . . . 0.0 110.631 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.63 -23.7 43.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.105 2.162 . . . . 0.0 113.029 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.97 -43.85 42.63 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.302 1.041 . . . . 0.0 110.945 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.2 mtm -69.57 -27.22 64.94 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.88 1.272 . . . . 0.0 110.219 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.86 -37.03 70.28 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.691 0.797 . . . . 0.0 110.131 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.9 tp -77.81 -31.72 51.9 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.233 1.413 . . . . 0.0 110.128 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.08 -45.08 82.52 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 0.0 111.256 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -69.34 -41.7 76.29 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.467 0.707 . . . . 0.0 111.637 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.9 ttm -61.9 -32.79 73.2 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.099 1.36 . . . . 0.0 111.149 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.54 -60.17 3.91 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.194 1.397 . . . . 0.0 110.786 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.01 58.69 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.718 1.607 . . . . 0.0 114.416 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.34 -33.28 18.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.469 -1.394 . . . . 0.0 110.3 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.11 -33.76 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 125.312 1.445 . . . . 0.0 108.393 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.53 -53.23 6.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.576 1.15 . . . . 0.0 110.041 -170.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.1 mtm -80.65 -23.69 39.5 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.92 90.55 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.36 -51.61 62.45 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.966 1.307 . . . . 0.0 112.29 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.05 13.99 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -170.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.15 57.77 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.87 -32.77 11.46 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 CA-C-N 119.156 0.889 . . . . 0.0 111.928 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.84 91.49 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.16 61.26 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 128.752 2.821 . . . . 0.0 110.831 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.62 82.07 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.906 0.882 . . . . 0.0 113.194 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.01 -37.61 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 C-N-CA 126.183 1.793 . . . . 0.0 110.052 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -33.71 32.54 Favored Glycine 0 CA--C 1.478 -2.227 0 CA-C-N 119.875 1.216 . . . . 0.0 113.682 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.6 -30.28 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.58 9.11 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.21 -73.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.139 0 C-N-CA 123.773 0.829 . . . . 0.0 112.543 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.68 -45.52 82.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.964 2.506 . . . . 0.0 111.335 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.27 -17.03 80.27 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.29 -36.56 30.48 Favored Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -74.98 -35.47 62.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.528 1.931 . . . . 0.0 108.883 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -34.66 76.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.657 1.183 . . . . 0.0 111.218 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -13.43 60.15 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 122.89 0.476 . . . . 0.0 112.149 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.53 -39.59 85.06 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 119.902 -1.748 . . . . 0.0 109.803 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.92 -26.77 66.01 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.9 59.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.924 1.289 . . . . 0.0 112.948 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.23 8.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.521 1.528 . . . . 0.0 111.639 -171.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -29.55 51.4 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 111.205 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -84.04 167.44 27.78 Favored Pre-proline 0 N--CA 1.441 -0.894 0 C-N-CA 125.193 1.397 . . . . 0.0 107.277 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.06 155.01 62.32 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 CA-C-N 123.538 2.299 . . . . 0.0 108.275 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.11 42.03 1.01 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.33 0.652 . . . . 0.0 110.066 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -93.5 -79.16 0.41 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.992 0.917 . . . . 0.0 108.7 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.79 -52.48 2.7 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-O 115.615 -2.136 . . . . 0.0 111.864 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.68 2.79 8.3 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 125.57 3.025 . . . . 0.0 110.858 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 -27.01 35.25 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 172.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -72.04 -36.48 69.64 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.798 0.839 . . . . 0.0 110.837 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -32.56 66.59 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.179 -0.951 . . . . 0.0 112.131 173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -62.79 -42.53 99.75 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.92 1.288 . . . . 0.0 113.109 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 11.6 pt20 -63.87 -45.05 91.14 Favored 'General case' 0 CA--C 1.464 -2.347 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -52.76 -30.8 34.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.889 1.276 . . . . 0.0 112.297 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 10.3 m-30 -78.15 -28.55 48.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 121.364 3.839 . . . . 0.0 121.364 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.79 -29.12 25.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 121.251 1.841 . . . . 0.0 108.597 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.81 -35.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 1 C-N-CA 132.645 4.378 . . . . 0.0 111.794 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.4 ttt -55.05 -33.21 62.51 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.724 1.21 . . . . 0.0 110.919 164.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -38.26 33.53 Favored Glycine 0 N--CA 1.433 -1.526 0 O-C-N 121.888 -0.508 . . . . 0.0 114.045 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.5 -35.07 76.99 Favored 'General case' 0 CA--C 1.508 -0.673 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.08 -25.73 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 C-N-CA 126.267 1.827 . . . . 0.0 110.93 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -71.53 -37.04 71.19 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.631 0.772 . . . . 0.0 111.681 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.71 -20.81 27.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.484 1.113 . . . . 0.0 112.882 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -45.9 78.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.14 -7.49 8.05 Favored 'Trans proline' 0 CA--C 1.494 -1.479 0 CA-C-N 124.189 2.532 . . . . 0.0 107.318 -168.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -91.4 -40.43 11.44 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 125.54 1.536 . . . . 0.0 107.77 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 tp -77.74 -30.58 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.15 57.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.162 0.985 . . . . 0.0 111.313 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -77.96 -28.67 15.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 CA-C-N 118.298 0.499 . . . . 0.0 109.947 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.94 -21.92 70.08 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -34.9 62.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.604 2.362 . . . . 0.0 110.462 170.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.43 -35.61 63.19 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.2 mt -73.74 -25.86 60.39 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 110.876 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -39.88 29.11 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.671 1.188 . . . . 0.0 110.814 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 -26.15 20.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.891 1.277 . . . . 0.0 109.247 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.18 57.48 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.61 0.764 . . . . 0.0 109.344 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.57 -33.68 69.28 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.798 1.239 . . . . 0.0 109.425 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.59 -23.68 61.77 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.733 0.813 . . . . 0.0 111.96 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -93.86 -36.42 7.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.668 0 CA-C-O 117.133 -1.413 . . . . 0.0 111.91 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' H1 ' ' H ' ' A' ' 4' ' ' LEU . 66.1 mtt . . . . . 0 CA--C 1.478 -1.801 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -36.62 82.76 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.35 1.06 . . . . 0.0 108.345 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.04 -48.85 16.75 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 125.254 1.422 . . . . 0.0 111.672 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' H ' ' H1 ' ' A' ' 1' ' ' MET 0.264 1.8 pp -56.78 -27.95 60.52 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.973 1.309 . . . . 0.0 113.099 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.88 -45.22 44.36 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.96 1.304 . . . . 0.0 110.837 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 81.8 mtp -64.07 -31.58 72.83 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.36 1.464 . . . . 0.0 110.282 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.98 -38.71 69.67 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.097 0.959 . . . . 0.0 110.701 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.46 -36.14 58.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 125.136 1.375 . . . . 0.0 110.181 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.31 -27.29 42.16 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.87 0.868 . . . . 0.0 111.852 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.41 -44.76 70.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 123.14 0.576 . . . . 0.0 109.913 168.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm -63.72 -25.78 68.35 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 111.712 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -59.14 4.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.061 1.345 . . . . 0.0 110.503 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.39 -9.61 2.5 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 126.428 1.891 . . . . 0.0 114.742 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.03 -28.26 14.71 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 120.865 -1.147 . . . . 0.0 109.153 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.24 -27.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.709 0.804 . . . . 0.0 109.334 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -59.99 2.56 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.638 1.575 . . . . 0.0 108.701 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.6 mtm -80.9 -22.81 39.44 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.921 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.8 -40.84 75.03 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.35 -51.03 65.37 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.105 0.962 . . . . 0.0 111.715 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.02 -51.86 10.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.25 -25.69 48.74 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.88 -33.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 119.828 1.195 . . . . 0.0 110.907 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.8 -38.27 95.68 Favored Glycine 0 C--N 1.355 1.619 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.95 -64.64 0.81 Allowed 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.266 1.826 . . . . 0.0 109.659 165.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.04 73.31 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.712 1.205 . . . . 0.0 113.964 -159.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.81 -47.11 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 C-N-CA 124.908 1.283 . . . . 0.0 109.54 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.9 27.76 Favored Glycine 0 CA--C 1.462 -3.235 0 C-N-CA 119.235 -1.46 . . . . 0.0 115.455 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -73.68 -10.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 118.924 1.362 . . . . 0.0 109.842 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.6 -50.27 8.25 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 167.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.73 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 123.493 0.717 . . . . 0.0 112.42 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.69 -44.29 86.64 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 129.417 3.087 . . . . 0.0 112.138 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.56 -18.33 68.73 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.7 -38.45 20.29 Favored Glycine 0 C--N 1.364 2.115 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 125.939 1.695 . . . . 0.0 109.925 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -39.3 85.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 124.456 1.102 . . . . 0.0 111.604 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -10.18 59.21 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.71 -43.04 80.97 Favored 'General case' 0 C--N 1.362 1.114 0 O-C-N 119.995 -1.691 . . . . 0.0 109.625 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.67 -27.11 65.76 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.04 60.77 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.662 1.185 . . . . 0.0 112.914 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.63 -56.4 5.91 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 125.198 1.399 . . . . 0.0 111.559 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -28.32 40.25 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 111.467 -173.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -84.02 164.78 42.47 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.94 155.2 62.48 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 CA-C-N 123.294 2.212 . . . . 0.0 108.38 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -87.21 45.02 1.22 Allowed 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.734 0.647 . . . . 0.0 109.455 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -79.19 0.41 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.058 0.943 . . . . 0.0 108.718 173.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.31 -54.26 2.5 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-O 115.766 -2.064 . . . . 0.0 111.587 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.66 0.19 10.21 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 CA-C-N 125.32 2.936 . . . . 0.0 111.001 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.6 -35.71 57.95 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -42.2 84.2 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.744 1.218 . . . . 0.0 110.956 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.01 -31.6 66.36 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.859 -1.15 . . . . 0.0 112.596 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -62.87 -45.09 94.2 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 124.735 1.214 . . . . 0.0 112.738 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.94 -54.29 48.8 Favored 'General case' 0 CA--C 1.461 -2.469 0 CA-C-O 116.819 -1.562 . . . . 0.0 109.322 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -44.91 -38.41 4.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 128.572 2.749 . . . . 0.0 113.039 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -76.95 -35.78 57.0 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -75.83 -29.09 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 C-N-CA 126.224 1.809 . . . . 0.0 109.382 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.15 -35.97 36.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 C-N-CA 125.307 1.443 . . . . 0.0 110.043 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.04 -33.86 63.03 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.979 0.911 . . . . 0.0 111.31 165.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.14 -20.54 62.6 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 124.053 0.835 . . . . 0.0 112.709 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -82.12 -26.95 33.1 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.644 1.978 . . . . 0.0 109.502 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.4 -27.24 17.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 125.731 1.612 . . . . 0.0 108.621 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.84 -24.92 58.68 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.034 0.933 . . . . 0.0 110.461 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.56 31.83 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.844 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -50.31 -58.97 8.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 171.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.82 -13.29 13.12 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.915 2.41 . . . . 0.0 108.913 -169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -59.44 3.2 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 127.353 2.261 . . . . 0.0 106.076 174.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -31.34 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.736 -164.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -28.77 47.76 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 118.984 0.811 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.37 -28.51 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.61 -15.4 79.67 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -39.94 62.21 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 126.712 2.005 . . . . 0.0 110.311 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.85 -35.06 46.4 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.75 -26.66 50.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.148 1.379 . . . . 0.0 112.17 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -80.31 -32.68 37.94 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 118.762 0.71 . . . . 0.0 110.17 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.51 -30.59 49.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 123.999 0.92 . . . . 0.0 109.667 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -37.21 66.54 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.546 0.739 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.31 -32.56 73.32 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 127.028 2.131 . . . . 0.0 110.314 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.67 60.73 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.97 0.908 . . . . 0.0 111.781 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.44 -46.68 24.98 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.652 0 CA-C-O 117.14 -1.409 . . . . 0.0 111.948 -178.619 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.41 -31.2 71.25 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.847 1.259 . . . . 0.0 109.711 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -76.38 -50.52 13.99 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.326 1.45 . . . . 0.0 109.678 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.62 -20.48 21.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.039 2.535 . . . . 0.0 113.249 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.45 -40.46 50.48 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.626 1.17 . . . . 0.0 111.358 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -26.16 61.48 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 124.29 1.036 . . . . 0.0 109.351 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.94 -35.02 69.49 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.594 0.757 . . . . 0.0 110.166 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.99 -48.05 55.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.5 1.52 . . . . 0.0 109.271 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.18 -37.3 86.99 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.239 1.016 . . . . 0.0 113.083 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.62 44.02 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.283 1.033 . . . . 0.0 110.267 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.6 mtp -74.98 -14.38 60.62 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.753 0.821 . . . . 0.0 111.977 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.61 -51.74 57.32 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.965 1.306 . . . . 0.0 109.616 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.92 64.24 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.706 2.002 . . . . 0.0 113.385 170.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.73 -29.31 32.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 119.709 -1.87 . . . . 0.0 110.218 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -79.89 -40.17 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 C-N-CA 125.686 1.595 . . . . 0.0 108.662 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.5 ttm -84.53 -43.04 14.9 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.579 0.752 . . . . 0.0 111.431 -168.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.2 mtp -80.16 -28.59 38.81 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.28 -41.88 91.15 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.31 -44.12 92.56 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.673 1.189 . . . . 0.0 111.322 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.23 7.15 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.27 -28.54 58.99 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.68 -31.86 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.6 74.3 Favored Glycine 0 C--N 1.361 1.935 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.05 -74.01 0.07 Allowed 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.965 1.306 . . . . 0.0 109.312 164.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.55 69.79 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.762 1.625 . . . . 0.0 114.774 -161.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.7 mm -71.07 -45.43 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 124.869 1.267 . . . . 0.0 110.495 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.82 -41.18 29.1 Favored Glycine 0 CA--C 1.461 -3.314 0 CA-C-N 120.348 1.431 . . . . 0.0 114.494 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.02 -5.88 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 118.823 1.311 . . . . 0.0 110.323 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.95 -50.06 6.63 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.509 HG22 ' HZ2' ' A' ' 34' ' ' LYS . 98.8 mt -65.59 -71.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.042 0.937 . . . . 0.0 111.997 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.43 -30.96 71.82 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 129.425 3.09 . . . . 0.0 112.601 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.14 -19.13 47.68 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 119.113 0.87 . . . . 0.0 110.956 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.12 -36.29 9.09 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 118.329 1.064 . . . . 0.0 110.608 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HZ2' HG22 ' A' ' 30' ' ' ILE . 60.4 mttp -79.96 -20.42 45.63 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.208 1.403 . . . . 0.0 109.559 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -42.13 98.7 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.757 1.223 . . . . 0.0 111.188 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -10.81 59.7 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 123.353 0.661 . . . . 0.0 111.829 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -71.87 -36.8 70.2 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 120.185 -1.572 . . . . 0.0 109.268 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.22 -33.72 56.29 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.46 71.84 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.163 1.385 . . . . 0.0 113.066 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.76 -41.26 68.62 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.251 1.42 . . . . 0.0 112.636 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -75.92 -36.99 59.21 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.546 1.138 . . . . 0.0 111.453 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -84.44 176.42 3.74 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.97 155.41 52.96 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 CA-C-N 125.622 3.044 . . . . 0.0 109.542 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -87.09 54.3 3.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 169.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 tp -93.68 -75.8 0.49 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 125.498 1.519 . . . . 0.0 107.436 172.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.1 -54.26 2.08 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 115.567 -2.159 . . . . 0.0 108.885 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 43.76 1.02 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 CA-C-N 125.129 2.867 . . . . 0.0 110.498 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 tt -90.1 -46.55 8.4 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 152.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -34.75 65.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.999 1.719 . . . . 0.0 111.935 -175.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -42.96 64.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.922 0.868 . . . . 0.0 109.757 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -62.89 -37.61 87.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.236 2.214 . . . . 0.0 113.693 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 4.5 pt20 -66.42 -50.3 63.88 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.42 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -48.98 -28.93 4.25 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 126.704 2.002 . . . . 0.0 112.691 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.289 2.5 m-85 -77.09 -41.71 41.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 119.349 3.092 . . . . 0.0 119.349 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 pt -72.31 -23.24 21.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 CA-C-N 121.675 2.034 . . . . 0.0 110.357 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.85 -35.42 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 C-N-CA 131.438 3.895 . . . . 0.0 111.607 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 38.1 ttp -55.36 -34.76 64.56 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.858 0.863 . . . . 0.0 111.257 162.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -12.87 80.65 Favored Glycine 0 C--N 1.353 1.486 0 C-N-CA 124.042 0.829 . . . . 0.0 112.701 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.82 -17.75 46.4 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.147 0.979 . . . . 0.0 110.433 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.6 -24.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 124.314 1.046 . . . . 0.0 108.628 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -77.97 -13.3 59.93 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.903 0.881 . . . . 0.0 111.305 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.22 -19.48 29.92 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.994 1.318 . . . . 0.0 111.834 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.321 0.3 OUTLIER -50.16 -58.77 8.6 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.22 -5.71 12.83 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.006 2.47 . . . . 0.0 108.828 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.63 -54.33 6.81 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -30.45 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.636 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.66 -29.38 40.87 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 119.124 0.874 . . . . 0.0 111.028 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.8 t -82.66 -29.78 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.26 80.03 Favored Glycine 0 C--N 1.359 1.83 0 CA-C-N 118.89 0.768 . . . . 0.0 111.432 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.84 68.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.34 1.856 . . . . 0.0 110.988 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.03 -42.66 28.96 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.21 -36.62 83.53 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 127.402 2.281 . . . . 0.0 112.616 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -79.91 -33.02 40.16 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.014 0.126 . . . . 0.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.25 -30.25 45.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.876 0 C-N-CA 124.095 0.958 . . . . 0.0 109.742 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.2 ttt -72.93 -31.69 64.79 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.71 -0.619 . . . . 0.0 110.397 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -71.75 -30.76 65.94 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 126.178 1.791 . . . . 0.0 110.124 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.0 44.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.661 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.36 -64.06 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.631 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.111 -177.51 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' H1 ' ' H ' ' A' ' 4' ' ' LEU . 1.8 mpt? . . . . . 0 CA--C 1.481 -1.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.16 -30.54 67.72 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.69 1.196 . . . . 0.0 108.348 164.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.03 -49.05 40.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.424 1.49 . . . . 0.0 110.501 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.529 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 90.2 mt -56.35 -28.64 59.7 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.89 -44.11 50.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.524 1.13 . . . . 0.0 110.786 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -25.03 61.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.363 1.465 . . . . 0.0 109.947 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.06 -43.03 65.52 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.031 0.932 . . . . 0.0 110.201 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.29 -35.31 71.26 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.318 1.447 . . . . 0.0 109.879 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -67.79 -40.91 83.9 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.258 1.823 . . . . 0.0 112.684 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -48.73 60.3 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.221 1.409 . . . . 0.0 108.84 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.0 mtt -68.51 -16.43 63.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.425 1.09 . . . . 0.0 112.076 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.09 62.43 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.398 1.079 . . . . 0.0 109.929 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.44 70.49 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 125.113 1.365 . . . . 0.0 113.509 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.83 -20.5 35.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.719 1.145 . . . . 0.0 110.421 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.64 -26.54 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 125.408 1.483 . . . . 0.0 107.767 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 mmt -81.35 -68.76 0.66 Allowed 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.68 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -16.58 53.38 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.81 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.44 -51.79 40.11 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.46 -61.98 1.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.291 0.636 . . . . 0.0 110.925 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -41.47 39.68 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.88 66.96 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.46 -31.3 9.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.66 -32.05 74.1 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.32 -63.89 1.11 Allowed 'General case' 0 CA--C 1.493 -1.222 0 C-N-CA 125.014 1.325 . . . . 0.0 110.169 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.41 -41.67 4.34 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 126.879 2.072 . . . . 0.0 115.258 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.75 -53.68 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 125.592 1.557 . . . . 0.0 111.487 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.67 67.4 Favored Glycine 0 CA--C 1.49 -1.508 0 CA-C-N 120.143 1.338 . . . . 0.0 114.988 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.22 -27.89 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -48.56 10.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.74 -76.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 124.32 1.048 . . . . 0.0 112.484 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.17 -36.76 83.96 Favored 'General case' 0 CA--C 1.493 -1.236 0 C-N-CA 126.45 1.9 . . . . 0.0 113.385 -170.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -21.01 64.18 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.11 -34.92 31.89 Favored Glycine 0 C--N 1.362 2.003 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -73.33 -31.13 63.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 126.763 2.025 . . . . 0.0 109.654 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -38.17 84.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.729 1.211 . . . . 0.0 111.176 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.28 -13.97 60.14 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.923 -0.485 . . . . 0.0 111.946 175.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -67.12 -38.38 85.5 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 119.777 -1.827 . . . . 0.0 110.333 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.53 -36.4 58.88 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.21 62.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.241 1.417 . . . . 0.0 113.859 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.57 -53.69 12.94 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.679 1.591 . . . . 0.0 111.392 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -23.54 41.09 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.84 0.856 . . . . 0.0 111.16 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.23 167.33 31.22 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.97 153.35 63.39 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.342 2.028 . . . . 0.0 108.078 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.26 42.86 1.06 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.254 0.622 . . . . 0.0 109.951 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.1 tp -93.28 -79.42 0.4 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.096 0.958 . . . . 0.0 108.656 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.78 -53.53 2.43 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-O 115.783 -2.056 . . . . 0.0 111.223 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.15 3.68 7.63 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 125.262 2.915 . . . . 0.0 110.933 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.09 -28.6 48.72 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -36.92 66.17 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.19 0.996 . . . . 0.0 110.917 -177.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.67 66.74 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.326 -0.859 . . . . 0.0 112.201 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -62.91 -43.63 98.28 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.804 1.242 . . . . 0.0 112.809 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 9.3 pt20 -63.97 -49.07 73.94 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 124.179 0.992 . . . . 0.0 109.869 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -49.63 -31.97 11.99 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.928 1.691 . . . . 0.0 112.28 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 5.3 m-30 -77.76 -34.59 52.31 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 121.163 3.764 . . . . 0.0 121.163 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 pt -76.79 -23.79 15.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 CA-C-N 120.95 1.705 . . . . 0.0 109.197 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.3 t -75.13 -40.37 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 1 C-N-CA 131.827 4.051 . . . . 0.0 112.114 174.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.8 ttt -55.17 -31.47 61.39 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.164 1.386 . . . . 0.0 110.597 165.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.17 -22.54 37.73 Favored Glycine 0 N--CA 1.426 -2.003 0 C-N-CA 124.254 0.931 . . . . 0.0 114.041 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.15 -40.57 27.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.614 1.566 . . . . 0.0 107.678 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.85 -18.93 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 C-N-CA 126.901 2.081 . . . . 0.0 111.382 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.46 -41.59 69.22 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.718 1.207 . . . . 0.0 110.141 173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.32 21.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.641 0.776 . . . . 0.0 112.351 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -48.7 72.85 Favored Pre-proline 0 CA--C 1.507 -0.709 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -85.21 0.28 8.82 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 124.33 2.582 . . . . 0.0 107.366 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -93.92 -39.52 10.63 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.718 1.207 . . . . 0.0 108.093 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.64 -31.78 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -26.89 57.53 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 118.653 0.661 . . . . 0.0 111.297 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.84 -26.33 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.77 -18.44 79.64 Favored Glycine 0 C--N 1.357 1.741 0 CA-C-N 119.082 0.856 . . . . 0.0 111.156 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -35.56 30.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 128.537 2.735 . . . . 0.0 109.205 175.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.07 -28.72 63.86 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -79.09 -29.09 43.12 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.043 1.737 . . . . 0.0 109.878 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.17 -35.5 36.41 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 124.017 0.927 . . . . 0.0 111.772 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.36 -26.71 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 C-N-CA 125.405 1.482 . . . . 0.0 108.716 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.8 tpt -74.27 -28.8 61.37 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.43 -29.0 59.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.677 1.591 . . . . 0.0 109.576 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.68 -23.9 49.44 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.569 0.748 . . . . 0.0 111.284 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -91.29 -71.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.61 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.87 -36.76 85.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.282 1.433 . . . . 0.0 109.412 168.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -74.63 -47.83 29.87 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.392 1.477 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.33 -25.91 50.61 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 126.811 2.044 . . . . 0.0 113.221 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.58 -43.76 46.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.563 1.145 . . . . 0.0 110.71 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -67.02 -30.41 70.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 124.666 1.186 . . . . 0.0 110.185 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.85 -36.6 70.19 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.058 0.943 . . . . 0.0 110.957 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.53 -50.57 51.07 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 126.487 1.915 . . . . 0.0 108.165 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 mt -71.05 -28.42 64.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.931 1.292 . . . . 0.0 112.613 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -54.12 16.22 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.482 0.713 . . . . 0.0 110.823 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -18.74 62.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.075 0.55 . . . . 0.0 111.255 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.52 42.02 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.299 1.44 . . . . 0.0 110.077 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.53 63.87 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.802 2.041 . . . . 0.0 113.993 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.65 -22.92 24.41 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 119.197 0.908 . . . . 0.0 109.909 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.16 -30.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.9 mmt -76.87 -77.11 0.15 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 124.183 0.993 . . . . 0.0 108.439 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.2 ptt? -81.29 -5.5 57.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.69 -52.05 32.02 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 165.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.43 -58.09 7.43 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 111.788 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.57 -47.51 19.25 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -171.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 17' ' ' MET . . . -56.69 -24.81 51.6 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pp -81.89 -32.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 CA-C-N 119.086 0.857 . . . . 0.0 111.562 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.17 -35.44 88.51 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 125.081 1.324 . . . . 0.0 111.181 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.22 60.58 Favored 'General case' 0 CA--C 1.486 -1.497 0 C-N-CA 128.334 2.654 . . . . 0.0 109.992 166.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.04 90.65 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 123.712 0.805 . . . . 0.0 112.068 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.3 -21.97 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.41 -32.08 9.06 Favored Glycine 0 CA--C 1.472 -2.605 0 CA-C-N 119.922 1.237 . . . . 0.0 112.3 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' HA3' ' A' ' 58' ' ' GLY . 64.4 mt -58.9 -36.98 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.15 -51.19 7.0 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 96.0 mt -66.31 -66.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 C-N-CA 124.316 1.046 . . . . 0.0 112.515 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.69 -58.47 6.21 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 126.021 1.728 . . . . 0.0 109.404 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.19 -16.6 62.58 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 119.221 0.919 . . . . 0.0 113.963 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.74 -43.52 14.57 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 118.861 1.331 . . . . 0.0 110.491 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.14 -32.85 56.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.515 1.526 . . . . 0.0 111.082 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 124.971 1.309 . . . . 0.0 111.014 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tp -76.46 -21.05 56.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.499 0.59 . . . . 0.0 111.814 172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -80.75 2.9 24.18 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.701 -1.25 . . . . 0.0 110.385 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.9 -31.9 7.11 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 164.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.93 -22.22 53.63 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.688 1.195 . . . . 0.0 112.705 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.14 63.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.873 1.669 . . . . 0.0 112.484 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.15 -25.37 47.3 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.364 1.065 . . . . 0.0 110.58 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -83.7 176.73 3.5 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 125.673 1.589 . . . . 0.0 106.993 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.32 153.49 50.74 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 123.787 2.388 . . . . 0.0 107.274 165.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -87.38 38.65 0.83 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.237 0.615 . . . . 0.0 109.757 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.64 -73.06 0.58 Allowed 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.82 -55.74 1.88 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 115.603 -2.142 . . . . 0.0 110.778 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -85.3 9.45 4.12 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 125.637 3.049 . . . . 0.0 111.71 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.53 -30.68 47.16 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -33.63 58.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.332 1.053 . . . . 0.0 111.43 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.23 -31.7 66.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.115 -0.991 . . . . 0.0 110.316 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 mm-40 -60.39 -55.52 32.57 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.992 -1.004 . . . . 0.0 108.947 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -44.74 -36.47 3.19 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.423 1.489 . . . . 0.0 112.678 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.357 52.7 m-85 -78.03 -37.5 46.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 pt -75.55 -25.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.752 -1.217 . . . . 0.0 109.089 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.3 t -74.9 -38.59 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 130.042 3.337 . . . . 0.0 111.494 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.4 ttm -53.43 -33.67 54.91 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.707 1.603 . . . . 0.0 111.198 167.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 28' ' ' ILE . . . -76.4 -41.44 25.51 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 116.349 -0.387 . . . . 0.0 113.821 173.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.1 mt -66.02 -32.12 73.41 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 118.233 1.016 . . . . 0.0 112.371 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -77.1 -24.93 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 125.652 1.581 . . . . 0.0 111.246 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.51 -39.96 85.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.373 0.669 . . . . 0.0 111.161 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.11 24.89 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 123.654 0.782 . . . . 0.0 112.812 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -48.36 73.96 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.03 -7.75 9.18 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 CA-C-N 124.234 2.548 . . . . 0.0 108.485 -170.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -96.08 -29.97 13.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.068 1.747 . . . . 0.0 108.606 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.21 -30.73 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 108.926 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.23 -28.76 38.5 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.537 1.135 . . . . 0.0 110.898 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.58 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.42 -18.69 77.6 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.23 -37.07 54.0 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 126.928 2.091 . . . . 0.0 110.111 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.63 58.49 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.9 -28.41 49.82 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.783 1.633 . . . . 0.0 110.596 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.06 -35.28 37.29 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.177 0.591 . . . . 0.0 110.801 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.14 -32.14 46.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 124.124 0.969 . . . . 0.0 109.122 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.8 ttt -75.5 -28.46 59.16 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.422 0.689 . . . . 0.0 110.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.33 -35.92 82.45 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.437 1.895 . . . . 0.0 109.422 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.813 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -177.012 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.99 -44.44 92.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.682 1.193 . . . . 0.0 110.031 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -82.01 -31.2 31.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.438 1.095 . . . . 0.0 110.958 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.44 -34.01 66.42 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.327 1.851 . . . . 0.0 111.632 168.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.54 -38.21 59.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.655 1.182 . . . . 0.0 111.404 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.83 -25.87 63.96 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.353 1.061 . . . . 0.0 110.153 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.08 -41.41 67.35 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.234 0.614 . . . . 0.0 110.128 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.93 -22.87 45.16 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.79 -45.36 64.81 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.113 1.365 . . . . 0.0 110.228 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -45.38 70.15 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.906 1.683 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.54 -35.23 75.51 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 126.291 1.836 . . . . 0.0 111.361 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.58 -52.97 62.91 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.735 1.214 . . . . 0.0 111.544 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.99 -36.04 74.22 Favored 'General case' 0 CA--C 1.484 -1.595 0 C-N-CA 125.544 1.538 . . . . 0.0 114.189 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.1 -22.16 25.57 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 119.532 1.06 . . . . 0.0 109.819 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -83.96 -27.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 125.05 1.34 . . . . 0.0 107.524 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.8 ttm -82.13 -71.62 0.48 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.335 0.654 . . . . 0.0 109.931 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -5.62 58.02 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.445 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.6 -54.98 7.89 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.45 -53.25 51.21 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.669 1.188 . . . . 0.0 111.134 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -48.97 16.16 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.91 64.89 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.79 -33.85 12.33 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 CA-C-N 118.651 0.66 . . . . 0.0 111.7 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.84 -38.34 95.99 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 124.65 1.119 . . . . 0.0 110.504 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.02 -68.84 0.16 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 127.845 2.458 . . . . 0.0 108.736 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.61 64.95 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -163.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -71.05 -45.23 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 125.275 1.43 . . . . 0.0 110.826 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.94 43.56 Favored Glycine 0 CA--C 1.465 -3.037 0 CA-C-N 120.246 1.385 . . . . 0.0 115.026 -174.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.98 -10.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 118.423 1.111 . . . . 0.0 110.721 171.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -51.15 7.33 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.49 -71.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.065 0 C-N-CA 123.915 0.886 . . . . 0.0 111.892 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -38.18 89.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.782 2.833 . . . . 0.0 111.775 -174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.64 -20.34 71.53 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.88 -38.08 20.7 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.98 -18.88 49.18 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.387 1.475 . . . . 0.0 110.801 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -67.72 -42.03 82.58 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.93 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.0 -8.44 56.96 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-N 119.572 1.078 . . . . 0.0 111.567 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.26 -39.35 68.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 119.771 -1.831 . . . . 0.0 108.655 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -42.73 80.07 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 125.048 1.309 . . . . 0.0 111.082 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.48 62.91 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.206 1.402 . . . . 0.0 112.966 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.27 -52.29 19.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.991 1.316 . . . . 0.0 111.246 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -19.06 36.94 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 122.831 0.452 . . . . 0.0 111.434 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.11 169.53 18.13 Favored Pre-proline 0 C--N 1.355 0.825 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.86 148.54 52.09 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 CA-C-N 123.989 2.46 . . . . 0.0 107.798 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -87.31 43.92 1.14 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.521 0.728 . . . . 0.0 109.203 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.56 -77.75 0.44 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.411 1.085 . . . . 0.0 108.33 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.03 -56.92 1.54 Allowed Pre-proline 0 N--CA 1.435 -1.192 0 CA-C-O 116.118 -1.896 . . . . 0.0 110.916 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -81.69 7.31 5.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-N 124.75 2.732 . . . . 0.0 111.721 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.68 -34.75 34.5 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 121.229 1.832 . . . . 0.0 107.821 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -37.73 73.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.737 1.215 . . . . 0.0 107.831 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -22.85 60.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 121.074 -1.016 . . . . 0.0 112.688 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -63.01 -46.67 86.52 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 120.369 -1.457 . . . . 0.0 111.411 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 56' ' ' VAL . 10.1 pt20 -66.17 -50.76 62.81 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -43.74 -31.33 0.78 Allowed 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 128.275 2.63 . . . . 0.0 112.724 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.72 -53.27 8.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.17 -24.48 35.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 121.097 1.771 . . . . 0.0 111.515 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 52' ' ' GLN . 84.9 t -74.73 -40.21 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 C-N-CA 130.808 3.643 . . . . 0.0 112.031 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.1 ttm -55.0 -28.26 50.63 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.058 1.343 . . . . 0.0 111.602 167.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -7.4 52.97 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 122.045 -0.409 . . . . 0.0 113.946 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -81.65 -35.72 29.64 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.62 1.21 . . . . 0.0 109.066 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -77.11 -20.3 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 C-N-CA 126.361 1.864 . . . . 0.0 111.338 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.99 -44.13 70.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.923 1.689 . . . . 0.0 110.41 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.55 -25.73 24.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 123.785 0.834 . . . . 0.0 112.662 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.268 0.3 OUTLIER -49.47 -52.7 47.52 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.63 -9.6 8.96 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 CA-C-N 123.773 2.383 . . . . 0.0 108.332 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -87.01 -45.61 10.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 127.009 2.124 . . . . 0.0 105.817 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.18 -32.54 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 109.628 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.49 -27.77 51.98 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.794 0.838 . . . . 0.0 111.086 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.69 -28.84 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.03 -19.88 76.69 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 119.087 0.858 . . . . 0.0 111.611 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.29 -35.33 48.05 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 127.753 2.421 . . . . 0.0 109.892 172.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.17 -32.59 62.77 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 mt -78.48 -23.33 46.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.438 1.895 . . . . 0.0 110.796 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -43.81 21.39 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.506 1.122 . . . . 0.0 110.295 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.1 -25.99 18.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 125.761 1.624 . . . . 0.0 109.162 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.8 ttm -76.63 -31.02 57.12 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 109.66 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -33.95 73.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.132 1.373 . . . . 0.0 109.575 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.775 0 C-N-CA 123.766 0.826 . . . . 0.0 111.559 -174.676 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.03 -27.99 65.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.061 0.944 . . . . 0.0 110.135 170.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -90.49 -32.47 16.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.729 1.212 . . . . 0.0 109.829 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.53 -34.83 67.41 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.228 1.811 . . . . 0.0 111.498 165.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.91 -37.48 58.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.613 1.165 . . . . 0.0 110.709 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.9 mtt -65.95 -30.91 71.56 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.799 1.24 . . . . 0.0 110.295 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.02 -36.9 69.82 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.784 0.834 . . . . 0.0 110.835 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.81 -28.41 36.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.71 1.204 . . . . 0.0 110.487 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 mt -79.68 -27.11 40.81 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.024 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.4 -43.11 74.11 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.829 0.852 . . . . 0.0 109.193 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.3 -23.7 66.42 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.476 1.511 . . . . 0.0 111.708 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -55.59 17.1 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.732 1.213 . . . . 0.0 110.304 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.14 -17.37 26.28 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.247 1.819 . . . . 0.0 114.234 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.37 -29.94 24.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.174 -1.579 . . . . 0.0 109.533 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.5 t -80.51 -37.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 125.774 1.63 . . . . 0.0 108.642 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.2 mmt -80.45 -51.18 9.12 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.924 1.29 . . . . 0.0 111.247 -172.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 34.7 mtm -80.77 -24.96 38.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.5 -48.08 77.28 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.24 -45.07 89.78 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 125.264 1.426 . . . . 0.0 112.458 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.22 2.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.55 -22.72 35.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.81 -33.82 12.29 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 CA-C-N 120.13 1.332 . . . . 0.0 111.589 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.45 -36.71 93.52 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.64 -67.48 0.28 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.611 1.964 . . . . 0.0 108.926 164.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.79 68.53 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.465 1.506 . . . . 0.0 114.554 -160.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.0 -51.97 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 C-N-CA 124.753 1.221 . . . . 0.0 109.122 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -37.49 29.17 Favored Glycine 0 CA--C 1.465 -3.074 0 C-N-CA 119.186 -1.483 . . . . 0.0 115.542 -171.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA3' ' A' ' 58' ' ' GLY . 1.9 pt -76.4 -9.48 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 118.682 1.241 . . . . 0.0 110.885 173.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 -51.22 7.53 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 165.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.44 -71.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 123.882 0.873 . . . . 0.0 111.909 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -38.88 91.55 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 129.245 3.018 . . . . 0.0 111.792 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.33 -19.74 68.46 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -37.82 20.14 Favored Glycine 0 C--N 1.361 1.932 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.97 -17.31 53.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.485 1.514 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -34.22 71.57 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.66 0.784 . . . . 0.0 110.802 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.4 -19.45 58.1 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-O 121.141 0.496 . . . . 0.0 112.051 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -75.16 -20.37 59.4 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.0 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.38 -24.64 67.71 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 125.071 1.32 . . . . 0.0 110.844 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.02 -26.82 54.19 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 118.9 1.35 . . . . 0.0 111.604 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -57.16 4.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.707 1.603 . . . . 0.0 112.144 -167.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -28.06 39.6 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.128 0.571 . . . . 0.0 111.303 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 29.0 mm100 -84.13 173.46 7.27 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 125.586 1.554 . . . . 0.0 106.921 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 56.4 Cg_endo -71.61 150.74 57.49 Favored 'Trans proline' 0 CA--C 1.5 -1.215 0 CA-C-N 123.946 2.445 . . . . 0.0 107.437 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.27 35.88 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.608 0.763 . . . . 0.0 109.592 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.43 -70.96 0.68 Allowed 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.84 -59.47 1.17 Allowed Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-O 116.103 -1.903 . . . . 0.0 110.483 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.43 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 71.6 Cg_endo -82.3 1.86 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 124.796 2.749 . . . . 0.0 112.695 -167.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.02 -27.69 21.87 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 121.241 1.837 . . . . 0.0 107.819 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -37.47 69.95 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -72.2 -24.86 61.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.044 -1.035 . . . . 0.0 112.084 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.5 m -63.09 -46.17 88.66 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.761 1.224 . . . . 0.0 112.046 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.1 pt20 -64.47 -49.95 69.38 Favored 'General case' 0 CA--C 1.469 -2.151 0 C-N-CA 123.752 0.821 . . . . 0.0 109.542 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -45.86 -33.67 3.32 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 126.538 1.935 . . . . 0.0 112.604 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.314 4.0 m-85 -77.28 -39.09 49.34 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.0 pt -74.16 -24.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 CA-C-N 121.283 1.856 . . . . 0.0 109.98 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLN . 67.5 t -74.9 -37.26 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 C-N-CA 131.509 3.924 . . . . 0.0 111.441 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.13 -32.94 62.47 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.201 1.0 . . . . 0.0 111.563 162.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -86.86 -9.34 74.51 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 123.447 0.546 . . . . 0.0 112.989 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.79 -16.8 49.76 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.933 0.893 . . . . 0.0 109.655 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.5 -30.03 19.04 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.91 -16.15 58.45 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.908 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 65' ' ' MET . . . -86.09 -24.07 26.44 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 110.997 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -50.19 68.41 Favored Pre-proline 0 C--N 1.35 0.63 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.44 0.87 9.66 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.335 2.69 . . . . 0.0 108.913 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 62' ' ' ALA . 2.7 ttt -67.99 -59.08 3.54 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.05 -38.17 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.684 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.886 -164.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.24 63.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.376 0.535 . . . . 0.0 111.562 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.8 -27.76 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.01 77.66 Favored Glycine 0 C--N 1.36 1.891 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.841 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.33 48.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.046 2.938 . . . . 0.0 110.869 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.68 -33.69 66.89 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.47 -22.24 51.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.36 1.464 . . . . 0.0 112.233 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.26 -36.59 34.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.619 0.645 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.4 -30.38 48.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.881 1.272 . . . . 0.0 109.242 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.1 tpt -76.67 -34.68 58.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.235 0.614 . . . . 0.0 110.261 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.03 -36.69 82.33 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 126.746 2.018 . . . . 0.0 109.712 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.854 0 C-N-CA 124.007 0.923 . . . . 0.0 111.724 -174.855 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.482 -1.656 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -70.59 -26.77 63.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.192 0.997 . . . . 0.0 109.721 167.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -88.91 -34.95 16.76 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.625 1.17 . . . . 0.0 109.602 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 tp -56.49 -30.88 63.5 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.562 1.945 . . . . 0.0 112.005 166.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -78.32 -35.26 47.95 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.834 1.253 . . . . 0.0 111.261 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -26.26 61.74 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.18 0.992 . . . . 0.0 109.573 172.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.1 -34.95 69.04 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 123.944 0.898 . . . . 0.0 110.058 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -70.13 -46.95 63.69 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.987 1.715 . . . . 0.0 109.126 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.06 -39.67 95.42 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.791 1.636 . . . . 0.0 112.451 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -48.96 59.11 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.104 0.962 . . . . 0.0 110.432 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.3 mtp -71.37 -17.37 62.42 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.178 0.991 . . . . 0.0 111.997 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -51.7 57.32 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.606 1.163 . . . . 0.0 110.071 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -20.83 56.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.025 2.13 . . . . 0.0 114.372 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.35 -31.34 24.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 120.062 -1.649 . . . . 0.0 110.0 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -80.84 -41.61 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 125.774 1.629 . . . . 0.0 108.526 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -77.51 -45.23 26.13 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.952 1.301 . . . . 0.0 110.788 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.2 mtp -81.01 -20.31 42.05 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.925 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.2 -38.17 54.45 Favored Glycine 0 C--N 1.356 1.639 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.68 -55.91 22.54 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.085 1.354 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.71 -46.75 24.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -164.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' SD ' ' A' ' 65' ' ' MET . . . -56.23 -27.45 54.96 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.18 -32.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 121.158 -0.964 . . . . 0.0 108.788 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -32.35 78.34 Favored Glycine 0 C--N 1.36 1.9 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.94 -66.67 0.44 Allowed 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.201 1.4 . . . . 0.0 109.645 168.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.68 -32.61 59.64 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.626 1.97 . . . . 0.0 115.017 -166.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.4 mt -70.02 -50.63 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 C-N-CA 124.424 1.089 . . . . 0.0 109.553 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.06 -41.28 32.57 Favored Glycine 0 CA--C 1.463 -3.181 0 C-N-CA 119.672 -1.252 . . . . 0.0 115.202 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 pt -75.82 -9.27 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.814 1.307 . . . . 0.0 109.727 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.66 -48.92 8.39 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 166.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.72 -75.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.059 0 CA-C-N 117.942 0.871 . . . . 0.0 112.162 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.55 -41.79 92.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 C-N-CA 129.556 3.142 . . . . 0.0 112.447 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.39 -16.79 70.45 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.12 -44.08 12.39 Favored Glycine 0 C--N 1.363 2.033 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.72 -27.26 61.1 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.288 1.435 . . . . 0.0 110.611 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.21 82.38 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.581 1.152 . . . . 0.0 111.553 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -76.25 -17.78 59.32 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 118.792 0.724 . . . . 0.0 112.102 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.51 -27.74 64.41 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.964 -1.71 . . . . 0.0 109.997 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.32 -37.28 36.99 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.36 -17.1 61.32 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.451 1.501 . . . . 0.0 113.831 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.58 -54.92 8.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.901 1.681 . . . . 0.0 111.254 -171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.79 -20.09 36.47 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.906 0.882 . . . . 0.0 111.116 -175.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.99 168.46 22.7 Favored Pre-proline 0 C--N 1.355 0.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.93 149.12 58.89 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 CA-C-N 122.476 1.92 . . . . 0.0 107.666 170.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.43 40.21 0.91 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.467 0.707 . . . . 0.0 109.575 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -93.67 -76.52 0.47 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 124.696 1.199 . . . . 0.0 109.101 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.84 -49.84 3.38 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 115.408 -2.234 . . . . 0.0 111.087 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -82.94 11.03 3.39 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 125.932 3.154 . . . . 0.0 111.111 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.56 -29.29 41.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -30.34 56.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.611 0.765 . . . . 0.0 112.123 -177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.71 -40.98 65.72 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.2 -0.938 . . . . 0.0 111.765 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.8 m -63.1 -38.54 91.59 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.605 1.562 . . . . 0.0 113.603 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.3 pp0? -62.77 -54.35 40.43 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 124.355 1.062 . . . . 0.0 109.655 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -47.63 -31.25 4.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 126.908 2.083 . . . . 0.0 112.577 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.305 6.1 m-30 -77.19 -45.46 26.56 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -71.76 -18.97 20.02 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 121.306 1.866 . . . . 0.0 110.836 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 52' ' ' GLN . 61.5 t -75.0 -42.88 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 130.329 3.452 . . . . 0.0 110.732 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ttt -55.19 -27.14 43.82 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.784 1.234 . . . . 0.0 111.743 162.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.52 -24.25 65.78 Favored Glycine 0 C--N 1.356 1.67 0 C-N-CA 124.739 1.162 . . . . 0.0 112.337 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.0 -21.71 36.93 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.145 1.378 . . . . 0.0 110.426 174.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.62 -28.11 17.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 124.908 1.283 . . . . 0.0 108.319 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 3.0 t70 -77.78 -29.76 51.05 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.062 0.945 . . . . 0.0 110.089 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 -14.65 42.76 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.083 1.353 . . . . 0.0 112.31 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.277 0.3 OUTLIER -49.94 -52.21 54.41 Favored Pre-proline 0 C--N 1.354 0.782 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 172.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.33 -13.21 12.48 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 123.707 2.36 . . . . 0.0 108.33 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.57 -51.21 45.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.35 2.26 . . . . 0.0 107.281 175.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.91 -39.15 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.178 -164.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.22 58.66 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 119.316 0.962 . . . . 0.0 111.588 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.94 -30.41 10.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.76 -18.27 75.66 Favored Glycine 0 C--N 1.359 1.82 0 CA-C-N 118.842 0.747 . . . . 0.0 111.425 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -35.67 59.72 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 127.778 2.431 . . . . 0.0 110.66 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.66 -41.26 24.7 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.62 -39.23 84.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.772 1.629 . . . . 0.0 112.128 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -80.18 -30.71 38.81 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 117.935 0.334 . . . . 0.0 111.425 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -71.02 -33.05 50.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.306 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 60.4 mtt -75.33 -31.75 60.68 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.297 0.639 . . . . 0.0 110.364 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.391 1.876 . . . . 0.0 109.751 172.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.847 0 C-N-CA 124.512 1.125 . . . . 0.0 112.807 -174.724 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 CA--C 1.483 -1.597 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.14 -27.21 65.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.323 1.049 . . . . 0.0 110.196 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -87.13 -41.31 13.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.293 1.037 . . . . 0.0 108.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.8 tp -56.11 -29.98 61.41 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 127.277 2.231 . . . . 0.0 112.608 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -72.66 -46.85 51.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.461 1.104 . . . . 0.0 110.877 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.12 -25.08 62.43 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.338 1.455 . . . . 0.0 109.739 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.05 -43.87 64.23 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.754 0.821 . . . . 0.0 110.418 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.7 tp -72.11 -48.57 42.9 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 110.585 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.54 -41.89 92.56 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.241 1.016 . . . . 0.0 112.759 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -51.17 37.43 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.389 1.075 . . . . 0.0 110.328 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.71 -19.31 62.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.63 -53.27 43.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.35 1.06 . . . . 0.0 110.173 170.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.79 -15.31 11.7 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.624 2.369 . . . . 0.0 114.453 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.85 -26.45 18.49 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 120.783 -1.198 . . . . 0.0 109.756 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.62 -34.17 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.084 1.353 . . . . 0.0 108.362 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.8 mtt -76.73 -65.72 0.9 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.738 1.615 . . . . 0.0 108.779 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.0 mtm -80.75 -18.96 46.04 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.39 -43.28 97.02 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -64.76 0.8 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.145 0.978 . . . . 0.0 110.588 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.64 -52.69 8.59 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.97 44.41 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.1 -38.29 16.58 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 CA-C-N 120.291 1.405 . . . . 0.0 111.81 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.19 -38.52 95.76 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -54.51 -70.28 0.1 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.947 2.499 . . . . 0.0 109.32 164.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.63 72.44 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 114.15 -158.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.11 -47.23 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 C-N-CA 124.96 1.304 . . . . 0.0 109.908 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 -37.8 27.18 Favored Glycine 0 CA--C 1.465 -3.072 0 CA-C-N 120.218 1.372 . . . . 0.0 115.508 -173.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.1 -9.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 118.583 1.192 . . . . 0.0 110.408 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.32 -51.01 7.75 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 166.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.6 -71.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.994 0.918 . . . . 0.0 112.212 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.47 -39.85 92.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 129.211 3.004 . . . . 0.0 112.622 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.85 -19.1 66.22 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.97 -33.44 26.76 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -71.5 -35.7 70.84 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.716 2.006 . . . . 0.0 109.042 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.45 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 125.77 1.628 . . . . 0.0 111.429 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -16.46 59.72 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.73 -26.45 62.48 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 120.006 -1.684 . . . . 0.0 110.199 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.5 -28.9 46.13 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -31.03 56.13 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.82 -50.91 25.47 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.519 1.128 . . . . 0.0 113.915 -163.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.05 -38.43 66.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.231 1.012 . . . . 0.0 111.785 -170.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.79 172.27 9.28 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.73 157.89 57.23 Favored 'Trans proline' 0 CA--C 1.496 -1.375 0 CA-C-N 124.585 2.673 . . . . 0.0 109.891 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.12 38.19 0.8 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.407 1.083 . . . . 0.0 110.063 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.17 -74.06 0.54 Allowed 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 123.723 0.809 . . . . 0.0 109.002 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.79 -54.15 2.27 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 115.834 -2.031 . . . . 0.0 110.967 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.31 -5.26 14.22 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 125.122 2.865 . . . . 0.0 111.676 -168.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.97 -33.59 70.6 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 119.914 1.234 . . . . 0.0 108.742 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.33 68.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.52 1.128 . . . . 0.0 110.729 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -72.39 -28.88 63.28 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.713 -1.242 . . . . 0.0 112.95 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.6 m -62.95 -45.52 92.07 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.291 1.436 . . . . 0.0 112.381 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 56' ' ' VAL . 8.2 pt20 -59.81 -55.12 38.2 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 123.698 0.799 . . . . 0.0 109.331 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -43.86 -35.56 2.0 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 127.566 2.346 . . . . 0.0 112.904 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.27 8.0 m-85 -76.95 -49.46 15.47 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.9 pt -67.75 -24.51 30.96 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-N 121.023 1.738 . . . . 0.0 111.172 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 52' ' ' GLN . 94.5 t -74.78 -40.58 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 C-N-CA 130.058 3.343 . . . . 0.0 112.065 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 50.0 ttp -51.5 -35.86 42.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.95 0.9 . . . . 0.0 111.309 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -11.82 62.87 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.56 -22.44 37.8 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.394 1.097 . . . . 0.0 109.28 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.76 -30.35 18.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 126.82 2.048 . . . . 0.0 108.749 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 7.6 t70 -70.13 -41.3 74.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.849 1.259 . . . . 0.0 111.082 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.61 31.7 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.695 0.798 . . . . 0.0 111.917 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -49.23 71.74 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.67 -11.5 10.34 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 CA-C-N 124.418 2.614 . . . . 0.0 107.986 -168.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.528 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -91.15 -34.76 14.91 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 126.002 1.721 . . . . 0.0 108.021 -178.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.49 -23.46 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 C-N-CA 123.357 0.663 . . . . 0.0 111.219 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -31.68 24.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.552 1.141 . . . . 0.0 110.101 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.37 -26.37 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.04 -16.51 79.72 Favored Glycine 0 CA--C 1.489 -1.537 0 C-N-CA 124.855 1.217 . . . . 0.0 110.728 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.73 -32.66 31.48 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 125.942 1.697 . . . . 0.0 109.311 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.16 -46.64 15.32 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.64 -39.71 94.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 126.446 1.899 . . . . 0.0 112.83 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -79.89 -28.87 39.84 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.06 -32.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 CA-C-N 118.753 0.706 . . . . 0.0 109.216 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.2 mmt -78.04 -19.78 53.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.275 0.63 . . . . 0.0 111.441 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.13 -37.82 53.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.297 1.439 . . . . 0.0 108.537 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.867 -169.926 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.483 -1.634 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.74 -36.61 82.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.735 1.214 . . . . 0.0 110.278 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.276 1.031 . . . . 0.0 110.804 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.77 -35.84 69.13 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 112.026 164.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -36.19 44.77 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 124.661 1.184 . . . . 0.0 110.133 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.95 -33.19 75.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.704 1.602 . . . . 0.0 109.748 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.01 -35.44 69.42 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.349 1.06 . . . . 0.0 110.096 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.5 -49.4 33.19 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 125.432 1.493 . . . . 0.0 109.852 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.9 -34.17 71.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.843 0.857 . . . . 0.0 112.024 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.63 -50.48 62.85 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.511 0.596 . . . . 0.0 111.273 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.6 mtp -72.73 -13.48 61.34 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.066 0.546 . . . . 0.0 112.215 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.32 12.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.727 1.211 . . . . 0.0 110.035 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.61 54.78 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.735 2.014 . . . . 0.0 114.33 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 -22.72 20.26 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 120.711 -1.243 . . . . 0.0 110.48 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.94 -33.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.7 tpp -79.61 -62.71 1.6 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 109.806 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mtm -81.31 -23.56 37.78 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.35 99.16 Favored Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.19 -67.98 0.39 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.94 -57.05 4.0 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.01 -27.84 54.75 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -31.73 10.24 Favored 'Isoleucine or valine' 0 C--N 1.369 1.42 0 CA-C-N 120.481 1.491 . . . . 0.0 111.638 172.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.05 76.23 Favored Glycine 0 C--N 1.363 2.044 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -73.2 0.08 Allowed 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 127.912 2.485 . . . . 0.0 108.65 167.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.59 30.89 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -167.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.6 mm -71.0 -50.31 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.187 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 -40.48 49.16 Favored Glycine 0 CA--C 1.46 -3.36 0 CA-C-N 120.087 1.312 . . . . 0.0 114.585 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 pt -75.87 -8.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 119.026 1.413 . . . . 0.0 110.703 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.92 -50.51 7.75 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -65.41 -70.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.144 0 CA-C-N 117.617 0.709 . . . . 0.0 112.278 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.81 -46.02 91.34 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 129.398 3.079 . . . . 0.0 111.506 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.09 -19.49 79.78 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 119.435 1.016 . . . . 0.0 111.996 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.57 14.64 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -74.23 -27.0 60.57 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.01 1.724 . . . . 0.0 110.693 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -43.73 91.17 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.45 1.5 . . . . 0.0 112.091 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -10.64 59.56 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -70.14 -34.53 73.17 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.035 -1.666 . . . . 0.0 110.434 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.43 -35.19 48.33 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.15 62.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.652 1.581 . . . . 0.0 113.729 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -48.42 47.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.31 1.444 . . . . 0.0 113.594 -169.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -37.23 63.91 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.159 0.984 . . . . 0.0 111.324 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -84.47 174.67 5.51 Favored Pre-proline 0 C--N 1.353 0.757 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.98 153.5 57.95 Favored 'Trans proline' 0 CA--C 1.5 -1.2 0 CA-C-N 125.435 2.977 . . . . 0.0 109.158 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -87.25 44.43 1.18 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.095 0.958 . . . . 0.0 108.551 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -93.77 -75.47 0.5 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 124.713 1.205 . . . . 0.0 108.255 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.84 -54.04 2.27 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 115.777 -2.058 . . . . 0.0 111.116 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.05 -1.75 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 CA-C-N 125.24 2.907 . . . . 0.0 111.429 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 tp -77.98 -26.85 48.94 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 120.049 1.295 . . . . 0.0 108.86 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.16 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.87 0.868 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.258 0.8 OUTLIER -72.41 -27.65 62.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 120.65 -1.281 . . . . 0.0 112.984 173.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -62.9 -44.52 95.88 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 112.962 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.4 pt20 -59.28 -51.11 71.35 Favored 'General case' 0 CA--C 1.474 -1.959 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.44 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -41.89 -37.66 1.35 Allowed 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.853 2.461 . . . . 0.0 113.566 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.12 -46.26 24.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.81 -21.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 120.889 1.677 . . . . 0.0 110.924 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 52' ' ' GLN . 73.9 t -75.02 -40.67 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 C-N-CA 130.9 3.68 . . . . 0.0 112.019 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.8 ttp -53.17 -31.83 44.73 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.387 1.075 . . . . 0.0 111.544 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.04 -3.92 51.33 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.186 0.435 . . . . 0.0 114.186 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.87 -38.05 25.98 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.5 -21.17 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 127.264 2.226 . . . . 0.0 110.289 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.05 -42.36 72.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.963 1.705 . . . . 0.0 110.628 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.48 -20.67 27.74 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.408 1.083 . . . . 0.0 112.729 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.276 0.3 OUTLIER -49.62 -52.27 52.06 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.45 -5.37 9.23 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 CA-C-N 123.748 2.374 . . . . 0.0 107.82 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.4 mmt -92.48 -41.27 10.38 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 126.701 2.0 . . . . 0.0 106.184 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -29.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 C-N-CA 124.392 1.077 . . . . 0.0 109.848 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.87 -29.88 56.02 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 124.031 0.932 . . . . 0.0 111.584 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.04 -31.88 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.06 -18.71 80.14 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.324 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -36.88 38.47 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 127.964 2.506 . . . . 0.0 110.559 174.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.86 -38.84 85.62 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.16 -23.31 61.27 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.544 1.538 . . . . 0.0 111.716 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -79.99 -35.21 37.81 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.847 0.859 . . . . 0.0 110.68 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.64 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 124.293 1.037 . . . . 0.0 109.538 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.4 mtp -77.96 -25.48 48.24 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.627 0.771 . . . . 0.0 111.268 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -36.99 78.54 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.95 1.7 . . . . 0.0 108.516 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.818 0 C-N-CA 124.322 1.049 . . . . 0.0 111.556 -174.591 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.34 -41.27 98.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.091 1.356 . . . . 0.0 110.074 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -78.26 -44.6 25.07 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.945 1.298 . . . . 0.0 110.631 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.63 -23.7 43.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.105 2.162 . . . . 0.0 113.029 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.97 -43.85 42.63 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.302 1.041 . . . . 0.0 110.945 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.2 mtm -69.57 -27.22 64.94 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.88 1.272 . . . . 0.0 110.219 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.86 -37.03 70.28 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.691 0.797 . . . . 0.0 110.131 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.9 tp -77.81 -31.72 51.9 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.233 1.413 . . . . 0.0 110.128 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.08 -45.08 82.52 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 0.0 111.256 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -69.34 -41.7 76.29 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.467 0.707 . . . . 0.0 111.637 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.9 ttm -61.9 -32.79 73.2 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.099 1.36 . . . . 0.0 111.149 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.54 -60.17 3.91 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.194 1.397 . . . . 0.0 110.786 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.01 58.69 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.718 1.607 . . . . 0.0 114.416 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.34 -33.28 18.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.469 -1.394 . . . . 0.0 110.3 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.11 -33.76 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 125.312 1.445 . . . . 0.0 108.393 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.53 -53.23 6.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.576 1.15 . . . . 0.0 110.041 -170.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.1 mtm -80.65 -23.69 39.5 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.92 90.55 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.36 -51.61 62.45 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.966 1.307 . . . . 0.0 112.29 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.04 -50.05 13.99 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -170.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.15 57.77 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.87 -32.77 11.46 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 CA-C-N 119.156 0.889 . . . . 0.0 111.928 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.84 91.49 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.45 -53.16 61.26 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 128.752 2.821 . . . . 0.0 110.831 165.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.62 82.07 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.906 0.882 . . . . 0.0 113.194 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.01 -37.61 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 C-N-CA 126.183 1.793 . . . . 0.0 110.052 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -33.71 32.54 Favored Glycine 0 CA--C 1.478 -2.227 0 CA-C-N 119.875 1.216 . . . . 0.0 113.682 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.476 HD11 ' HA3' ' A' ' 58' ' ' GLY . 21.1 mt -62.6 -30.28 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.58 9.11 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.21 -73.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.139 0 C-N-CA 123.773 0.829 . . . . 0.0 112.543 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.68 -45.52 82.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.964 2.506 . . . . 0.0 111.335 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.27 -17.03 80.27 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.29 -36.56 30.48 Favored Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -74.98 -35.47 62.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.528 1.931 . . . . 0.0 108.883 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -34.66 76.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.657 1.183 . . . . 0.0 111.218 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -76.3 -13.43 60.15 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 122.89 0.476 . . . . 0.0 112.149 175.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.53 -39.59 85.06 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 119.902 -1.748 . . . . 0.0 109.803 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.92 -26.77 66.01 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.9 59.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.924 1.289 . . . . 0.0 112.948 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.23 8.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.521 1.528 . . . . 0.0 111.639 -171.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -29.55 51.4 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 111.205 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -84.04 167.44 27.78 Favored Pre-proline 0 N--CA 1.441 -0.894 0 C-N-CA 125.193 1.397 . . . . 0.0 107.277 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.06 155.01 62.32 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 CA-C-N 123.538 2.299 . . . . 0.0 108.275 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.11 42.03 1.01 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.33 0.652 . . . . 0.0 110.066 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -93.5 -79.16 0.41 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.992 0.917 . . . . 0.0 108.7 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.79 -52.48 2.7 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-O 115.615 -2.136 . . . . 0.0 111.864 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.68 2.79 8.3 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 125.57 3.025 . . . . 0.0 110.858 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 -27.01 35.25 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 172.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -72.04 -36.48 69.64 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.798 0.839 . . . . 0.0 110.837 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -32.56 66.59 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.179 -0.951 . . . . 0.0 112.131 173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -62.79 -42.53 99.75 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.92 1.288 . . . . 0.0 113.109 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 11.6 pt20 -63.87 -45.05 91.14 Favored 'General case' 0 CA--C 1.464 -2.347 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -52.76 -30.8 34.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.889 1.276 . . . . 0.0 112.297 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 10.3 m-30 -78.15 -28.55 48.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 121.364 3.839 . . . . 0.0 121.364 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.79 -29.12 25.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 121.251 1.841 . . . . 0.0 108.597 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.81 -35.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 1 C-N-CA 132.645 4.378 . . . . 0.0 111.794 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.4 ttt -55.05 -33.21 62.51 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.724 1.21 . . . . 0.0 110.919 164.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -76.48 -38.26 33.53 Favored Glycine 0 N--CA 1.433 -1.526 0 O-C-N 121.888 -0.508 . . . . 0.0 114.045 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.5 -35.07 76.99 Favored 'General case' 0 CA--C 1.508 -0.673 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.08 -25.73 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 C-N-CA 126.267 1.827 . . . . 0.0 110.93 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 19.0 t70 -71.53 -37.04 71.19 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.631 0.772 . . . . 0.0 111.681 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.71 -20.81 27.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.484 1.113 . . . . 0.0 112.882 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -45.9 78.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.14 -7.49 8.05 Favored 'Trans proline' 0 CA--C 1.494 -1.479 0 CA-C-N 124.189 2.532 . . . . 0.0 107.318 -168.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -91.4 -40.43 11.44 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 125.54 1.536 . . . . 0.0 107.77 -176.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 tp -77.74 -30.58 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.15 57.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.162 0.985 . . . . 0.0 111.313 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -77.96 -28.67 15.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 CA-C-N 118.298 0.499 . . . . 0.0 109.947 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.94 -21.92 70.08 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -34.9 62.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.604 2.362 . . . . 0.0 110.462 170.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.43 -35.61 63.19 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.2 mt -73.74 -25.86 60.39 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 110.876 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -39.88 29.11 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.671 1.188 . . . . 0.0 110.814 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 -26.15 20.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.891 1.277 . . . . 0.0 109.247 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.18 57.48 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.61 0.764 . . . . 0.0 109.344 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.57 -33.68 69.28 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.798 1.239 . . . . 0.0 109.425 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 0.798 0 C-N-CA 123.733 0.813 . . . . 0.0 111.96 -173.958 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.478 -1.801 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -36.62 82.76 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.35 1.06 . . . . 0.0 108.345 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.04 -48.85 16.75 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 125.254 1.422 . . . . 0.0 111.672 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.264 1.8 pp -56.78 -27.95 60.52 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.973 1.309 . . . . 0.0 113.099 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.88 -45.22 44.36 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.96 1.304 . . . . 0.0 110.837 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 81.8 mtp -64.07 -31.58 72.83 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.36 1.464 . . . . 0.0 110.282 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.98 -38.71 69.67 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.097 0.959 . . . . 0.0 110.701 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.46 -36.14 58.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 125.136 1.375 . . . . 0.0 110.181 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.31 -27.29 42.16 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.87 0.868 . . . . 0.0 111.852 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.41 -44.76 70.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 123.14 0.576 . . . . 0.0 109.913 168.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm -63.72 -25.78 68.35 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 111.712 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -59.14 4.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.061 1.345 . . . . 0.0 110.503 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.39 -9.61 2.5 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 126.428 1.891 . . . . 0.0 114.742 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.03 -28.26 14.71 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 120.865 -1.147 . . . . 0.0 109.153 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.24 -27.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.709 0.804 . . . . 0.0 109.334 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -59.99 2.56 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.638 1.575 . . . . 0.0 108.701 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.6 mtm -80.9 -22.81 39.44 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.921 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.8 -40.84 75.03 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.35 -51.03 65.37 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.105 0.962 . . . . 0.0 111.715 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.02 -51.86 10.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.25 -25.69 48.74 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.88 -33.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 119.828 1.195 . . . . 0.0 110.907 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.8 -38.27 95.68 Favored Glycine 0 C--N 1.355 1.619 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -56.95 -64.64 0.81 Allowed 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.266 1.826 . . . . 0.0 109.659 165.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.04 73.31 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.712 1.205 . . . . 0.0 113.964 -159.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.81 -47.11 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 C-N-CA 124.908 1.283 . . . . 0.0 109.54 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.9 27.76 Favored Glycine 0 CA--C 1.462 -3.235 0 C-N-CA 119.235 -1.46 . . . . 0.0 115.455 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -73.68 -10.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 118.924 1.362 . . . . 0.0 109.842 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.6 -50.27 8.25 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 167.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.73 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 123.493 0.717 . . . . 0.0 112.42 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.69 -44.29 86.64 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 129.417 3.087 . . . . 0.0 112.138 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.56 -18.33 68.73 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.7 -38.45 20.29 Favored Glycine 0 C--N 1.364 2.115 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 125.939 1.695 . . . . 0.0 109.925 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -39.3 85.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 124.456 1.102 . . . . 0.0 111.604 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -10.18 59.21 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.71 -43.04 80.97 Favored 'General case' 0 C--N 1.362 1.114 0 O-C-N 119.995 -1.691 . . . . 0.0 109.625 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.67 -27.11 65.76 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.04 60.77 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.662 1.185 . . . . 0.0 112.914 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.63 -56.4 5.91 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 125.198 1.399 . . . . 0.0 111.559 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -28.32 40.25 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 111.467 -173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -84.02 164.78 42.47 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.94 155.2 62.48 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 CA-C-N 123.294 2.212 . . . . 0.0 108.38 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -87.21 45.02 1.22 Allowed 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.734 0.647 . . . . 0.0 109.455 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -79.19 0.41 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.058 0.943 . . . . 0.0 108.718 173.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.31 -54.26 2.5 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-O 115.766 -2.064 . . . . 0.0 111.587 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.66 0.19 10.21 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 CA-C-N 125.32 2.936 . . . . 0.0 111.001 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.6 -35.71 57.95 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -42.2 84.2 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.744 1.218 . . . . 0.0 110.956 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.01 -31.6 66.36 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.859 -1.15 . . . . 0.0 112.596 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -62.87 -45.09 94.2 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 124.735 1.214 . . . . 0.0 112.738 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 56' ' ' VAL . 11.7 pt20 -58.94 -54.29 48.8 Favored 'General case' 0 CA--C 1.461 -2.469 0 CA-C-O 116.819 -1.562 . . . . 0.0 109.322 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -44.91 -38.41 4.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 128.572 2.749 . . . . 0.0 113.039 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -76.95 -35.78 57.0 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -75.83 -29.09 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 C-N-CA 126.224 1.809 . . . . 0.0 109.382 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -75.15 -35.97 36.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 C-N-CA 125.307 1.443 . . . . 0.0 110.043 175.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.04 -33.86 63.03 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.979 0.911 . . . . 0.0 111.31 165.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.14 -20.54 62.6 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 124.053 0.835 . . . . 0.0 112.709 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -82.12 -26.95 33.1 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.644 1.978 . . . . 0.0 109.502 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.4 -27.24 17.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 125.731 1.612 . . . . 0.0 108.621 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.9 t70 -74.84 -24.92 58.68 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.034 0.933 . . . . 0.0 110.461 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.56 31.83 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.844 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.348 0.3 OUTLIER -50.31 -58.97 8.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 171.992 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' HG22 ' A' ' 63' ' ' ILE . 74.4 Cg_endo -79.82 -13.29 13.12 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.915 2.41 . . . . 0.0 108.913 -169.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -59.44 3.2 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 127.353 2.261 . . . . 0.0 106.076 174.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -31.34 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.736 -164.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -28.77 47.76 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 118.984 0.811 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.37 -28.51 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.61 -15.4 79.67 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -39.94 62.21 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 126.712 2.005 . . . . 0.0 110.311 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.85 -35.06 46.4 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.75 -26.66 50.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.148 1.379 . . . . 0.0 112.17 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -80.31 -32.68 37.94 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 118.762 0.71 . . . . 0.0 110.17 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.51 -30.59 49.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 123.999 0.92 . . . . 0.0 109.667 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -37.21 66.54 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.546 0.739 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.31 -32.56 73.32 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 127.028 2.131 . . . . 0.0 110.314 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.871 0 C-N-CA 123.97 0.908 . . . . 0.0 111.781 -176.633 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.41 -31.2 71.25 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.847 1.259 . . . . 0.0 109.711 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -76.38 -50.52 13.99 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.326 1.45 . . . . 0.0 109.678 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.62 -20.48 21.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.039 2.535 . . . . 0.0 113.249 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.45 -40.46 50.48 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.626 1.17 . . . . 0.0 111.358 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -26.16 61.48 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 124.29 1.036 . . . . 0.0 109.351 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.94 -35.02 69.49 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.594 0.757 . . . . 0.0 110.166 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.99 -48.05 55.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.5 1.52 . . . . 0.0 109.271 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.18 -37.3 86.99 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.239 1.016 . . . . 0.0 113.083 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.62 44.02 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.283 1.033 . . . . 0.0 110.267 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.6 mtp -74.98 -14.38 60.62 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.753 0.821 . . . . 0.0 111.977 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.61 -51.74 57.32 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.965 1.306 . . . . 0.0 109.616 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.92 64.24 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.706 2.002 . . . . 0.0 113.385 170.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.73 -29.31 32.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 119.709 -1.87 . . . . 0.0 110.218 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -79.89 -40.17 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 C-N-CA 125.686 1.595 . . . . 0.0 108.662 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.5 ttm -84.53 -43.04 14.9 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.579 0.752 . . . . 0.0 111.431 -168.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.2 mtp -80.16 -28.59 38.81 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.28 -41.88 91.15 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.31 -44.12 92.56 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.673 1.189 . . . . 0.0 111.322 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.23 7.15 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.27 -28.54 58.99 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.68 -31.86 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.6 74.3 Favored Glycine 0 C--N 1.361 1.935 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -58.05 -74.01 0.07 Allowed 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.965 1.306 . . . . 0.0 109.312 164.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.55 69.79 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.762 1.625 . . . . 0.0 114.774 -161.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.7 mm -71.07 -45.43 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 124.869 1.267 . . . . 0.0 110.495 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.82 -41.18 29.1 Favored Glycine 0 CA--C 1.461 -3.314 0 CA-C-N 120.348 1.431 . . . . 0.0 114.494 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.02 -5.88 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 118.823 1.311 . . . . 0.0 110.323 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.95 -50.06 6.63 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -65.59 -71.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.042 0.937 . . . . 0.0 111.997 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.43 -30.96 71.82 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 129.425 3.09 . . . . 0.0 112.601 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.14 -19.13 47.68 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 119.113 0.87 . . . . 0.0 110.956 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.12 -36.29 9.09 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 118.329 1.064 . . . . 0.0 110.608 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.96 -20.42 45.63 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.208 1.403 . . . . 0.0 109.559 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -42.13 98.7 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.757 1.223 . . . . 0.0 111.188 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -10.81 59.7 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 123.353 0.661 . . . . 0.0 111.829 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -71.87 -36.8 70.2 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 120.185 -1.572 . . . . 0.0 109.268 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.22 -33.72 56.29 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.46 71.84 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.163 1.385 . . . . 0.0 113.066 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.76 -41.26 68.62 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.251 1.42 . . . . 0.0 112.636 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -75.92 -36.99 59.21 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.546 1.138 . . . . 0.0 111.453 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -84.44 176.42 3.74 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.97 155.41 52.96 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 CA-C-N 125.622 3.044 . . . . 0.0 109.542 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -87.09 54.3 3.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 169.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 tp -93.68 -75.8 0.49 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 125.498 1.519 . . . . 0.0 107.436 172.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.1 -54.26 2.08 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 115.567 -2.159 . . . . 0.0 108.885 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 43.76 1.02 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 CA-C-N 125.129 2.867 . . . . 0.0 110.498 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 tt -90.1 -46.55 8.4 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 152.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -34.75 65.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.999 1.719 . . . . 0.0 111.935 -175.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -42.96 64.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.922 0.868 . . . . 0.0 109.757 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -62.89 -37.61 87.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.236 2.214 . . . . 0.0 113.693 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 4.5 pt20 -66.42 -50.3 63.88 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.42 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -48.98 -28.93 4.25 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 126.704 2.002 . . . . 0.0 112.691 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.289 2.5 m-85 -77.09 -41.71 41.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 119.349 3.092 . . . . 0.0 119.349 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 pt -72.31 -23.24 21.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 CA-C-N 121.675 2.034 . . . . 0.0 110.357 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 52' ' ' GLN . 64.2 t -74.85 -35.42 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 C-N-CA 131.438 3.895 . . . . 0.0 111.607 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 38.1 ttp -55.36 -34.76 64.56 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.858 0.863 . . . . 0.0 111.257 162.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -12.87 80.65 Favored Glycine 0 C--N 1.353 1.486 0 C-N-CA 124.042 0.829 . . . . 0.0 112.701 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.82 -17.75 46.4 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.147 0.979 . . . . 0.0 110.433 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.6 -24.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 124.314 1.046 . . . . 0.0 108.628 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.1 t70 -77.97 -13.3 59.93 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.903 0.881 . . . . 0.0 111.305 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.22 -19.48 29.92 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.994 1.318 . . . . 0.0 111.834 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.321 0.3 OUTLIER -50.16 -58.77 8.6 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.22 -5.71 12.83 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.006 2.47 . . . . 0.0 108.828 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.63 -54.33 6.81 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -30.45 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.636 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.66 -29.38 40.87 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 119.124 0.874 . . . . 0.0 111.028 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.8 t -82.66 -29.78 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.26 80.03 Favored Glycine 0 C--N 1.359 1.83 0 CA-C-N 118.89 0.768 . . . . 0.0 111.432 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.84 68.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.34 1.856 . . . . 0.0 110.988 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.03 -42.66 28.96 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.21 -36.62 83.53 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 127.402 2.281 . . . . 0.0 112.616 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -79.91 -33.02 40.16 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.014 0.126 . . . . 0.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.25 -30.25 45.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.876 0 C-N-CA 124.095 0.958 . . . . 0.0 109.742 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.2 ttt -72.93 -31.69 64.79 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.71 -0.619 . . . . 0.0 110.397 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -71.75 -30.76 65.94 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 126.178 1.791 . . . . 0.0 110.124 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.661 -174.251 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.481 -1.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.16 -30.54 67.72 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.69 1.196 . . . . 0.0 108.348 164.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.03 -49.05 40.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.424 1.49 . . . . 0.0 110.501 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.35 -28.64 59.7 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.89 -44.11 50.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.524 1.13 . . . . 0.0 110.786 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -25.03 61.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.363 1.465 . . . . 0.0 109.947 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.06 -43.03 65.52 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.031 0.932 . . . . 0.0 110.201 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.29 -35.31 71.26 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.318 1.447 . . . . 0.0 109.879 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -67.79 -40.91 83.9 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.258 1.823 . . . . 0.0 112.684 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -48.73 60.3 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.221 1.409 . . . . 0.0 108.84 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.0 mtt -68.51 -16.43 63.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.425 1.09 . . . . 0.0 112.076 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.09 62.43 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.398 1.079 . . . . 0.0 109.929 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.44 70.49 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 125.113 1.365 . . . . 0.0 113.509 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.83 -20.5 35.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.719 1.145 . . . . 0.0 110.421 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.64 -26.54 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 125.408 1.483 . . . . 0.0 107.767 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 mmt -81.35 -68.76 0.66 Allowed 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.68 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -16.58 53.38 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.81 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.44 -51.79 40.11 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.46 -61.98 1.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.291 0.636 . . . . 0.0 110.925 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.577 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.43 -41.47 39.68 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -161.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.88 66.96 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.46 -31.3 9.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.66 -32.05 74.1 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.32 -63.89 1.11 Allowed 'General case' 0 CA--C 1.493 -1.222 0 C-N-CA 125.014 1.325 . . . . 0.0 110.169 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.41 -41.67 4.34 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 126.879 2.072 . . . . 0.0 115.258 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.75 -53.68 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 125.592 1.557 . . . . 0.0 111.487 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.67 67.4 Favored Glycine 0 CA--C 1.49 -1.508 0 CA-C-N 120.143 1.338 . . . . 0.0 114.988 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.445 HG12 ' HA3' ' A' ' 58' ' ' GLY . 8.4 mt -74.22 -27.89 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -48.56 10.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.74 -76.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 124.32 1.048 . . . . 0.0 112.484 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.17 -36.76 83.96 Favored 'General case' 0 CA--C 1.493 -1.236 0 C-N-CA 126.45 1.9 . . . . 0.0 113.385 -170.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -21.01 64.18 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.11 -34.92 31.89 Favored Glycine 0 C--N 1.362 2.003 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -73.33 -31.13 63.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 126.763 2.025 . . . . 0.0 109.654 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -38.17 84.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.729 1.211 . . . . 0.0 111.176 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.28 -13.97 60.14 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.923 -0.485 . . . . 0.0 111.946 175.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -67.12 -38.38 85.5 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 119.777 -1.827 . . . . 0.0 110.333 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.53 -36.4 58.88 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.21 62.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.241 1.417 . . . . 0.0 113.859 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.57 -53.69 12.94 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.679 1.591 . . . . 0.0 111.392 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -23.54 41.09 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.84 0.856 . . . . 0.0 111.16 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.23 167.33 31.22 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.97 153.35 63.39 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.342 2.028 . . . . 0.0 108.078 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.26 42.86 1.06 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.254 0.622 . . . . 0.0 109.951 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.1 tp -93.28 -79.42 0.4 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.096 0.958 . . . . 0.0 108.656 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.78 -53.53 2.43 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-O 115.783 -2.056 . . . . 0.0 111.223 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.15 3.68 7.63 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 125.262 2.915 . . . . 0.0 110.933 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.09 -28.6 48.72 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -36.92 66.17 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.19 0.996 . . . . 0.0 110.917 -177.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.67 66.74 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.326 -0.859 . . . . 0.0 112.201 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -62.91 -43.63 98.28 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.804 1.242 . . . . 0.0 112.809 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 9.3 pt20 -63.97 -49.07 73.94 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 124.179 0.992 . . . . 0.0 109.869 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -49.63 -31.97 11.99 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.928 1.691 . . . . 0.0 112.28 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 5.3 m-30 -77.76 -34.59 52.31 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 121.163 3.764 . . . . 0.0 121.163 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 pt -76.79 -23.79 15.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 CA-C-N 120.95 1.705 . . . . 0.0 109.197 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 52' ' ' GLN . 76.3 t -75.13 -40.37 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 1 C-N-CA 131.827 4.051 . . . . 0.0 112.114 174.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.8 ttt -55.17 -31.47 61.39 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.164 1.386 . . . . 0.0 110.597 165.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 28' ' ' ILE . . . -89.17 -22.54 37.73 Favored Glycine 0 N--CA 1.426 -2.003 0 C-N-CA 124.254 0.931 . . . . 0.0 114.041 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.15 -40.57 27.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.614 1.566 . . . . 0.0 107.678 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.85 -18.93 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 C-N-CA 126.901 2.081 . . . . 0.0 111.382 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.46 -41.59 69.22 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.718 1.207 . . . . 0.0 110.141 173.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.32 21.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.641 0.776 . . . . 0.0 112.351 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -48.7 72.85 Favored Pre-proline 0 CA--C 1.507 -0.709 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -85.21 0.28 8.82 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 124.33 2.582 . . . . 0.0 107.366 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -93.92 -39.52 10.63 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.718 1.207 . . . . 0.0 108.093 -177.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.64 -31.78 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -26.89 57.53 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 118.653 0.661 . . . . 0.0 111.297 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.84 -26.33 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.77 -18.44 79.64 Favored Glycine 0 C--N 1.357 1.741 0 CA-C-N 119.082 0.856 . . . . 0.0 111.156 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -35.56 30.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 128.537 2.735 . . . . 0.0 109.205 175.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.07 -28.72 63.86 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -79.09 -29.09 43.12 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.043 1.737 . . . . 0.0 109.878 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.17 -35.5 36.41 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 124.017 0.927 . . . . 0.0 111.772 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.36 -26.71 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 C-N-CA 125.405 1.482 . . . . 0.0 108.716 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.8 tpt -74.27 -28.8 61.37 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.43 -29.0 59.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.677 1.591 . . . . 0.0 109.576 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 123.569 0.748 . . . . 0.0 111.284 -177.852 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.87 -36.76 85.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.282 1.433 . . . . 0.0 109.412 168.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -74.63 -47.83 29.87 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.392 1.477 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.33 -25.91 50.61 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 126.811 2.044 . . . . 0.0 113.221 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.58 -43.76 46.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.563 1.145 . . . . 0.0 110.71 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -67.02 -30.41 70.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 124.666 1.186 . . . . 0.0 110.185 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.85 -36.6 70.19 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.058 0.943 . . . . 0.0 110.957 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.53 -50.57 51.07 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 126.487 1.915 . . . . 0.0 108.165 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 mt -71.05 -28.42 64.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.931 1.292 . . . . 0.0 112.613 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -54.12 16.22 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.482 0.713 . . . . 0.0 110.823 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -18.74 62.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.075 0.55 . . . . 0.0 111.255 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.52 42.02 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.299 1.44 . . . . 0.0 110.077 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.53 63.87 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.802 2.041 . . . . 0.0 113.993 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.65 -22.92 24.41 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 119.197 0.908 . . . . 0.0 109.909 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.16 -30.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.9 mmt -76.87 -77.11 0.15 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 124.183 0.993 . . . . 0.0 108.439 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.2 ptt? -81.29 -5.5 57.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.69 -52.05 32.02 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 165.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.43 -58.09 7.43 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 111.788 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.57 -47.51 19.25 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -171.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 17' ' ' MET . . . -56.69 -24.81 51.6 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pp -81.89 -32.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 CA-C-N 119.086 0.857 . . . . 0.0 111.562 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.17 -35.44 88.51 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 125.081 1.324 . . . . 0.0 111.181 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.22 60.58 Favored 'General case' 0 CA--C 1.486 -1.497 0 C-N-CA 128.334 2.654 . . . . 0.0 109.992 166.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.04 90.65 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 123.712 0.805 . . . . 0.0 112.068 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.3 -21.97 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.41 -32.08 9.06 Favored Glycine 0 CA--C 1.472 -2.605 0 CA-C-N 119.922 1.237 . . . . 0.0 112.3 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' HA3' ' A' ' 58' ' ' GLY . 64.4 mt -58.9 -36.98 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.15 -51.19 7.0 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 96.0 mt -66.31 -66.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 C-N-CA 124.316 1.046 . . . . 0.0 112.515 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.69 -58.47 6.21 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 126.021 1.728 . . . . 0.0 109.404 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.19 -16.6 62.58 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 119.221 0.919 . . . . 0.0 113.963 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.74 -43.52 14.57 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 118.861 1.331 . . . . 0.0 110.491 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.14 -32.85 56.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.515 1.526 . . . . 0.0 111.082 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 124.971 1.309 . . . . 0.0 111.014 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tp -76.46 -21.05 56.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.499 0.59 . . . . 0.0 111.814 172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -80.75 2.9 24.18 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.701 -1.25 . . . . 0.0 110.385 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.9 -31.9 7.11 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 164.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.93 -22.22 53.63 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.688 1.195 . . . . 0.0 112.705 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.14 63.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.873 1.669 . . . . 0.0 112.484 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.15 -25.37 47.3 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.364 1.065 . . . . 0.0 110.58 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -83.7 176.73 3.5 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 125.673 1.589 . . . . 0.0 106.993 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.32 153.49 50.74 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 123.787 2.388 . . . . 0.0 107.274 165.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -87.38 38.65 0.83 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.237 0.615 . . . . 0.0 109.757 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.64 -73.06 0.58 Allowed 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.82 -55.74 1.88 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 115.603 -2.142 . . . . 0.0 110.778 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -85.3 9.45 4.12 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 125.637 3.049 . . . . 0.0 111.71 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.53 -30.68 47.16 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -33.63 58.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.332 1.053 . . . . 0.0 111.43 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.23 -31.7 66.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.115 -0.991 . . . . 0.0 110.316 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 mm-40 -60.39 -55.52 32.57 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.992 -1.004 . . . . 0.0 108.947 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -44.74 -36.47 3.19 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.423 1.489 . . . . 0.0 112.678 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.357 52.7 m-85 -78.03 -37.5 46.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 pt -75.55 -25.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.752 -1.217 . . . . 0.0 109.089 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.3 t -74.9 -38.59 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 130.042 3.337 . . . . 0.0 111.494 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.4 ttm -53.43 -33.67 54.91 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.707 1.603 . . . . 0.0 111.198 167.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 28' ' ' ILE . . . -76.4 -41.44 25.51 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 116.349 -0.387 . . . . 0.0 113.821 173.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.1 mt -66.02 -32.12 73.41 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 118.233 1.016 . . . . 0.0 112.371 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -77.1 -24.93 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 125.652 1.581 . . . . 0.0 111.246 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.51 -39.96 85.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.373 0.669 . . . . 0.0 111.161 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.11 24.89 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 123.654 0.782 . . . . 0.0 112.812 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -48.36 73.96 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.03 -7.75 9.18 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 CA-C-N 124.234 2.548 . . . . 0.0 108.485 -170.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -96.08 -29.97 13.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.068 1.747 . . . . 0.0 108.606 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.21 -30.73 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 108.926 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.23 -28.76 38.5 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.537 1.135 . . . . 0.0 110.898 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.58 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.42 -18.69 77.6 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.23 -37.07 54.0 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 126.928 2.091 . . . . 0.0 110.111 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.63 58.49 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.9 -28.41 49.82 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.783 1.633 . . . . 0.0 110.596 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.06 -35.28 37.29 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.177 0.591 . . . . 0.0 110.801 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.14 -32.14 46.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 124.124 0.969 . . . . 0.0 109.122 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.8 ttt -75.5 -28.46 59.16 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.422 0.689 . . . . 0.0 110.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.33 -35.92 82.45 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.437 1.895 . . . . 0.0 109.422 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.24 60.98 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -83.42 -45.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.877 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.595 0 C-N-CA 124.143 0.977 . . . . 0.0 112.465 -176.525 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.99 -44.44 92.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.682 1.193 . . . . 0.0 110.031 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -82.01 -31.2 31.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.438 1.095 . . . . 0.0 110.958 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.44 -34.01 66.42 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.327 1.851 . . . . 0.0 111.632 168.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.54 -38.21 59.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.655 1.182 . . . . 0.0 111.404 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.83 -25.87 63.96 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.353 1.061 . . . . 0.0 110.153 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.08 -41.41 67.35 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.234 0.614 . . . . 0.0 110.128 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.93 -22.87 45.16 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.79 -45.36 64.81 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.113 1.365 . . . . 0.0 110.228 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -45.38 70.15 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.906 1.683 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.54 -35.23 75.51 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 126.291 1.836 . . . . 0.0 111.361 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.58 -52.97 62.91 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.735 1.214 . . . . 0.0 111.544 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.99 -36.04 74.22 Favored 'General case' 0 CA--C 1.484 -1.595 0 C-N-CA 125.544 1.538 . . . . 0.0 114.189 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.1 -22.16 25.57 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 119.532 1.06 . . . . 0.0 109.819 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -83.96 -27.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 125.05 1.34 . . . . 0.0 107.524 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.8 ttm -82.13 -71.62 0.48 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.335 0.654 . . . . 0.0 109.931 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -5.62 58.02 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.445 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.6 -54.98 7.89 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.45 -53.25 51.21 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.669 1.188 . . . . 0.0 111.134 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -48.97 16.16 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.91 64.89 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.79 -33.85 12.33 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 CA-C-N 118.651 0.66 . . . . 0.0 111.7 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.84 -38.34 95.99 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 124.65 1.119 . . . . 0.0 110.504 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.02 -68.84 0.16 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 127.845 2.458 . . . . 0.0 108.736 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.61 64.95 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -163.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -71.05 -45.23 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 125.275 1.43 . . . . 0.0 110.826 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.94 43.56 Favored Glycine 0 CA--C 1.465 -3.037 0 CA-C-N 120.246 1.385 . . . . 0.0 115.026 -174.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.98 -10.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 118.423 1.111 . . . . 0.0 110.721 171.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -51.15 7.33 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.49 -71.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.065 0 C-N-CA 123.915 0.886 . . . . 0.0 111.892 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -38.18 89.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.782 2.833 . . . . 0.0 111.775 -174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.64 -20.34 71.53 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.88 -38.08 20.7 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.98 -18.88 49.18 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.387 1.475 . . . . 0.0 110.801 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -67.72 -42.03 82.58 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.93 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.0 -8.44 56.96 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-N 119.572 1.078 . . . . 0.0 111.567 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.26 -39.35 68.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 119.771 -1.831 . . . . 0.0 108.655 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -42.73 80.07 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 125.048 1.309 . . . . 0.0 111.082 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.48 62.91 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.206 1.402 . . . . 0.0 112.966 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.27 -52.29 19.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.991 1.316 . . . . 0.0 111.246 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -19.06 36.94 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 122.831 0.452 . . . . 0.0 111.434 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.11 169.53 18.13 Favored Pre-proline 0 C--N 1.355 0.825 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.86 148.54 52.09 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 CA-C-N 123.989 2.46 . . . . 0.0 107.798 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -87.31 43.92 1.14 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.521 0.728 . . . . 0.0 109.203 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.56 -77.75 0.44 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.411 1.085 . . . . 0.0 108.33 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.03 -56.92 1.54 Allowed Pre-proline 0 N--CA 1.435 -1.192 0 CA-C-O 116.118 -1.896 . . . . 0.0 110.916 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -81.69 7.31 5.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-N 124.75 2.732 . . . . 0.0 111.721 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.68 -34.75 34.5 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 121.229 1.832 . . . . 0.0 107.821 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -37.73 73.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.737 1.215 . . . . 0.0 107.831 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -22.85 60.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 121.074 -1.016 . . . . 0.0 112.688 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -63.01 -46.67 86.52 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 120.369 -1.457 . . . . 0.0 111.411 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 56' ' ' VAL . 10.1 pt20 -66.17 -50.76 62.81 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -43.74 -31.33 0.78 Allowed 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 128.275 2.63 . . . . 0.0 112.724 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.72 -53.27 8.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.17 -24.48 35.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 121.097 1.771 . . . . 0.0 111.515 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 52' ' ' GLN . 84.9 t -74.73 -40.21 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 C-N-CA 130.808 3.643 . . . . 0.0 112.031 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.1 ttm -55.0 -28.26 50.63 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.058 1.343 . . . . 0.0 111.602 167.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -7.4 52.97 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 122.045 -0.409 . . . . 0.0 113.946 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -81.65 -35.72 29.64 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.62 1.21 . . . . 0.0 109.066 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -77.11 -20.3 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 C-N-CA 126.361 1.864 . . . . 0.0 111.338 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.99 -44.13 70.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.923 1.689 . . . . 0.0 110.41 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.55 -25.73 24.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 123.785 0.834 . . . . 0.0 112.662 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.268 0.3 OUTLIER -49.47 -52.7 47.52 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.63 -9.6 8.96 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 CA-C-N 123.773 2.383 . . . . 0.0 108.332 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -87.01 -45.61 10.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 127.009 2.124 . . . . 0.0 105.817 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.18 -32.54 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 109.628 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.49 -27.77 51.98 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.794 0.838 . . . . 0.0 111.086 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.69 -28.84 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.03 -19.88 76.69 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 119.087 0.858 . . . . 0.0 111.611 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.29 -35.33 48.05 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 127.753 2.421 . . . . 0.0 109.892 172.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.17 -32.59 62.77 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 mt -78.48 -23.33 46.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.438 1.895 . . . . 0.0 110.796 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -43.81 21.39 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.506 1.122 . . . . 0.0 110.295 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.1 -25.99 18.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 125.761 1.624 . . . . 0.0 109.162 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.8 ttm -76.63 -31.02 57.12 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 109.66 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -33.95 73.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.132 1.373 . . . . 0.0 109.575 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.66 -22.1 57.06 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.766 0.826 . . . . 0.0 111.559 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.0 t -91.38 -49.31 13.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.686 0 CA-C-O 117.158 -1.401 . . . . 0.0 112.071 -177.018 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.03 -27.99 65.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.061 0.944 . . . . 0.0 110.135 170.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -90.49 -32.47 16.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.729 1.212 . . . . 0.0 109.829 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.53 -34.83 67.41 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.228 1.811 . . . . 0.0 111.498 165.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.91 -37.48 58.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.613 1.165 . . . . 0.0 110.709 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.9 mtt -65.95 -30.91 71.56 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.799 1.24 . . . . 0.0 110.295 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.02 -36.9 69.82 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.784 0.834 . . . . 0.0 110.835 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.81 -28.41 36.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.71 1.204 . . . . 0.0 110.487 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 mt -79.68 -27.11 40.81 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.024 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.4 -43.11 74.11 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.829 0.852 . . . . 0.0 109.193 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.3 -23.7 66.42 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.476 1.511 . . . . 0.0 111.708 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -55.59 17.1 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.732 1.213 . . . . 0.0 110.304 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.14 -17.37 26.28 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.247 1.819 . . . . 0.0 114.234 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.37 -29.94 24.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.174 -1.579 . . . . 0.0 109.533 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.5 t -80.51 -37.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 125.774 1.63 . . . . 0.0 108.642 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.2 mmt -80.45 -51.18 9.12 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.924 1.29 . . . . 0.0 111.247 -172.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 34.7 mtm -80.77 -24.96 38.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.5 -48.08 77.28 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.24 -45.07 89.78 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 125.264 1.426 . . . . 0.0 112.458 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.22 2.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.55 -22.72 35.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.81 -33.82 12.29 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 CA-C-N 120.13 1.332 . . . . 0.0 111.589 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.45 -36.71 93.52 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.64 -67.48 0.28 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.611 1.964 . . . . 0.0 108.926 164.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.79 68.53 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.465 1.506 . . . . 0.0 114.554 -160.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.0 -51.97 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 C-N-CA 124.753 1.221 . . . . 0.0 109.122 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -37.49 29.17 Favored Glycine 0 CA--C 1.465 -3.074 0 C-N-CA 119.186 -1.483 . . . . 0.0 115.542 -171.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA3' ' A' ' 58' ' ' GLY . 1.9 pt -76.4 -9.48 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 118.682 1.241 . . . . 0.0 110.885 173.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 -51.22 7.53 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 165.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.44 -71.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 123.882 0.873 . . . . 0.0 111.909 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -38.88 91.55 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 129.245 3.018 . . . . 0.0 111.792 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.33 -19.74 68.46 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -37.82 20.14 Favored Glycine 0 C--N 1.361 1.932 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.97 -17.31 53.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.485 1.514 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -34.22 71.57 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.66 0.784 . . . . 0.0 110.802 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.4 -19.45 58.1 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-O 121.141 0.496 . . . . 0.0 112.051 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -75.16 -20.37 59.4 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.0 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.38 -24.64 67.71 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 125.071 1.32 . . . . 0.0 110.844 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.02 -26.82 54.19 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 118.9 1.35 . . . . 0.0 111.604 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -57.16 4.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.707 1.603 . . . . 0.0 112.144 -167.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -28.06 39.6 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.128 0.571 . . . . 0.0 111.303 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 29.0 mm100 -84.13 173.46 7.27 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 125.586 1.554 . . . . 0.0 106.921 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 56.4 Cg_endo -71.61 150.74 57.49 Favored 'Trans proline' 0 CA--C 1.5 -1.215 0 CA-C-N 123.946 2.445 . . . . 0.0 107.437 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.27 35.88 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.608 0.763 . . . . 0.0 109.592 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.43 -70.96 0.68 Allowed 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.84 -59.47 1.17 Allowed Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-O 116.103 -1.903 . . . . 0.0 110.483 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.43 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 71.6 Cg_endo -82.3 1.86 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 124.796 2.749 . . . . 0.0 112.695 -167.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.02 -27.69 21.87 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 121.241 1.837 . . . . 0.0 107.819 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -37.47 69.95 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -72.2 -24.86 61.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.044 -1.035 . . . . 0.0 112.084 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.5 m -63.09 -46.17 88.66 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.761 1.224 . . . . 0.0 112.046 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.1 pt20 -64.47 -49.95 69.38 Favored 'General case' 0 CA--C 1.469 -2.151 0 C-N-CA 123.752 0.821 . . . . 0.0 109.542 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -45.86 -33.67 3.32 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 126.538 1.935 . . . . 0.0 112.604 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.314 4.0 m-85 -77.28 -39.09 49.34 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.0 pt -74.16 -24.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 CA-C-N 121.283 1.856 . . . . 0.0 109.98 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLN . 67.5 t -74.9 -37.26 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 C-N-CA 131.509 3.924 . . . . 0.0 111.441 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.13 -32.94 62.47 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.201 1.0 . . . . 0.0 111.563 162.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -86.86 -9.34 74.51 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 123.447 0.546 . . . . 0.0 112.989 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.79 -16.8 49.76 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.933 0.893 . . . . 0.0 109.655 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.5 -30.03 19.04 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.91 -16.15 58.45 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.908 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 65' ' ' MET . . . -86.09 -24.07 26.44 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 110.997 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -50.19 68.41 Favored Pre-proline 0 C--N 1.35 0.63 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.44 0.87 9.66 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.335 2.69 . . . . 0.0 108.913 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 62' ' ' ALA . 2.7 ttt -67.99 -59.08 3.54 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.05 -38.17 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.684 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.886 -164.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.24 63.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.376 0.535 . . . . 0.0 111.562 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.8 -27.76 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.01 77.66 Favored Glycine 0 C--N 1.36 1.891 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.841 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.33 48.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.046 2.938 . . . . 0.0 110.869 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.68 -33.69 66.89 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.47 -22.24 51.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.36 1.464 . . . . 0.0 112.233 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.26 -36.59 34.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.619 0.645 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.4 -30.38 48.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.881 1.272 . . . . 0.0 109.242 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.1 tpt -76.67 -34.68 58.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.235 0.614 . . . . 0.0 110.261 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.03 -36.69 82.33 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 126.746 2.018 . . . . 0.0 109.712 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.4 -22.7 61.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.007 0.923 . . . . 0.0 111.724 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.68 -77.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.645 0 CA-C-O 117.605 -1.188 . . . . 0.0 109.73 -175.29 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.482 -1.656 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -70.59 -26.77 63.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.192 0.997 . . . . 0.0 109.721 167.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -88.91 -34.95 16.76 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.625 1.17 . . . . 0.0 109.602 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 tp -56.49 -30.88 63.5 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.562 1.945 . . . . 0.0 112.005 166.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -78.32 -35.26 47.95 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.834 1.253 . . . . 0.0 111.261 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -26.26 61.74 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.18 0.992 . . . . 0.0 109.573 172.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.1 -34.95 69.04 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 123.944 0.898 . . . . 0.0 110.058 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -70.13 -46.95 63.69 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.987 1.715 . . . . 0.0 109.126 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.06 -39.67 95.42 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.791 1.636 . . . . 0.0 112.451 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -48.96 59.11 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.104 0.962 . . . . 0.0 110.432 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.3 mtp -71.37 -17.37 62.42 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.178 0.991 . . . . 0.0 111.997 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -51.7 57.32 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.606 1.163 . . . . 0.0 110.071 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -20.83 56.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.025 2.13 . . . . 0.0 114.372 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.35 -31.34 24.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 120.062 -1.649 . . . . 0.0 110.0 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -80.84 -41.61 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 125.774 1.629 . . . . 0.0 108.526 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -77.51 -45.23 26.13 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.952 1.301 . . . . 0.0 110.788 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.2 mtp -81.01 -20.31 42.05 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.925 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.2 -38.17 54.45 Favored Glycine 0 C--N 1.356 1.639 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.68 -55.91 22.54 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.085 1.354 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.71 -46.75 24.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -164.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' SD ' ' A' ' 65' ' ' MET . . . -56.23 -27.45 54.96 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.18 -32.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 121.158 -0.964 . . . . 0.0 108.788 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -32.35 78.34 Favored Glycine 0 C--N 1.36 1.9 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.94 -66.67 0.44 Allowed 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.201 1.4 . . . . 0.0 109.645 168.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.68 -32.61 59.64 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.626 1.97 . . . . 0.0 115.017 -166.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.4 mt -70.02 -50.63 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 C-N-CA 124.424 1.089 . . . . 0.0 109.553 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.06 -41.28 32.57 Favored Glycine 0 CA--C 1.463 -3.181 0 C-N-CA 119.672 -1.252 . . . . 0.0 115.202 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 pt -75.82 -9.27 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.814 1.307 . . . . 0.0 109.727 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.66 -48.92 8.39 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 166.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.72 -75.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.059 0 CA-C-N 117.942 0.871 . . . . 0.0 112.162 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.55 -41.79 92.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 C-N-CA 129.556 3.142 . . . . 0.0 112.447 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.39 -16.79 70.45 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.12 -44.08 12.39 Favored Glycine 0 C--N 1.363 2.033 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.72 -27.26 61.1 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.288 1.435 . . . . 0.0 110.611 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.21 82.38 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.581 1.152 . . . . 0.0 111.553 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -76.25 -17.78 59.32 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 118.792 0.724 . . . . 0.0 112.102 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.51 -27.74 64.41 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.964 -1.71 . . . . 0.0 109.997 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.32 -37.28 36.99 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.36 -17.1 61.32 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.451 1.501 . . . . 0.0 113.831 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.58 -54.92 8.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.901 1.681 . . . . 0.0 111.254 -171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.79 -20.09 36.47 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.906 0.882 . . . . 0.0 111.116 -175.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.99 168.46 22.7 Favored Pre-proline 0 C--N 1.355 0.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.93 149.12 58.89 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 CA-C-N 122.476 1.92 . . . . 0.0 107.666 170.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.43 40.21 0.91 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.467 0.707 . . . . 0.0 109.575 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -93.67 -76.52 0.47 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 124.696 1.199 . . . . 0.0 109.101 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.84 -49.84 3.38 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 115.408 -2.234 . . . . 0.0 111.087 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -82.94 11.03 3.39 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 125.932 3.154 . . . . 0.0 111.111 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.56 -29.29 41.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -30.34 56.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.611 0.765 . . . . 0.0 112.123 -177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.71 -40.98 65.72 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.2 -0.938 . . . . 0.0 111.765 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.8 m -63.1 -38.54 91.59 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.605 1.562 . . . . 0.0 113.603 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.3 pp0? -62.77 -54.35 40.43 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 124.355 1.062 . . . . 0.0 109.655 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -47.63 -31.25 4.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 126.908 2.083 . . . . 0.0 112.577 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.305 6.1 m-30 -77.19 -45.46 26.56 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -71.76 -18.97 20.02 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 121.306 1.866 . . . . 0.0 110.836 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 52' ' ' GLN . 61.5 t -75.0 -42.88 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 130.329 3.452 . . . . 0.0 110.732 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ttt -55.19 -27.14 43.82 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.784 1.234 . . . . 0.0 111.743 162.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.52 -24.25 65.78 Favored Glycine 0 C--N 1.356 1.67 0 C-N-CA 124.739 1.162 . . . . 0.0 112.337 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.0 -21.71 36.93 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.145 1.378 . . . . 0.0 110.426 174.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.62 -28.11 17.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 124.908 1.283 . . . . 0.0 108.319 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 3.0 t70 -77.78 -29.76 51.05 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.062 0.945 . . . . 0.0 110.089 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 -14.65 42.76 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.083 1.353 . . . . 0.0 112.31 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.277 0.3 OUTLIER -49.94 -52.21 54.41 Favored Pre-proline 0 C--N 1.354 0.782 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 172.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.33 -13.21 12.48 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 123.707 2.36 . . . . 0.0 108.33 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.57 -51.21 45.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.35 2.26 . . . . 0.0 107.281 175.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.91 -39.15 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.178 -164.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.22 58.66 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 119.316 0.962 . . . . 0.0 111.588 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.94 -30.41 10.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.76 -18.27 75.66 Favored Glycine 0 C--N 1.359 1.82 0 CA-C-N 118.842 0.747 . . . . 0.0 111.425 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -35.67 59.72 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 127.778 2.431 . . . . 0.0 110.66 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.66 -41.26 24.7 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.62 -39.23 84.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.772 1.629 . . . . 0.0 112.128 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -80.18 -30.71 38.81 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 117.935 0.334 . . . . 0.0 111.425 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -71.02 -33.05 50.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.306 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 60.4 mtt -75.33 -31.75 60.68 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.297 0.639 . . . . 0.0 110.364 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.391 1.876 . . . . 0.0 109.751 172.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.31 -17.61 60.23 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.512 1.125 . . . . 0.0 112.807 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.52 -75.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.613 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.658 -176.823 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 CA--C 1.483 -1.597 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.14 -27.21 65.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.323 1.049 . . . . 0.0 110.196 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -87.13 -41.31 13.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.293 1.037 . . . . 0.0 108.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.8 tp -56.11 -29.98 61.41 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 127.277 2.231 . . . . 0.0 112.608 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -72.66 -46.85 51.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.461 1.104 . . . . 0.0 110.877 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.12 -25.08 62.43 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.338 1.455 . . . . 0.0 109.739 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.05 -43.87 64.23 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.754 0.821 . . . . 0.0 110.418 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.7 tp -72.11 -48.57 42.9 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 110.585 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.54 -41.89 92.56 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.241 1.016 . . . . 0.0 112.759 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -51.17 37.43 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.389 1.075 . . . . 0.0 110.328 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.71 -19.31 62.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.63 -53.27 43.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.35 1.06 . . . . 0.0 110.173 170.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.79 -15.31 11.7 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.624 2.369 . . . . 0.0 114.453 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.85 -26.45 18.49 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 120.783 -1.198 . . . . 0.0 109.756 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.62 -34.17 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.084 1.353 . . . . 0.0 108.362 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.8 mtt -76.73 -65.72 0.9 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.738 1.615 . . . . 0.0 108.779 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.0 mtm -80.75 -18.96 46.04 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.39 -43.28 97.02 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -64.76 0.8 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.145 0.978 . . . . 0.0 110.588 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.64 -52.69 8.59 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.97 44.41 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.1 -38.29 16.58 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 CA-C-N 120.291 1.405 . . . . 0.0 111.81 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.19 -38.52 95.76 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -54.51 -70.28 0.1 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.947 2.499 . . . . 0.0 109.32 164.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.63 72.44 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 114.15 -158.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.11 -47.23 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 C-N-CA 124.96 1.304 . . . . 0.0 109.908 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 -37.8 27.18 Favored Glycine 0 CA--C 1.465 -3.072 0 CA-C-N 120.218 1.372 . . . . 0.0 115.508 -173.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.1 -9.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 118.583 1.192 . . . . 0.0 110.408 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.32 -51.01 7.75 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 166.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.6 -71.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.994 0.918 . . . . 0.0 112.212 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.47 -39.85 92.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 129.211 3.004 . . . . 0.0 112.622 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.85 -19.1 66.22 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.97 -33.44 26.76 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -71.5 -35.7 70.84 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.716 2.006 . . . . 0.0 109.042 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.45 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 125.77 1.628 . . . . 0.0 111.429 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -16.46 59.72 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.73 -26.45 62.48 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 120.006 -1.684 . . . . 0.0 110.199 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.5 -28.9 46.13 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -31.03 56.13 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.82 -50.91 25.47 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.519 1.128 . . . . 0.0 113.915 -163.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.05 -38.43 66.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.231 1.012 . . . . 0.0 111.785 -170.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.79 172.27 9.28 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.73 157.89 57.23 Favored 'Trans proline' 0 CA--C 1.496 -1.375 0 CA-C-N 124.585 2.673 . . . . 0.0 109.891 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.12 38.19 0.8 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.407 1.083 . . . . 0.0 110.063 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.17 -74.06 0.54 Allowed 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 123.723 0.809 . . . . 0.0 109.002 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.79 -54.15 2.27 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 115.834 -2.031 . . . . 0.0 110.967 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.31 -5.26 14.22 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 125.122 2.865 . . . . 0.0 111.676 -168.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.97 -33.59 70.6 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 119.914 1.234 . . . . 0.0 108.742 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.33 68.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.52 1.128 . . . . 0.0 110.729 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -72.39 -28.88 63.28 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.713 -1.242 . . . . 0.0 112.95 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.6 m -62.95 -45.52 92.07 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.291 1.436 . . . . 0.0 112.381 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 56' ' ' VAL . 8.2 pt20 -59.81 -55.12 38.2 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 123.698 0.799 . . . . 0.0 109.331 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -43.86 -35.56 2.0 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 127.566 2.346 . . . . 0.0 112.904 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.27 8.0 m-85 -76.95 -49.46 15.47 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.9 pt -67.75 -24.51 30.96 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-N 121.023 1.738 . . . . 0.0 111.172 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 52' ' ' GLN . 94.5 t -74.78 -40.58 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 C-N-CA 130.058 3.343 . . . . 0.0 112.065 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 50.0 ttp -51.5 -35.86 42.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.95 0.9 . . . . 0.0 111.309 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -11.82 62.87 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.56 -22.44 37.8 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.394 1.097 . . . . 0.0 109.28 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.76 -30.35 18.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 126.82 2.048 . . . . 0.0 108.749 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 7.6 t70 -70.13 -41.3 74.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.849 1.259 . . . . 0.0 111.082 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.61 31.7 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.695 0.798 . . . . 0.0 111.917 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -49.23 71.74 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.67 -11.5 10.34 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 CA-C-N 124.418 2.614 . . . . 0.0 107.986 -168.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.528 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -91.15 -34.76 14.91 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 126.002 1.721 . . . . 0.0 108.021 -178.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.49 -23.46 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 C-N-CA 123.357 0.663 . . . . 0.0 111.219 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -31.68 24.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.552 1.141 . . . . 0.0 110.101 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.37 -26.37 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.04 -16.51 79.72 Favored Glycine 0 CA--C 1.489 -1.537 0 C-N-CA 124.855 1.217 . . . . 0.0 110.728 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.73 -32.66 31.48 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 125.942 1.697 . . . . 0.0 109.311 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.16 -46.64 15.32 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.64 -39.71 94.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 126.446 1.899 . . . . 0.0 112.83 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -79.89 -28.87 39.84 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.06 -32.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 CA-C-N 118.753 0.706 . . . . 0.0 109.216 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.2 mmt -78.04 -19.78 53.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.275 0.63 . . . . 0.0 111.441 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.13 -37.82 53.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.297 1.439 . . . . 0.0 108.537 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.63 -18.96 46.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.867 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 p -83.23 -53.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -169.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.624 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.923 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.483 -1.634 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.74 -36.61 82.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.735 1.214 . . . . 0.0 110.278 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.276 1.031 . . . . 0.0 110.804 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.77 -35.84 69.13 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 112.026 164.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -36.19 44.77 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 124.661 1.184 . . . . 0.0 110.133 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.95 -33.19 75.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.704 1.602 . . . . 0.0 109.748 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.01 -35.44 69.42 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.349 1.06 . . . . 0.0 110.096 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.5 -49.4 33.19 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 125.432 1.493 . . . . 0.0 109.852 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.9 -34.17 71.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.843 0.857 . . . . 0.0 112.024 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.63 -50.48 62.85 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.511 0.596 . . . . 0.0 111.273 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.6 mtp -72.73 -13.48 61.34 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.066 0.546 . . . . 0.0 112.215 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.32 12.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.727 1.211 . . . . 0.0 110.035 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.61 54.78 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.735 2.014 . . . . 0.0 114.33 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 -22.72 20.26 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 120.711 -1.243 . . . . 0.0 110.48 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.94 -33.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.7 tpp -79.61 -62.71 1.6 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 109.806 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mtm -81.31 -23.56 37.78 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.35 99.16 Favored Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.19 -67.98 0.39 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.94 -57.05 4.0 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.01 -27.84 54.75 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -31.73 10.24 Favored 'Isoleucine or valine' 0 C--N 1.369 1.42 0 CA-C-N 120.481 1.491 . . . . 0.0 111.638 172.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.05 76.23 Favored Glycine 0 C--N 1.363 2.044 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -73.2 0.08 Allowed 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 127.912 2.485 . . . . 0.0 108.65 167.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.59 30.89 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -167.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.6 mm -71.0 -50.31 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.187 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 -40.48 49.16 Favored Glycine 0 CA--C 1.46 -3.36 0 CA-C-N 120.087 1.312 . . . . 0.0 114.585 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 pt -75.87 -8.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 119.026 1.413 . . . . 0.0 110.703 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.92 -50.51 7.75 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -65.41 -70.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.144 0 CA-C-N 117.617 0.709 . . . . 0.0 112.278 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.81 -46.02 91.34 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 129.398 3.079 . . . . 0.0 111.506 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.09 -19.49 79.78 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 119.435 1.016 . . . . 0.0 111.996 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.57 14.64 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -74.23 -27.0 60.57 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.01 1.724 . . . . 0.0 110.693 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -43.73 91.17 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.45 1.5 . . . . 0.0 112.091 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -10.64 59.56 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -70.14 -34.53 73.17 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.035 -1.666 . . . . 0.0 110.434 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.43 -35.19 48.33 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.15 62.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.652 1.581 . . . . 0.0 113.729 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -48.42 47.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.31 1.444 . . . . 0.0 113.594 -169.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -37.23 63.91 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.159 0.984 . . . . 0.0 111.324 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -84.47 174.67 5.51 Favored Pre-proline 0 C--N 1.353 0.757 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.98 153.5 57.95 Favored 'Trans proline' 0 CA--C 1.5 -1.2 0 CA-C-N 125.435 2.977 . . . . 0.0 109.158 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -87.25 44.43 1.18 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.095 0.958 . . . . 0.0 108.551 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -93.77 -75.47 0.5 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 124.713 1.205 . . . . 0.0 108.255 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.84 -54.04 2.27 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 115.777 -2.058 . . . . 0.0 111.116 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.05 -1.75 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 CA-C-N 125.24 2.907 . . . . 0.0 111.429 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 tp -77.98 -26.85 48.94 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 120.049 1.295 . . . . 0.0 108.86 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.16 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.87 0.868 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.258 0.8 OUTLIER -72.41 -27.65 62.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 120.65 -1.281 . . . . 0.0 112.984 173.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -62.9 -44.52 95.88 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 112.962 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.4 pt20 -59.28 -51.11 71.35 Favored 'General case' 0 CA--C 1.474 -1.959 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.44 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -41.89 -37.66 1.35 Allowed 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.853 2.461 . . . . 0.0 113.566 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.12 -46.26 24.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.81 -21.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 120.889 1.677 . . . . 0.0 110.924 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 52' ' ' GLN . 73.9 t -75.02 -40.67 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 C-N-CA 130.9 3.68 . . . . 0.0 112.019 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.8 ttp -53.17 -31.83 44.73 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.387 1.075 . . . . 0.0 111.544 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.04 -3.92 51.33 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.186 0.435 . . . . 0.0 114.186 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.87 -38.05 25.98 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.5 -21.17 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 127.264 2.226 . . . . 0.0 110.289 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.05 -42.36 72.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.963 1.705 . . . . 0.0 110.628 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.48 -20.67 27.74 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.408 1.083 . . . . 0.0 112.729 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.276 0.3 OUTLIER -49.62 -52.27 52.06 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.45 -5.37 9.23 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 CA-C-N 123.748 2.374 . . . . 0.0 107.82 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.4 mmt -92.48 -41.27 10.38 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 126.701 2.0 . . . . 0.0 106.184 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -29.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 C-N-CA 124.392 1.077 . . . . 0.0 109.848 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.87 -29.88 56.02 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 124.031 0.932 . . . . 0.0 111.584 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.04 -31.88 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.06 -18.71 80.14 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.324 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -36.88 38.47 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 127.964 2.506 . . . . 0.0 110.559 174.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.86 -38.84 85.62 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.16 -23.31 61.27 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.544 1.538 . . . . 0.0 111.716 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -79.99 -35.21 37.81 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.847 0.859 . . . . 0.0 110.68 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.64 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 124.293 1.037 . . . . 0.0 109.538 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.4 mtp -77.96 -25.48 48.24 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.627 0.771 . . . . 0.0 111.268 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -36.99 78.54 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.95 1.7 . . . . 0.0 108.516 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.69 62.71 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.322 1.049 . . . . 0.0 111.556 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -87.56 -85.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.603 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.046 -178.271 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.34 -41.27 98.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.091 1.356 . . . . 0.0 110.074 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -78.26 -44.6 25.07 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.945 1.298 . . . . 0.0 110.631 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.63 -23.7 43.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.105 2.162 . . . . 0.0 113.029 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.97 -43.85 42.63 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.302 1.041 . . . . 0.0 110.945 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.2 mtm -69.57 -27.22 64.94 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.88 1.272 . . . . 0.0 110.219 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.86 -37.03 70.28 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.691 0.797 . . . . 0.0 110.131 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.9 tp -77.81 -31.72 51.9 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.233 1.413 . . . . 0.0 110.128 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.08 -45.08 82.52 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 0.0 111.256 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -69.34 -41.7 76.29 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.467 0.707 . . . . 0.0 111.637 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.9 ttm -61.9 -32.79 73.2 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.099 1.36 . . . . 0.0 111.149 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.54 -60.17 3.91 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.194 1.397 . . . . 0.0 110.786 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.01 58.69 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.718 1.607 . . . . 0.0 114.416 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.34 -33.28 18.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.469 -1.394 . . . . 0.0 110.3 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.11 -33.76 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 125.312 1.445 . . . . 0.0 108.393 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.53 -53.23 6.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.576 1.15 . . . . 0.0 110.041 -170.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.1 mtm -80.65 -23.69 39.5 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.92 90.55 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.36 -51.61 62.45 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.966 1.307 . . . . 0.0 112.29 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.04 -50.05 13.99 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -170.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.15 57.77 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.87 -32.77 11.46 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 CA-C-N 119.156 0.889 . . . . 0.0 111.928 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.84 91.49 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.45 -53.16 61.26 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 128.752 2.821 . . . . 0.0 110.831 165.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.62 82.07 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.906 0.882 . . . . 0.0 113.194 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.01 -37.61 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 C-N-CA 126.183 1.793 . . . . 0.0 110.052 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -33.71 32.54 Favored Glycine 0 CA--C 1.478 -2.227 0 CA-C-N 119.875 1.216 . . . . 0.0 113.682 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.476 HD11 ' HA3' ' A' ' 58' ' ' GLY . 21.1 mt -62.6 -30.28 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.58 9.11 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.21 -73.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.139 0 C-N-CA 123.773 0.829 . . . . 0.0 112.543 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.68 -45.52 82.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.964 2.506 . . . . 0.0 111.335 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.27 -17.03 80.27 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.29 -36.56 30.48 Favored Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -74.98 -35.47 62.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.528 1.931 . . . . 0.0 108.883 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -34.66 76.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.657 1.183 . . . . 0.0 111.218 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -76.3 -13.43 60.15 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 122.89 0.476 . . . . 0.0 112.149 175.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.53 -39.59 85.06 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 119.902 -1.748 . . . . 0.0 109.803 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.92 -26.77 66.01 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.9 59.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.924 1.289 . . . . 0.0 112.948 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.23 8.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.521 1.528 . . . . 0.0 111.639 -171.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -29.55 51.4 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 111.205 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -84.04 167.44 27.78 Favored Pre-proline 0 N--CA 1.441 -0.894 0 C-N-CA 125.193 1.397 . . . . 0.0 107.277 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.06 155.01 62.32 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 CA-C-N 123.538 2.299 . . . . 0.0 108.275 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.11 42.03 1.01 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.33 0.652 . . . . 0.0 110.066 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -93.5 -79.16 0.41 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.992 0.917 . . . . 0.0 108.7 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.79 -52.48 2.7 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-O 115.615 -2.136 . . . . 0.0 111.864 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.68 2.79 8.3 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 125.57 3.025 . . . . 0.0 110.858 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 -27.01 35.25 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 172.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -72.04 -36.48 69.64 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.798 0.839 . . . . 0.0 110.837 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -32.56 66.59 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.179 -0.951 . . . . 0.0 112.131 173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -62.79 -42.53 99.75 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.92 1.288 . . . . 0.0 113.109 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 11.6 pt20 -63.87 -45.05 91.14 Favored 'General case' 0 CA--C 1.464 -2.347 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -52.76 -30.8 34.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.889 1.276 . . . . 0.0 112.297 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 10.3 m-30 -78.15 -28.55 48.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 121.364 3.839 . . . . 0.0 121.364 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.79 -29.12 25.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 121.251 1.841 . . . . 0.0 108.597 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.81 -35.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 1 C-N-CA 132.645 4.378 . . . . 0.0 111.794 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.4 ttt -55.05 -33.21 62.51 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.724 1.21 . . . . 0.0 110.919 164.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -76.48 -38.26 33.53 Favored Glycine 0 N--CA 1.433 -1.526 0 O-C-N 121.888 -0.508 . . . . 0.0 114.045 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.5 -35.07 76.99 Favored 'General case' 0 CA--C 1.508 -0.673 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.08 -25.73 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 C-N-CA 126.267 1.827 . . . . 0.0 110.93 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 19.0 t70 -71.53 -37.04 71.19 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.631 0.772 . . . . 0.0 111.681 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.71 -20.81 27.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.484 1.113 . . . . 0.0 112.882 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -45.9 78.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.14 -7.49 8.05 Favored 'Trans proline' 0 CA--C 1.494 -1.479 0 CA-C-N 124.189 2.532 . . . . 0.0 107.318 -168.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -91.4 -40.43 11.44 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 125.54 1.536 . . . . 0.0 107.77 -176.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 tp -77.74 -30.58 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.15 57.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.162 0.985 . . . . 0.0 111.313 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -77.96 -28.67 15.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 CA-C-N 118.298 0.499 . . . . 0.0 109.947 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.94 -21.92 70.08 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -34.9 62.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.604 2.362 . . . . 0.0 110.462 170.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.43 -35.61 63.19 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.2 mt -73.74 -25.86 60.39 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 110.876 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -39.88 29.11 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.671 1.188 . . . . 0.0 110.814 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 -26.15 20.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.891 1.277 . . . . 0.0 109.247 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.18 57.48 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.61 0.764 . . . . 0.0 109.344 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.57 -33.68 69.28 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.798 1.239 . . . . 0.0 109.425 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.59 -23.68 61.77 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.733 0.813 . . . . 0.0 111.96 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -93.86 -36.42 7.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.668 0 CA-C-O 117.133 -1.413 . . . . 0.0 111.91 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.478 -1.801 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -36.62 82.76 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.35 1.06 . . . . 0.0 108.345 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.04 -48.85 16.75 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 125.254 1.422 . . . . 0.0 111.672 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.264 1.8 pp -56.78 -27.95 60.52 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.973 1.309 . . . . 0.0 113.099 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.88 -45.22 44.36 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.96 1.304 . . . . 0.0 110.837 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 81.8 mtp -64.07 -31.58 72.83 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.36 1.464 . . . . 0.0 110.282 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.98 -38.71 69.67 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.097 0.959 . . . . 0.0 110.701 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.46 -36.14 58.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 125.136 1.375 . . . . 0.0 110.181 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.31 -27.29 42.16 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.87 0.868 . . . . 0.0 111.852 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.41 -44.76 70.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 123.14 0.576 . . . . 0.0 109.913 168.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm -63.72 -25.78 68.35 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 111.712 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -59.14 4.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.061 1.345 . . . . 0.0 110.503 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.39 -9.61 2.5 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 126.428 1.891 . . . . 0.0 114.742 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.03 -28.26 14.71 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 120.865 -1.147 . . . . 0.0 109.153 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.24 -27.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.709 0.804 . . . . 0.0 109.334 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -59.99 2.56 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.638 1.575 . . . . 0.0 108.701 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.6 mtm -80.9 -22.81 39.44 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.921 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.8 -40.84 75.03 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.35 -51.03 65.37 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.105 0.962 . . . . 0.0 111.715 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.02 -51.86 10.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.25 -25.69 48.74 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.88 -33.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 119.828 1.195 . . . . 0.0 110.907 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.8 -38.27 95.68 Favored Glycine 0 C--N 1.355 1.619 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -56.95 -64.64 0.81 Allowed 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.266 1.826 . . . . 0.0 109.659 165.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.04 73.31 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.712 1.205 . . . . 0.0 113.964 -159.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.81 -47.11 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 C-N-CA 124.908 1.283 . . . . 0.0 109.54 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.9 27.76 Favored Glycine 0 CA--C 1.462 -3.235 0 C-N-CA 119.235 -1.46 . . . . 0.0 115.455 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -73.68 -10.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 118.924 1.362 . . . . 0.0 109.842 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.6 -50.27 8.25 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 167.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.73 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 123.493 0.717 . . . . 0.0 112.42 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.69 -44.29 86.64 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 129.417 3.087 . . . . 0.0 112.138 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.56 -18.33 68.73 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.7 -38.45 20.29 Favored Glycine 0 C--N 1.364 2.115 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 125.939 1.695 . . . . 0.0 109.925 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -39.3 85.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 124.456 1.102 . . . . 0.0 111.604 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -10.18 59.21 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.71 -43.04 80.97 Favored 'General case' 0 C--N 1.362 1.114 0 O-C-N 119.995 -1.691 . . . . 0.0 109.625 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.67 -27.11 65.76 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.04 60.77 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.662 1.185 . . . . 0.0 112.914 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.63 -56.4 5.91 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 125.198 1.399 . . . . 0.0 111.559 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -28.32 40.25 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 111.467 -173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -84.02 164.78 42.47 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.94 155.2 62.48 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 CA-C-N 123.294 2.212 . . . . 0.0 108.38 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -87.21 45.02 1.22 Allowed 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.734 0.647 . . . . 0.0 109.455 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -79.19 0.41 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.058 0.943 . . . . 0.0 108.718 173.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.31 -54.26 2.5 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-O 115.766 -2.064 . . . . 0.0 111.587 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.66 0.19 10.21 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 CA-C-N 125.32 2.936 . . . . 0.0 111.001 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.6 -35.71 57.95 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -42.2 84.2 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.744 1.218 . . . . 0.0 110.956 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.01 -31.6 66.36 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.859 -1.15 . . . . 0.0 112.596 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -62.87 -45.09 94.2 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 124.735 1.214 . . . . 0.0 112.738 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 56' ' ' VAL . 11.7 pt20 -58.94 -54.29 48.8 Favored 'General case' 0 CA--C 1.461 -2.469 0 CA-C-O 116.819 -1.562 . . . . 0.0 109.322 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -44.91 -38.41 4.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 128.572 2.749 . . . . 0.0 113.039 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -76.95 -35.78 57.0 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -75.83 -29.09 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 C-N-CA 126.224 1.809 . . . . 0.0 109.382 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -75.15 -35.97 36.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 C-N-CA 125.307 1.443 . . . . 0.0 110.043 175.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.04 -33.86 63.03 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.979 0.911 . . . . 0.0 111.31 165.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.14 -20.54 62.6 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 124.053 0.835 . . . . 0.0 112.709 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -82.12 -26.95 33.1 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.644 1.978 . . . . 0.0 109.502 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.4 -27.24 17.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 125.731 1.612 . . . . 0.0 108.621 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.9 t70 -74.84 -24.92 58.68 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.034 0.933 . . . . 0.0 110.461 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.56 31.83 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.844 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.348 0.3 OUTLIER -50.31 -58.97 8.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 171.992 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' HG22 ' A' ' 63' ' ' ILE . 74.4 Cg_endo -79.82 -13.29 13.12 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.915 2.41 . . . . 0.0 108.913 -169.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -59.44 3.2 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 127.353 2.261 . . . . 0.0 106.076 174.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -31.34 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.736 -164.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -28.77 47.76 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 118.984 0.811 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.37 -28.51 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.61 -15.4 79.67 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -39.94 62.21 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 126.712 2.005 . . . . 0.0 110.311 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.85 -35.06 46.4 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.75 -26.66 50.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.148 1.379 . . . . 0.0 112.17 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -80.31 -32.68 37.94 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 118.762 0.71 . . . . 0.0 110.17 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.51 -30.59 49.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 123.999 0.92 . . . . 0.0 109.667 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -37.21 66.54 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.546 0.739 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.31 -32.56 73.32 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 127.028 2.131 . . . . 0.0 110.314 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.67 60.73 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.97 0.908 . . . . 0.0 111.781 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.44 -46.68 24.98 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.652 0 CA-C-O 117.14 -1.409 . . . . 0.0 111.948 -178.619 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.41 -31.2 71.25 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.847 1.259 . . . . 0.0 109.711 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -76.38 -50.52 13.99 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.326 1.45 . . . . 0.0 109.678 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.62 -20.48 21.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.039 2.535 . . . . 0.0 113.249 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.45 -40.46 50.48 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.626 1.17 . . . . 0.0 111.358 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -26.16 61.48 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 124.29 1.036 . . . . 0.0 109.351 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.94 -35.02 69.49 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.594 0.757 . . . . 0.0 110.166 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.99 -48.05 55.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.5 1.52 . . . . 0.0 109.271 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.18 -37.3 86.99 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.239 1.016 . . . . 0.0 113.083 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.62 44.02 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.283 1.033 . . . . 0.0 110.267 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.6 mtp -74.98 -14.38 60.62 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.753 0.821 . . . . 0.0 111.977 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.61 -51.74 57.32 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.965 1.306 . . . . 0.0 109.616 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.92 64.24 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.706 2.002 . . . . 0.0 113.385 170.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.73 -29.31 32.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 119.709 -1.87 . . . . 0.0 110.218 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -79.89 -40.17 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 C-N-CA 125.686 1.595 . . . . 0.0 108.662 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.5 ttm -84.53 -43.04 14.9 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.579 0.752 . . . . 0.0 111.431 -168.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.2 mtp -80.16 -28.59 38.81 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.28 -41.88 91.15 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.31 -44.12 92.56 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.673 1.189 . . . . 0.0 111.322 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.23 7.15 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.27 -28.54 58.99 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.68 -31.86 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.6 74.3 Favored Glycine 0 C--N 1.361 1.935 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -58.05 -74.01 0.07 Allowed 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.965 1.306 . . . . 0.0 109.312 164.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.55 69.79 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.762 1.625 . . . . 0.0 114.774 -161.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.7 mm -71.07 -45.43 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 124.869 1.267 . . . . 0.0 110.495 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.82 -41.18 29.1 Favored Glycine 0 CA--C 1.461 -3.314 0 CA-C-N 120.348 1.431 . . . . 0.0 114.494 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.02 -5.88 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 118.823 1.311 . . . . 0.0 110.323 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.95 -50.06 6.63 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -65.59 -71.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.042 0.937 . . . . 0.0 111.997 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.43 -30.96 71.82 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 129.425 3.09 . . . . 0.0 112.601 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.14 -19.13 47.68 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 119.113 0.87 . . . . 0.0 110.956 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.12 -36.29 9.09 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 118.329 1.064 . . . . 0.0 110.608 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.96 -20.42 45.63 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.208 1.403 . . . . 0.0 109.559 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -42.13 98.7 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.757 1.223 . . . . 0.0 111.188 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -10.81 59.7 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 123.353 0.661 . . . . 0.0 111.829 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -71.87 -36.8 70.2 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 120.185 -1.572 . . . . 0.0 109.268 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.22 -33.72 56.29 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.46 71.84 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.163 1.385 . . . . 0.0 113.066 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.76 -41.26 68.62 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.251 1.42 . . . . 0.0 112.636 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -75.92 -36.99 59.21 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.546 1.138 . . . . 0.0 111.453 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -84.44 176.42 3.74 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.97 155.41 52.96 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 CA-C-N 125.622 3.044 . . . . 0.0 109.542 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -87.09 54.3 3.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 169.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 tp -93.68 -75.8 0.49 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 125.498 1.519 . . . . 0.0 107.436 172.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.1 -54.26 2.08 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 115.567 -2.159 . . . . 0.0 108.885 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 43.76 1.02 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 CA-C-N 125.129 2.867 . . . . 0.0 110.498 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 tt -90.1 -46.55 8.4 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 152.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -34.75 65.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.999 1.719 . . . . 0.0 111.935 -175.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -42.96 64.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.922 0.868 . . . . 0.0 109.757 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -62.89 -37.61 87.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.236 2.214 . . . . 0.0 113.693 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 4.5 pt20 -66.42 -50.3 63.88 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.42 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -48.98 -28.93 4.25 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 126.704 2.002 . . . . 0.0 112.691 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.289 2.5 m-85 -77.09 -41.71 41.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 119.349 3.092 . . . . 0.0 119.349 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 pt -72.31 -23.24 21.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 CA-C-N 121.675 2.034 . . . . 0.0 110.357 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 52' ' ' GLN . 64.2 t -74.85 -35.42 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 C-N-CA 131.438 3.895 . . . . 0.0 111.607 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 38.1 ttp -55.36 -34.76 64.56 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.858 0.863 . . . . 0.0 111.257 162.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -12.87 80.65 Favored Glycine 0 C--N 1.353 1.486 0 C-N-CA 124.042 0.829 . . . . 0.0 112.701 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.82 -17.75 46.4 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.147 0.979 . . . . 0.0 110.433 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.6 -24.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 124.314 1.046 . . . . 0.0 108.628 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.1 t70 -77.97 -13.3 59.93 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.903 0.881 . . . . 0.0 111.305 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.22 -19.48 29.92 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.994 1.318 . . . . 0.0 111.834 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.321 0.3 OUTLIER -50.16 -58.77 8.6 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.22 -5.71 12.83 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.006 2.47 . . . . 0.0 108.828 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.63 -54.33 6.81 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -30.45 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.636 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.66 -29.38 40.87 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 119.124 0.874 . . . . 0.0 111.028 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.8 t -82.66 -29.78 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.26 80.03 Favored Glycine 0 C--N 1.359 1.83 0 CA-C-N 118.89 0.768 . . . . 0.0 111.432 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.84 68.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.34 1.856 . . . . 0.0 110.988 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.03 -42.66 28.96 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.21 -36.62 83.53 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 127.402 2.281 . . . . 0.0 112.616 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -79.91 -33.02 40.16 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.014 0.126 . . . . 0.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.25 -30.25 45.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.876 0 C-N-CA 124.095 0.958 . . . . 0.0 109.742 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.2 ttt -72.93 -31.69 64.79 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.71 -0.619 . . . . 0.0 110.397 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -71.75 -30.76 65.94 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 126.178 1.791 . . . . 0.0 110.124 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.0 44.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.661 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.36 -64.06 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.631 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.111 -177.51 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.481 -1.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.16 -30.54 67.72 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.69 1.196 . . . . 0.0 108.348 164.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.03 -49.05 40.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.424 1.49 . . . . 0.0 110.501 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.35 -28.64 59.7 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.89 -44.11 50.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.524 1.13 . . . . 0.0 110.786 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -25.03 61.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.363 1.465 . . . . 0.0 109.947 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.06 -43.03 65.52 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.031 0.932 . . . . 0.0 110.201 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.29 -35.31 71.26 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.318 1.447 . . . . 0.0 109.879 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -67.79 -40.91 83.9 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.258 1.823 . . . . 0.0 112.684 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -48.73 60.3 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.221 1.409 . . . . 0.0 108.84 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.0 mtt -68.51 -16.43 63.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.425 1.09 . . . . 0.0 112.076 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.09 62.43 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.398 1.079 . . . . 0.0 109.929 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.44 70.49 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 125.113 1.365 . . . . 0.0 113.509 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.83 -20.5 35.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.719 1.145 . . . . 0.0 110.421 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.64 -26.54 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 125.408 1.483 . . . . 0.0 107.767 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 mmt -81.35 -68.76 0.66 Allowed 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.68 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -16.58 53.38 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.81 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.44 -51.79 40.11 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.46 -61.98 1.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.291 0.636 . . . . 0.0 110.925 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.577 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.43 -41.47 39.68 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -161.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.88 66.96 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.46 -31.3 9.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.66 -32.05 74.1 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.32 -63.89 1.11 Allowed 'General case' 0 CA--C 1.493 -1.222 0 C-N-CA 125.014 1.325 . . . . 0.0 110.169 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.41 -41.67 4.34 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 126.879 2.072 . . . . 0.0 115.258 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.75 -53.68 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 125.592 1.557 . . . . 0.0 111.487 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.67 67.4 Favored Glycine 0 CA--C 1.49 -1.508 0 CA-C-N 120.143 1.338 . . . . 0.0 114.988 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.445 HG12 ' HA3' ' A' ' 58' ' ' GLY . 8.4 mt -74.22 -27.89 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -48.56 10.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.74 -76.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 124.32 1.048 . . . . 0.0 112.484 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.17 -36.76 83.96 Favored 'General case' 0 CA--C 1.493 -1.236 0 C-N-CA 126.45 1.9 . . . . 0.0 113.385 -170.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -21.01 64.18 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.11 -34.92 31.89 Favored Glycine 0 C--N 1.362 2.003 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -73.33 -31.13 63.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 126.763 2.025 . . . . 0.0 109.654 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -38.17 84.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.729 1.211 . . . . 0.0 111.176 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.28 -13.97 60.14 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.923 -0.485 . . . . 0.0 111.946 175.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -67.12 -38.38 85.5 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 119.777 -1.827 . . . . 0.0 110.333 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.53 -36.4 58.88 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.21 62.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.241 1.417 . . . . 0.0 113.859 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.57 -53.69 12.94 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.679 1.591 . . . . 0.0 111.392 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -23.54 41.09 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.84 0.856 . . . . 0.0 111.16 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.23 167.33 31.22 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.97 153.35 63.39 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.342 2.028 . . . . 0.0 108.078 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.26 42.86 1.06 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.254 0.622 . . . . 0.0 109.951 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.1 tp -93.28 -79.42 0.4 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.096 0.958 . . . . 0.0 108.656 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.78 -53.53 2.43 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-O 115.783 -2.056 . . . . 0.0 111.223 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.15 3.68 7.63 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 125.262 2.915 . . . . 0.0 110.933 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.09 -28.6 48.72 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -36.92 66.17 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.19 0.996 . . . . 0.0 110.917 -177.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.67 66.74 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.326 -0.859 . . . . 0.0 112.201 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -62.91 -43.63 98.28 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.804 1.242 . . . . 0.0 112.809 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 9.3 pt20 -63.97 -49.07 73.94 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 124.179 0.992 . . . . 0.0 109.869 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -49.63 -31.97 11.99 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.928 1.691 . . . . 0.0 112.28 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 5.3 m-30 -77.76 -34.59 52.31 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 121.163 3.764 . . . . 0.0 121.163 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 pt -76.79 -23.79 15.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 CA-C-N 120.95 1.705 . . . . 0.0 109.197 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 52' ' ' GLN . 76.3 t -75.13 -40.37 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 1 C-N-CA 131.827 4.051 . . . . 0.0 112.114 174.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.8 ttt -55.17 -31.47 61.39 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.164 1.386 . . . . 0.0 110.597 165.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 28' ' ' ILE . . . -89.17 -22.54 37.73 Favored Glycine 0 N--CA 1.426 -2.003 0 C-N-CA 124.254 0.931 . . . . 0.0 114.041 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.15 -40.57 27.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.614 1.566 . . . . 0.0 107.678 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.85 -18.93 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 C-N-CA 126.901 2.081 . . . . 0.0 111.382 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.46 -41.59 69.22 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.718 1.207 . . . . 0.0 110.141 173.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.32 21.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.641 0.776 . . . . 0.0 112.351 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -48.7 72.85 Favored Pre-proline 0 CA--C 1.507 -0.709 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -85.21 0.28 8.82 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 124.33 2.582 . . . . 0.0 107.366 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -93.92 -39.52 10.63 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.718 1.207 . . . . 0.0 108.093 -177.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.64 -31.78 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -26.89 57.53 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 118.653 0.661 . . . . 0.0 111.297 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.84 -26.33 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.77 -18.44 79.64 Favored Glycine 0 C--N 1.357 1.741 0 CA-C-N 119.082 0.856 . . . . 0.0 111.156 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -35.56 30.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 128.537 2.735 . . . . 0.0 109.205 175.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.07 -28.72 63.86 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -79.09 -29.09 43.12 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.043 1.737 . . . . 0.0 109.878 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.17 -35.5 36.41 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 124.017 0.927 . . . . 0.0 111.772 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.36 -26.71 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 C-N-CA 125.405 1.482 . . . . 0.0 108.716 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.8 tpt -74.27 -28.8 61.37 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.43 -29.0 59.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.677 1.591 . . . . 0.0 109.576 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.68 -23.9 49.44 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.569 0.748 . . . . 0.0 111.284 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -91.29 -71.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.61 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.87 -36.76 85.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.282 1.433 . . . . 0.0 109.412 168.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -74.63 -47.83 29.87 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.392 1.477 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.33 -25.91 50.61 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 126.811 2.044 . . . . 0.0 113.221 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.58 -43.76 46.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.563 1.145 . . . . 0.0 110.71 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -67.02 -30.41 70.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 124.666 1.186 . . . . 0.0 110.185 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.85 -36.6 70.19 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.058 0.943 . . . . 0.0 110.957 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.53 -50.57 51.07 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 126.487 1.915 . . . . 0.0 108.165 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 mt -71.05 -28.42 64.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.931 1.292 . . . . 0.0 112.613 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -54.12 16.22 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.482 0.713 . . . . 0.0 110.823 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -18.74 62.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.075 0.55 . . . . 0.0 111.255 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.52 42.02 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.299 1.44 . . . . 0.0 110.077 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.53 63.87 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.802 2.041 . . . . 0.0 113.993 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.65 -22.92 24.41 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 119.197 0.908 . . . . 0.0 109.909 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.16 -30.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.9 mmt -76.87 -77.11 0.15 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 124.183 0.993 . . . . 0.0 108.439 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.2 ptt? -81.29 -5.5 57.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.69 -52.05 32.02 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 165.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.43 -58.09 7.43 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 111.788 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.57 -47.51 19.25 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -171.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 17' ' ' MET . . . -56.69 -24.81 51.6 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pp -81.89 -32.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 CA-C-N 119.086 0.857 . . . . 0.0 111.562 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.17 -35.44 88.51 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 125.081 1.324 . . . . 0.0 111.181 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.22 60.58 Favored 'General case' 0 CA--C 1.486 -1.497 0 C-N-CA 128.334 2.654 . . . . 0.0 109.992 166.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.04 90.65 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 123.712 0.805 . . . . 0.0 112.068 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.3 -21.97 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.41 -32.08 9.06 Favored Glycine 0 CA--C 1.472 -2.605 0 CA-C-N 119.922 1.237 . . . . 0.0 112.3 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' HA3' ' A' ' 58' ' ' GLY . 64.4 mt -58.9 -36.98 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.15 -51.19 7.0 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 96.0 mt -66.31 -66.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 C-N-CA 124.316 1.046 . . . . 0.0 112.515 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.69 -58.47 6.21 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 126.021 1.728 . . . . 0.0 109.404 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.19 -16.6 62.58 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 119.221 0.919 . . . . 0.0 113.963 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.74 -43.52 14.57 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 118.861 1.331 . . . . 0.0 110.491 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.14 -32.85 56.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.515 1.526 . . . . 0.0 111.082 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 124.971 1.309 . . . . 0.0 111.014 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tp -76.46 -21.05 56.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.499 0.59 . . . . 0.0 111.814 172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -80.75 2.9 24.18 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.701 -1.25 . . . . 0.0 110.385 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.9 -31.9 7.11 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 164.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.93 -22.22 53.63 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.688 1.195 . . . . 0.0 112.705 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.14 63.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.873 1.669 . . . . 0.0 112.484 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.15 -25.37 47.3 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.364 1.065 . . . . 0.0 110.58 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -83.7 176.73 3.5 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 125.673 1.589 . . . . 0.0 106.993 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.32 153.49 50.74 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 123.787 2.388 . . . . 0.0 107.274 165.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -87.38 38.65 0.83 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.237 0.615 . . . . 0.0 109.757 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.64 -73.06 0.58 Allowed 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.82 -55.74 1.88 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 115.603 -2.142 . . . . 0.0 110.778 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -85.3 9.45 4.12 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 125.637 3.049 . . . . 0.0 111.71 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.53 -30.68 47.16 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -33.63 58.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.332 1.053 . . . . 0.0 111.43 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.23 -31.7 66.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.115 -0.991 . . . . 0.0 110.316 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 mm-40 -60.39 -55.52 32.57 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.992 -1.004 . . . . 0.0 108.947 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -44.74 -36.47 3.19 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.423 1.489 . . . . 0.0 112.678 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.357 52.7 m-85 -78.03 -37.5 46.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 pt -75.55 -25.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.752 -1.217 . . . . 0.0 109.089 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.3 t -74.9 -38.59 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 130.042 3.337 . . . . 0.0 111.494 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.4 ttm -53.43 -33.67 54.91 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.707 1.603 . . . . 0.0 111.198 167.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 28' ' ' ILE . . . -76.4 -41.44 25.51 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 116.349 -0.387 . . . . 0.0 113.821 173.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.1 mt -66.02 -32.12 73.41 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 118.233 1.016 . . . . 0.0 112.371 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -77.1 -24.93 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 125.652 1.581 . . . . 0.0 111.246 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.51 -39.96 85.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.373 0.669 . . . . 0.0 111.161 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.11 24.89 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 123.654 0.782 . . . . 0.0 112.812 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -48.36 73.96 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.03 -7.75 9.18 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 CA-C-N 124.234 2.548 . . . . 0.0 108.485 -170.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -96.08 -29.97 13.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.068 1.747 . . . . 0.0 108.606 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.21 -30.73 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 108.926 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.23 -28.76 38.5 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.537 1.135 . . . . 0.0 110.898 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.58 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.42 -18.69 77.6 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.23 -37.07 54.0 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 126.928 2.091 . . . . 0.0 110.111 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.63 58.49 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.9 -28.41 49.82 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.783 1.633 . . . . 0.0 110.596 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.06 -35.28 37.29 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.177 0.591 . . . . 0.0 110.801 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.14 -32.14 46.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 124.124 0.969 . . . . 0.0 109.122 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.8 ttt -75.5 -28.46 59.16 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.422 0.689 . . . . 0.0 110.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.33 -35.92 82.45 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.437 1.895 . . . . 0.0 109.422 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.813 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -177.012 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.99 -44.44 92.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.682 1.193 . . . . 0.0 110.031 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -82.01 -31.2 31.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.438 1.095 . . . . 0.0 110.958 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.44 -34.01 66.42 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.327 1.851 . . . . 0.0 111.632 168.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.54 -38.21 59.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.655 1.182 . . . . 0.0 111.404 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.83 -25.87 63.96 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.353 1.061 . . . . 0.0 110.153 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.08 -41.41 67.35 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.234 0.614 . . . . 0.0 110.128 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.93 -22.87 45.16 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.79 -45.36 64.81 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.113 1.365 . . . . 0.0 110.228 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -45.38 70.15 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.906 1.683 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.54 -35.23 75.51 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 126.291 1.836 . . . . 0.0 111.361 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.58 -52.97 62.91 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.735 1.214 . . . . 0.0 111.544 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.99 -36.04 74.22 Favored 'General case' 0 CA--C 1.484 -1.595 0 C-N-CA 125.544 1.538 . . . . 0.0 114.189 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.1 -22.16 25.57 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 119.532 1.06 . . . . 0.0 109.819 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -83.96 -27.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 125.05 1.34 . . . . 0.0 107.524 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.8 ttm -82.13 -71.62 0.48 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.335 0.654 . . . . 0.0 109.931 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -5.62 58.02 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.445 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.6 -54.98 7.89 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.45 -53.25 51.21 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.669 1.188 . . . . 0.0 111.134 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -48.97 16.16 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.91 64.89 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.79 -33.85 12.33 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 CA-C-N 118.651 0.66 . . . . 0.0 111.7 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.84 -38.34 95.99 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 124.65 1.119 . . . . 0.0 110.504 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.02 -68.84 0.16 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 127.845 2.458 . . . . 0.0 108.736 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.61 64.95 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -163.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -71.05 -45.23 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 125.275 1.43 . . . . 0.0 110.826 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.94 43.56 Favored Glycine 0 CA--C 1.465 -3.037 0 CA-C-N 120.246 1.385 . . . . 0.0 115.026 -174.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.98 -10.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 118.423 1.111 . . . . 0.0 110.721 171.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -51.15 7.33 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.49 -71.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.065 0 C-N-CA 123.915 0.886 . . . . 0.0 111.892 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -38.18 89.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.782 2.833 . . . . 0.0 111.775 -174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.64 -20.34 71.53 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.88 -38.08 20.7 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.98 -18.88 49.18 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.387 1.475 . . . . 0.0 110.801 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -67.72 -42.03 82.58 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.93 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.0 -8.44 56.96 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-N 119.572 1.078 . . . . 0.0 111.567 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.26 -39.35 68.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 119.771 -1.831 . . . . 0.0 108.655 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -42.73 80.07 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 125.048 1.309 . . . . 0.0 111.082 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.48 62.91 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.206 1.402 . . . . 0.0 112.966 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.27 -52.29 19.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.991 1.316 . . . . 0.0 111.246 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -19.06 36.94 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 122.831 0.452 . . . . 0.0 111.434 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.11 169.53 18.13 Favored Pre-proline 0 C--N 1.355 0.825 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.86 148.54 52.09 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 CA-C-N 123.989 2.46 . . . . 0.0 107.798 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -87.31 43.92 1.14 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.521 0.728 . . . . 0.0 109.203 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.56 -77.75 0.44 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.411 1.085 . . . . 0.0 108.33 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.03 -56.92 1.54 Allowed Pre-proline 0 N--CA 1.435 -1.192 0 CA-C-O 116.118 -1.896 . . . . 0.0 110.916 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -81.69 7.31 5.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-N 124.75 2.732 . . . . 0.0 111.721 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.68 -34.75 34.5 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 121.229 1.832 . . . . 0.0 107.821 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -37.73 73.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.737 1.215 . . . . 0.0 107.831 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -22.85 60.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 121.074 -1.016 . . . . 0.0 112.688 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -63.01 -46.67 86.52 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 120.369 -1.457 . . . . 0.0 111.411 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 56' ' ' VAL . 10.1 pt20 -66.17 -50.76 62.81 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -43.74 -31.33 0.78 Allowed 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 128.275 2.63 . . . . 0.0 112.724 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.72 -53.27 8.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.17 -24.48 35.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 121.097 1.771 . . . . 0.0 111.515 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 52' ' ' GLN . 84.9 t -74.73 -40.21 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 C-N-CA 130.808 3.643 . . . . 0.0 112.031 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.1 ttm -55.0 -28.26 50.63 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.058 1.343 . . . . 0.0 111.602 167.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -7.4 52.97 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 122.045 -0.409 . . . . 0.0 113.946 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -81.65 -35.72 29.64 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.62 1.21 . . . . 0.0 109.066 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -77.11 -20.3 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 C-N-CA 126.361 1.864 . . . . 0.0 111.338 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.99 -44.13 70.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.923 1.689 . . . . 0.0 110.41 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.55 -25.73 24.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 123.785 0.834 . . . . 0.0 112.662 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.268 0.3 OUTLIER -49.47 -52.7 47.52 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.63 -9.6 8.96 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 CA-C-N 123.773 2.383 . . . . 0.0 108.332 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -87.01 -45.61 10.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 127.009 2.124 . . . . 0.0 105.817 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.18 -32.54 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 109.628 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.49 -27.77 51.98 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.794 0.838 . . . . 0.0 111.086 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.69 -28.84 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.03 -19.88 76.69 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 119.087 0.858 . . . . 0.0 111.611 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.29 -35.33 48.05 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 127.753 2.421 . . . . 0.0 109.892 172.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.17 -32.59 62.77 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 mt -78.48 -23.33 46.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.438 1.895 . . . . 0.0 110.796 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -43.81 21.39 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.506 1.122 . . . . 0.0 110.295 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.1 -25.99 18.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 125.761 1.624 . . . . 0.0 109.162 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.8 ttm -76.63 -31.02 57.12 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 109.66 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -33.95 73.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.132 1.373 . . . . 0.0 109.575 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.775 0 C-N-CA 123.766 0.826 . . . . 0.0 111.559 -174.676 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.03 -27.99 65.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.061 0.944 . . . . 0.0 110.135 170.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -90.49 -32.47 16.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.729 1.212 . . . . 0.0 109.829 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.53 -34.83 67.41 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.228 1.811 . . . . 0.0 111.498 165.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.91 -37.48 58.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.613 1.165 . . . . 0.0 110.709 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.9 mtt -65.95 -30.91 71.56 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.799 1.24 . . . . 0.0 110.295 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.02 -36.9 69.82 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.784 0.834 . . . . 0.0 110.835 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.81 -28.41 36.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.71 1.204 . . . . 0.0 110.487 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 mt -79.68 -27.11 40.81 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.024 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.4 -43.11 74.11 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.829 0.852 . . . . 0.0 109.193 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.3 -23.7 66.42 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.476 1.511 . . . . 0.0 111.708 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -55.59 17.1 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.732 1.213 . . . . 0.0 110.304 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.14 -17.37 26.28 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.247 1.819 . . . . 0.0 114.234 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.37 -29.94 24.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.174 -1.579 . . . . 0.0 109.533 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.5 t -80.51 -37.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 125.774 1.63 . . . . 0.0 108.642 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.2 mmt -80.45 -51.18 9.12 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.924 1.29 . . . . 0.0 111.247 -172.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 34.7 mtm -80.77 -24.96 38.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.5 -48.08 77.28 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.24 -45.07 89.78 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 125.264 1.426 . . . . 0.0 112.458 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.22 2.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.55 -22.72 35.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.81 -33.82 12.29 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 CA-C-N 120.13 1.332 . . . . 0.0 111.589 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.45 -36.71 93.52 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.64 -67.48 0.28 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.611 1.964 . . . . 0.0 108.926 164.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.79 68.53 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.465 1.506 . . . . 0.0 114.554 -160.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.0 -51.97 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 C-N-CA 124.753 1.221 . . . . 0.0 109.122 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -37.49 29.17 Favored Glycine 0 CA--C 1.465 -3.074 0 C-N-CA 119.186 -1.483 . . . . 0.0 115.542 -171.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA3' ' A' ' 58' ' ' GLY . 1.9 pt -76.4 -9.48 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 118.682 1.241 . . . . 0.0 110.885 173.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 -51.22 7.53 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 165.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.44 -71.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 123.882 0.873 . . . . 0.0 111.909 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -38.88 91.55 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 129.245 3.018 . . . . 0.0 111.792 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.33 -19.74 68.46 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -37.82 20.14 Favored Glycine 0 C--N 1.361 1.932 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.97 -17.31 53.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.485 1.514 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -34.22 71.57 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.66 0.784 . . . . 0.0 110.802 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.4 -19.45 58.1 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-O 121.141 0.496 . . . . 0.0 112.051 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -75.16 -20.37 59.4 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.0 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.38 -24.64 67.71 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 125.071 1.32 . . . . 0.0 110.844 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.02 -26.82 54.19 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 118.9 1.35 . . . . 0.0 111.604 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -57.16 4.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.707 1.603 . . . . 0.0 112.144 -167.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -28.06 39.6 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.128 0.571 . . . . 0.0 111.303 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 29.0 mm100 -84.13 173.46 7.27 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 125.586 1.554 . . . . 0.0 106.921 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 56.4 Cg_endo -71.61 150.74 57.49 Favored 'Trans proline' 0 CA--C 1.5 -1.215 0 CA-C-N 123.946 2.445 . . . . 0.0 107.437 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.27 35.88 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.608 0.763 . . . . 0.0 109.592 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.43 -70.96 0.68 Allowed 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.84 -59.47 1.17 Allowed Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-O 116.103 -1.903 . . . . 0.0 110.483 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.43 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 71.6 Cg_endo -82.3 1.86 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 124.796 2.749 . . . . 0.0 112.695 -167.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.02 -27.69 21.87 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 121.241 1.837 . . . . 0.0 107.819 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -37.47 69.95 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -72.2 -24.86 61.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.044 -1.035 . . . . 0.0 112.084 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.5 m -63.09 -46.17 88.66 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.761 1.224 . . . . 0.0 112.046 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.1 pt20 -64.47 -49.95 69.38 Favored 'General case' 0 CA--C 1.469 -2.151 0 C-N-CA 123.752 0.821 . . . . 0.0 109.542 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -45.86 -33.67 3.32 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 126.538 1.935 . . . . 0.0 112.604 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.314 4.0 m-85 -77.28 -39.09 49.34 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.0 pt -74.16 -24.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 CA-C-N 121.283 1.856 . . . . 0.0 109.98 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLN . 67.5 t -74.9 -37.26 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 C-N-CA 131.509 3.924 . . . . 0.0 111.441 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.13 -32.94 62.47 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.201 1.0 . . . . 0.0 111.563 162.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -86.86 -9.34 74.51 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 123.447 0.546 . . . . 0.0 112.989 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.79 -16.8 49.76 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.933 0.893 . . . . 0.0 109.655 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.5 -30.03 19.04 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.91 -16.15 58.45 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.908 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 65' ' ' MET . . . -86.09 -24.07 26.44 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 110.997 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -50.19 68.41 Favored Pre-proline 0 C--N 1.35 0.63 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.44 0.87 9.66 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.335 2.69 . . . . 0.0 108.913 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 62' ' ' ALA . 2.7 ttt -67.99 -59.08 3.54 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.05 -38.17 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.684 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.886 -164.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.24 63.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.376 0.535 . . . . 0.0 111.562 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.8 -27.76 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.01 77.66 Favored Glycine 0 C--N 1.36 1.891 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.841 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.33 48.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.046 2.938 . . . . 0.0 110.869 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.68 -33.69 66.89 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.47 -22.24 51.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.36 1.464 . . . . 0.0 112.233 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.26 -36.59 34.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.619 0.645 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.4 -30.38 48.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.881 1.272 . . . . 0.0 109.242 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.1 tpt -76.67 -34.68 58.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.235 0.614 . . . . 0.0 110.261 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.03 -36.69 82.33 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 126.746 2.018 . . . . 0.0 109.712 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.854 0 C-N-CA 124.007 0.923 . . . . 0.0 111.724 -174.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.482 -1.656 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -70.59 -26.77 63.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.192 0.997 . . . . 0.0 109.721 167.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -88.91 -34.95 16.76 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.625 1.17 . . . . 0.0 109.602 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 tp -56.49 -30.88 63.5 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.562 1.945 . . . . 0.0 112.005 166.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -78.32 -35.26 47.95 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.834 1.253 . . . . 0.0 111.261 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -26.26 61.74 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.18 0.992 . . . . 0.0 109.573 172.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.1 -34.95 69.04 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 123.944 0.898 . . . . 0.0 110.058 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -70.13 -46.95 63.69 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.987 1.715 . . . . 0.0 109.126 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.06 -39.67 95.42 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.791 1.636 . . . . 0.0 112.451 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -48.96 59.11 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.104 0.962 . . . . 0.0 110.432 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.3 mtp -71.37 -17.37 62.42 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.178 0.991 . . . . 0.0 111.997 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -51.7 57.32 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.606 1.163 . . . . 0.0 110.071 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -20.83 56.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.025 2.13 . . . . 0.0 114.372 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.35 -31.34 24.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 120.062 -1.649 . . . . 0.0 110.0 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -80.84 -41.61 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 125.774 1.629 . . . . 0.0 108.526 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -77.51 -45.23 26.13 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.952 1.301 . . . . 0.0 110.788 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.2 mtp -81.01 -20.31 42.05 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.925 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.2 -38.17 54.45 Favored Glycine 0 C--N 1.356 1.639 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.68 -55.91 22.54 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.085 1.354 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.71 -46.75 24.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -164.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' SD ' ' A' ' 65' ' ' MET . . . -56.23 -27.45 54.96 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.18 -32.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 121.158 -0.964 . . . . 0.0 108.788 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -32.35 78.34 Favored Glycine 0 C--N 1.36 1.9 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.94 -66.67 0.44 Allowed 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.201 1.4 . . . . 0.0 109.645 168.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.68 -32.61 59.64 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.626 1.97 . . . . 0.0 115.017 -166.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.4 mt -70.02 -50.63 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 C-N-CA 124.424 1.089 . . . . 0.0 109.553 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.06 -41.28 32.57 Favored Glycine 0 CA--C 1.463 -3.181 0 C-N-CA 119.672 -1.252 . . . . 0.0 115.202 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 pt -75.82 -9.27 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.814 1.307 . . . . 0.0 109.727 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.66 -48.92 8.39 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 166.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.72 -75.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.059 0 CA-C-N 117.942 0.871 . . . . 0.0 112.162 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.55 -41.79 92.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 C-N-CA 129.556 3.142 . . . . 0.0 112.447 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.39 -16.79 70.45 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.12 -44.08 12.39 Favored Glycine 0 C--N 1.363 2.033 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.72 -27.26 61.1 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.288 1.435 . . . . 0.0 110.611 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.21 82.38 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.581 1.152 . . . . 0.0 111.553 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -76.25 -17.78 59.32 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 118.792 0.724 . . . . 0.0 112.102 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.51 -27.74 64.41 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.964 -1.71 . . . . 0.0 109.997 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.32 -37.28 36.99 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.36 -17.1 61.32 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.451 1.501 . . . . 0.0 113.831 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.58 -54.92 8.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.901 1.681 . . . . 0.0 111.254 -171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.79 -20.09 36.47 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.906 0.882 . . . . 0.0 111.116 -175.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.99 168.46 22.7 Favored Pre-proline 0 C--N 1.355 0.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.93 149.12 58.89 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 CA-C-N 122.476 1.92 . . . . 0.0 107.666 170.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.43 40.21 0.91 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.467 0.707 . . . . 0.0 109.575 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -93.67 -76.52 0.47 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 124.696 1.199 . . . . 0.0 109.101 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.84 -49.84 3.38 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 115.408 -2.234 . . . . 0.0 111.087 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -82.94 11.03 3.39 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 125.932 3.154 . . . . 0.0 111.111 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.56 -29.29 41.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -30.34 56.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.611 0.765 . . . . 0.0 112.123 -177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.71 -40.98 65.72 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.2 -0.938 . . . . 0.0 111.765 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.8 m -63.1 -38.54 91.59 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.605 1.562 . . . . 0.0 113.603 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.3 pp0? -62.77 -54.35 40.43 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 124.355 1.062 . . . . 0.0 109.655 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -47.63 -31.25 4.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 126.908 2.083 . . . . 0.0 112.577 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.305 6.1 m-30 -77.19 -45.46 26.56 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -71.76 -18.97 20.02 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 121.306 1.866 . . . . 0.0 110.836 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 52' ' ' GLN . 61.5 t -75.0 -42.88 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 130.329 3.452 . . . . 0.0 110.732 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ttt -55.19 -27.14 43.82 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.784 1.234 . . . . 0.0 111.743 162.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.52 -24.25 65.78 Favored Glycine 0 C--N 1.356 1.67 0 C-N-CA 124.739 1.162 . . . . 0.0 112.337 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.0 -21.71 36.93 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.145 1.378 . . . . 0.0 110.426 174.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.62 -28.11 17.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 124.908 1.283 . . . . 0.0 108.319 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 3.0 t70 -77.78 -29.76 51.05 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.062 0.945 . . . . 0.0 110.089 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 -14.65 42.76 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.083 1.353 . . . . 0.0 112.31 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.277 0.3 OUTLIER -49.94 -52.21 54.41 Favored Pre-proline 0 C--N 1.354 0.782 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 172.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.33 -13.21 12.48 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 123.707 2.36 . . . . 0.0 108.33 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.57 -51.21 45.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.35 2.26 . . . . 0.0 107.281 175.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.91 -39.15 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.178 -164.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.22 58.66 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 119.316 0.962 . . . . 0.0 111.588 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.94 -30.41 10.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.76 -18.27 75.66 Favored Glycine 0 C--N 1.359 1.82 0 CA-C-N 118.842 0.747 . . . . 0.0 111.425 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -35.67 59.72 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 127.778 2.431 . . . . 0.0 110.66 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.66 -41.26 24.7 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.62 -39.23 84.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.772 1.629 . . . . 0.0 112.128 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -80.18 -30.71 38.81 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 117.935 0.334 . . . . 0.0 111.425 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -71.02 -33.05 50.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.306 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 60.4 mtt -75.33 -31.75 60.68 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.297 0.639 . . . . 0.0 110.364 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.391 1.876 . . . . 0.0 109.751 172.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.847 0 C-N-CA 124.512 1.125 . . . . 0.0 112.807 -174.724 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 CA--C 1.483 -1.597 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.14 -27.21 65.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.323 1.049 . . . . 0.0 110.196 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -87.13 -41.31 13.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.293 1.037 . . . . 0.0 108.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.8 tp -56.11 -29.98 61.41 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 127.277 2.231 . . . . 0.0 112.608 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -72.66 -46.85 51.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.461 1.104 . . . . 0.0 110.877 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.12 -25.08 62.43 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.338 1.455 . . . . 0.0 109.739 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.05 -43.87 64.23 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.754 0.821 . . . . 0.0 110.418 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.7 tp -72.11 -48.57 42.9 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 110.585 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.54 -41.89 92.56 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.241 1.016 . . . . 0.0 112.759 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -51.17 37.43 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.389 1.075 . . . . 0.0 110.328 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.71 -19.31 62.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.63 -53.27 43.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.35 1.06 . . . . 0.0 110.173 170.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.79 -15.31 11.7 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.624 2.369 . . . . 0.0 114.453 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.85 -26.45 18.49 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 120.783 -1.198 . . . . 0.0 109.756 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.62 -34.17 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.084 1.353 . . . . 0.0 108.362 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.8 mtt -76.73 -65.72 0.9 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.738 1.615 . . . . 0.0 108.779 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.0 mtm -80.75 -18.96 46.04 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.39 -43.28 97.02 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -64.76 0.8 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.145 0.978 . . . . 0.0 110.588 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.64 -52.69 8.59 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.97 44.41 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.1 -38.29 16.58 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 CA-C-N 120.291 1.405 . . . . 0.0 111.81 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.19 -38.52 95.76 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -54.51 -70.28 0.1 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.947 2.499 . . . . 0.0 109.32 164.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.63 72.44 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 114.15 -158.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.11 -47.23 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 C-N-CA 124.96 1.304 . . . . 0.0 109.908 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 -37.8 27.18 Favored Glycine 0 CA--C 1.465 -3.072 0 CA-C-N 120.218 1.372 . . . . 0.0 115.508 -173.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.1 -9.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 118.583 1.192 . . . . 0.0 110.408 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.32 -51.01 7.75 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 166.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.6 -71.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.994 0.918 . . . . 0.0 112.212 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.47 -39.85 92.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 129.211 3.004 . . . . 0.0 112.622 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.85 -19.1 66.22 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.97 -33.44 26.76 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -71.5 -35.7 70.84 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.716 2.006 . . . . 0.0 109.042 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.45 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 125.77 1.628 . . . . 0.0 111.429 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -16.46 59.72 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.73 -26.45 62.48 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 120.006 -1.684 . . . . 0.0 110.199 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.5 -28.9 46.13 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -31.03 56.13 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.82 -50.91 25.47 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.519 1.128 . . . . 0.0 113.915 -163.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.05 -38.43 66.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.231 1.012 . . . . 0.0 111.785 -170.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.79 172.27 9.28 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.73 157.89 57.23 Favored 'Trans proline' 0 CA--C 1.496 -1.375 0 CA-C-N 124.585 2.673 . . . . 0.0 109.891 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.12 38.19 0.8 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.407 1.083 . . . . 0.0 110.063 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.17 -74.06 0.54 Allowed 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 123.723 0.809 . . . . 0.0 109.002 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.79 -54.15 2.27 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 115.834 -2.031 . . . . 0.0 110.967 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.31 -5.26 14.22 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 125.122 2.865 . . . . 0.0 111.676 -168.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.97 -33.59 70.6 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 119.914 1.234 . . . . 0.0 108.742 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.33 68.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.52 1.128 . . . . 0.0 110.729 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -72.39 -28.88 63.28 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.713 -1.242 . . . . 0.0 112.95 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.6 m -62.95 -45.52 92.07 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.291 1.436 . . . . 0.0 112.381 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 56' ' ' VAL . 8.2 pt20 -59.81 -55.12 38.2 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 123.698 0.799 . . . . 0.0 109.331 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -43.86 -35.56 2.0 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 127.566 2.346 . . . . 0.0 112.904 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.27 8.0 m-85 -76.95 -49.46 15.47 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.9 pt -67.75 -24.51 30.96 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-N 121.023 1.738 . . . . 0.0 111.172 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 52' ' ' GLN . 94.5 t -74.78 -40.58 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 C-N-CA 130.058 3.343 . . . . 0.0 112.065 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 50.0 ttp -51.5 -35.86 42.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.95 0.9 . . . . 0.0 111.309 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -11.82 62.87 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.56 -22.44 37.8 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.394 1.097 . . . . 0.0 109.28 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.76 -30.35 18.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 126.82 2.048 . . . . 0.0 108.749 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 7.6 t70 -70.13 -41.3 74.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.849 1.259 . . . . 0.0 111.082 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.61 31.7 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.695 0.798 . . . . 0.0 111.917 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -49.23 71.74 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.67 -11.5 10.34 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 CA-C-N 124.418 2.614 . . . . 0.0 107.986 -168.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.528 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -91.15 -34.76 14.91 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 126.002 1.721 . . . . 0.0 108.021 -178.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.49 -23.46 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 C-N-CA 123.357 0.663 . . . . 0.0 111.219 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -31.68 24.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.552 1.141 . . . . 0.0 110.101 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.37 -26.37 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.04 -16.51 79.72 Favored Glycine 0 CA--C 1.489 -1.537 0 C-N-CA 124.855 1.217 . . . . 0.0 110.728 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.73 -32.66 31.48 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 125.942 1.697 . . . . 0.0 109.311 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.16 -46.64 15.32 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.64 -39.71 94.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 126.446 1.899 . . . . 0.0 112.83 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -79.89 -28.87 39.84 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.06 -32.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 CA-C-N 118.753 0.706 . . . . 0.0 109.216 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.2 mmt -78.04 -19.78 53.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.275 0.63 . . . . 0.0 111.441 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.13 -37.82 53.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.297 1.439 . . . . 0.0 108.537 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.867 -169.926 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.483 -1.634 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.74 -36.61 82.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.735 1.214 . . . . 0.0 110.278 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.276 1.031 . . . . 0.0 110.804 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.77 -35.84 69.13 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 112.026 164.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -36.19 44.77 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 124.661 1.184 . . . . 0.0 110.133 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.95 -33.19 75.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.704 1.602 . . . . 0.0 109.748 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.01 -35.44 69.42 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.349 1.06 . . . . 0.0 110.096 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.5 -49.4 33.19 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 125.432 1.493 . . . . 0.0 109.852 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.9 -34.17 71.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.843 0.857 . . . . 0.0 112.024 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.63 -50.48 62.85 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.511 0.596 . . . . 0.0 111.273 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.6 mtp -72.73 -13.48 61.34 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.066 0.546 . . . . 0.0 112.215 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.32 12.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.727 1.211 . . . . 0.0 110.035 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.61 54.78 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.735 2.014 . . . . 0.0 114.33 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 -22.72 20.26 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 120.711 -1.243 . . . . 0.0 110.48 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.94 -33.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.7 tpp -79.61 -62.71 1.6 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 109.806 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mtm -81.31 -23.56 37.78 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.35 99.16 Favored Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.19 -67.98 0.39 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.94 -57.05 4.0 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.01 -27.84 54.75 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -31.73 10.24 Favored 'Isoleucine or valine' 0 C--N 1.369 1.42 0 CA-C-N 120.481 1.491 . . . . 0.0 111.638 172.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.05 76.23 Favored Glycine 0 C--N 1.363 2.044 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -73.2 0.08 Allowed 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 127.912 2.485 . . . . 0.0 108.65 167.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.59 30.89 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -167.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.6 mm -71.0 -50.31 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.187 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 -40.48 49.16 Favored Glycine 0 CA--C 1.46 -3.36 0 CA-C-N 120.087 1.312 . . . . 0.0 114.585 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 pt -75.87 -8.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 119.026 1.413 . . . . 0.0 110.703 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.92 -50.51 7.75 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -65.41 -70.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.144 0 CA-C-N 117.617 0.709 . . . . 0.0 112.278 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.81 -46.02 91.34 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 129.398 3.079 . . . . 0.0 111.506 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.09 -19.49 79.78 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 119.435 1.016 . . . . 0.0 111.996 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.57 14.64 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -74.23 -27.0 60.57 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.01 1.724 . . . . 0.0 110.693 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -43.73 91.17 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.45 1.5 . . . . 0.0 112.091 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -10.64 59.56 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -70.14 -34.53 73.17 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.035 -1.666 . . . . 0.0 110.434 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.43 -35.19 48.33 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.15 62.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.652 1.581 . . . . 0.0 113.729 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -48.42 47.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.31 1.444 . . . . 0.0 113.594 -169.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -37.23 63.91 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.159 0.984 . . . . 0.0 111.324 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -84.47 174.67 5.51 Favored Pre-proline 0 C--N 1.353 0.757 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.98 153.5 57.95 Favored 'Trans proline' 0 CA--C 1.5 -1.2 0 CA-C-N 125.435 2.977 . . . . 0.0 109.158 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -87.25 44.43 1.18 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.095 0.958 . . . . 0.0 108.551 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -93.77 -75.47 0.5 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 124.713 1.205 . . . . 0.0 108.255 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.84 -54.04 2.27 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 115.777 -2.058 . . . . 0.0 111.116 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.05 -1.75 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 CA-C-N 125.24 2.907 . . . . 0.0 111.429 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 tp -77.98 -26.85 48.94 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 120.049 1.295 . . . . 0.0 108.86 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.16 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.87 0.868 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.258 0.8 OUTLIER -72.41 -27.65 62.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 120.65 -1.281 . . . . 0.0 112.984 173.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -62.9 -44.52 95.88 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 112.962 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.4 pt20 -59.28 -51.11 71.35 Favored 'General case' 0 CA--C 1.474 -1.959 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.44 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -41.89 -37.66 1.35 Allowed 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.853 2.461 . . . . 0.0 113.566 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.12 -46.26 24.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.81 -21.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 120.889 1.677 . . . . 0.0 110.924 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 52' ' ' GLN . 73.9 t -75.02 -40.67 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 C-N-CA 130.9 3.68 . . . . 0.0 112.019 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.8 ttp -53.17 -31.83 44.73 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.387 1.075 . . . . 0.0 111.544 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.04 -3.92 51.33 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.186 0.435 . . . . 0.0 114.186 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.87 -38.05 25.98 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.5 -21.17 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 127.264 2.226 . . . . 0.0 110.289 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.05 -42.36 72.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.963 1.705 . . . . 0.0 110.628 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.48 -20.67 27.74 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.408 1.083 . . . . 0.0 112.729 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.276 0.3 OUTLIER -49.62 -52.27 52.06 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.45 -5.37 9.23 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 CA-C-N 123.748 2.374 . . . . 0.0 107.82 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.4 mmt -92.48 -41.27 10.38 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 126.701 2.0 . . . . 0.0 106.184 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -29.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 C-N-CA 124.392 1.077 . . . . 0.0 109.848 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.87 -29.88 56.02 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 124.031 0.932 . . . . 0.0 111.584 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.04 -31.88 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.06 -18.71 80.14 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.324 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -36.88 38.47 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 127.964 2.506 . . . . 0.0 110.559 174.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.86 -38.84 85.62 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.16 -23.31 61.27 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.544 1.538 . . . . 0.0 111.716 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -79.99 -35.21 37.81 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.847 0.859 . . . . 0.0 110.68 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.64 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 124.293 1.037 . . . . 0.0 109.538 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.4 mtp -77.96 -25.48 48.24 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.627 0.771 . . . . 0.0 111.268 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -36.99 78.54 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.95 1.7 . . . . 0.0 108.516 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.818 0 C-N-CA 124.322 1.049 . . . . 0.0 111.556 -174.591 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.34 -41.27 98.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.091 1.356 . . . . 0.0 110.074 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -78.26 -44.6 25.07 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.945 1.298 . . . . 0.0 110.631 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.63 -23.7 43.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.105 2.162 . . . . 0.0 113.029 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.97 -43.85 42.63 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.302 1.041 . . . . 0.0 110.945 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.2 mtm -69.57 -27.22 64.94 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.88 1.272 . . . . 0.0 110.219 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.86 -37.03 70.28 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.691 0.797 . . . . 0.0 110.131 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.9 tp -77.81 -31.72 51.9 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.233 1.413 . . . . 0.0 110.128 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.08 -45.08 82.52 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 0.0 111.256 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -69.34 -41.7 76.29 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.467 0.707 . . . . 0.0 111.637 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.9 ttm -61.9 -32.79 73.2 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.099 1.36 . . . . 0.0 111.149 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.54 -60.17 3.91 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.194 1.397 . . . . 0.0 110.786 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.01 58.69 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.718 1.607 . . . . 0.0 114.416 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.34 -33.28 18.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.469 -1.394 . . . . 0.0 110.3 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.11 -33.76 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 125.312 1.445 . . . . 0.0 108.393 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.53 -53.23 6.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.576 1.15 . . . . 0.0 110.041 -170.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.1 mtm -80.65 -23.69 39.5 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.92 90.55 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.36 -51.61 62.45 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.966 1.307 . . . . 0.0 112.29 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.04 -50.05 13.99 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -170.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.15 57.77 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.87 -32.77 11.46 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 CA-C-N 119.156 0.889 . . . . 0.0 111.928 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.84 91.49 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.45 -53.16 61.26 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 128.752 2.821 . . . . 0.0 110.831 165.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.62 82.07 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.906 0.882 . . . . 0.0 113.194 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.01 -37.61 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 C-N-CA 126.183 1.793 . . . . 0.0 110.052 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -33.71 32.54 Favored Glycine 0 CA--C 1.478 -2.227 0 CA-C-N 119.875 1.216 . . . . 0.0 113.682 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.476 HD11 ' HA3' ' A' ' 58' ' ' GLY . 21.1 mt -62.6 -30.28 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.58 9.11 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.21 -73.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.139 0 C-N-CA 123.773 0.829 . . . . 0.0 112.543 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.68 -45.52 82.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.964 2.506 . . . . 0.0 111.335 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.27 -17.03 80.27 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.29 -36.56 30.48 Favored Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -74.98 -35.47 62.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.528 1.931 . . . . 0.0 108.883 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -34.66 76.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.657 1.183 . . . . 0.0 111.218 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -76.3 -13.43 60.15 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 122.89 0.476 . . . . 0.0 112.149 175.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.53 -39.59 85.06 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 119.902 -1.748 . . . . 0.0 109.803 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.92 -26.77 66.01 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.9 59.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.924 1.289 . . . . 0.0 112.948 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.23 8.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.521 1.528 . . . . 0.0 111.639 -171.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -29.55 51.4 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 111.205 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -84.04 167.44 27.78 Favored Pre-proline 0 N--CA 1.441 -0.894 0 C-N-CA 125.193 1.397 . . . . 0.0 107.277 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.06 155.01 62.32 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 CA-C-N 123.538 2.299 . . . . 0.0 108.275 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.11 42.03 1.01 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.33 0.652 . . . . 0.0 110.066 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -93.5 -79.16 0.41 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.992 0.917 . . . . 0.0 108.7 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.79 -52.48 2.7 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-O 115.615 -2.136 . . . . 0.0 111.864 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.68 2.79 8.3 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 125.57 3.025 . . . . 0.0 110.858 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 -27.01 35.25 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 172.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -72.04 -36.48 69.64 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.798 0.839 . . . . 0.0 110.837 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -32.56 66.59 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.179 -0.951 . . . . 0.0 112.131 173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -62.79 -42.53 99.75 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.92 1.288 . . . . 0.0 113.109 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 11.6 pt20 -63.87 -45.05 91.14 Favored 'General case' 0 CA--C 1.464 -2.347 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -52.76 -30.8 34.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.889 1.276 . . . . 0.0 112.297 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 10.3 m-30 -78.15 -28.55 48.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 121.364 3.839 . . . . 0.0 121.364 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.79 -29.12 25.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 121.251 1.841 . . . . 0.0 108.597 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.81 -35.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 1 C-N-CA 132.645 4.378 . . . . 0.0 111.794 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.4 ttt -55.05 -33.21 62.51 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.724 1.21 . . . . 0.0 110.919 164.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -76.48 -38.26 33.53 Favored Glycine 0 N--CA 1.433 -1.526 0 O-C-N 121.888 -0.508 . . . . 0.0 114.045 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.5 -35.07 76.99 Favored 'General case' 0 CA--C 1.508 -0.673 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.08 -25.73 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 C-N-CA 126.267 1.827 . . . . 0.0 110.93 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 19.0 t70 -71.53 -37.04 71.19 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.631 0.772 . . . . 0.0 111.681 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.71 -20.81 27.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.484 1.113 . . . . 0.0 112.882 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -45.9 78.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.14 -7.49 8.05 Favored 'Trans proline' 0 CA--C 1.494 -1.479 0 CA-C-N 124.189 2.532 . . . . 0.0 107.318 -168.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -91.4 -40.43 11.44 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 125.54 1.536 . . . . 0.0 107.77 -176.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 tp -77.74 -30.58 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.15 57.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.162 0.985 . . . . 0.0 111.313 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -77.96 -28.67 15.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 CA-C-N 118.298 0.499 . . . . 0.0 109.947 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.94 -21.92 70.08 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -34.9 62.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.604 2.362 . . . . 0.0 110.462 170.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.43 -35.61 63.19 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.2 mt -73.74 -25.86 60.39 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 110.876 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -39.88 29.11 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.671 1.188 . . . . 0.0 110.814 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 -26.15 20.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.891 1.277 . . . . 0.0 109.247 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.18 57.48 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.61 0.764 . . . . 0.0 109.344 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.57 -33.68 69.28 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.798 1.239 . . . . 0.0 109.425 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 0.798 0 C-N-CA 123.733 0.813 . . . . 0.0 111.96 -173.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.478 -1.801 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -36.62 82.76 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.35 1.06 . . . . 0.0 108.345 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.04 -48.85 16.75 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 125.254 1.422 . . . . 0.0 111.672 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.264 1.8 pp -56.78 -27.95 60.52 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.973 1.309 . . . . 0.0 113.099 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.88 -45.22 44.36 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.96 1.304 . . . . 0.0 110.837 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 81.8 mtp -64.07 -31.58 72.83 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.36 1.464 . . . . 0.0 110.282 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.98 -38.71 69.67 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.097 0.959 . . . . 0.0 110.701 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.46 -36.14 58.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 125.136 1.375 . . . . 0.0 110.181 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.31 -27.29 42.16 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.87 0.868 . . . . 0.0 111.852 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.41 -44.76 70.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 123.14 0.576 . . . . 0.0 109.913 168.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm -63.72 -25.78 68.35 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 111.712 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -59.14 4.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.061 1.345 . . . . 0.0 110.503 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.39 -9.61 2.5 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 126.428 1.891 . . . . 0.0 114.742 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.03 -28.26 14.71 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 120.865 -1.147 . . . . 0.0 109.153 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.24 -27.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.709 0.804 . . . . 0.0 109.334 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -59.99 2.56 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.638 1.575 . . . . 0.0 108.701 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.6 mtm -80.9 -22.81 39.44 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.921 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.8 -40.84 75.03 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.35 -51.03 65.37 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.105 0.962 . . . . 0.0 111.715 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.02 -51.86 10.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.25 -25.69 48.74 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.88 -33.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 119.828 1.195 . . . . 0.0 110.907 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.8 -38.27 95.68 Favored Glycine 0 C--N 1.355 1.619 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -56.95 -64.64 0.81 Allowed 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.266 1.826 . . . . 0.0 109.659 165.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.04 73.31 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.712 1.205 . . . . 0.0 113.964 -159.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.81 -47.11 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 C-N-CA 124.908 1.283 . . . . 0.0 109.54 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.9 27.76 Favored Glycine 0 CA--C 1.462 -3.235 0 C-N-CA 119.235 -1.46 . . . . 0.0 115.455 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -73.68 -10.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 118.924 1.362 . . . . 0.0 109.842 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.6 -50.27 8.25 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 167.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.73 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 123.493 0.717 . . . . 0.0 112.42 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.69 -44.29 86.64 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 129.417 3.087 . . . . 0.0 112.138 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.56 -18.33 68.73 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.7 -38.45 20.29 Favored Glycine 0 C--N 1.364 2.115 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 125.939 1.695 . . . . 0.0 109.925 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -39.3 85.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 124.456 1.102 . . . . 0.0 111.604 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -10.18 59.21 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.71 -43.04 80.97 Favored 'General case' 0 C--N 1.362 1.114 0 O-C-N 119.995 -1.691 . . . . 0.0 109.625 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.67 -27.11 65.76 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.04 60.77 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.662 1.185 . . . . 0.0 112.914 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.63 -56.4 5.91 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 125.198 1.399 . . . . 0.0 111.559 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -28.32 40.25 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 111.467 -173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -84.02 164.78 42.47 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.94 155.2 62.48 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 CA-C-N 123.294 2.212 . . . . 0.0 108.38 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -87.21 45.02 1.22 Allowed 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.734 0.647 . . . . 0.0 109.455 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -79.19 0.41 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.058 0.943 . . . . 0.0 108.718 173.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.31 -54.26 2.5 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-O 115.766 -2.064 . . . . 0.0 111.587 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.66 0.19 10.21 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 CA-C-N 125.32 2.936 . . . . 0.0 111.001 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.6 -35.71 57.95 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -42.2 84.2 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.744 1.218 . . . . 0.0 110.956 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.01 -31.6 66.36 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.859 -1.15 . . . . 0.0 112.596 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -62.87 -45.09 94.2 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 124.735 1.214 . . . . 0.0 112.738 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 56' ' ' VAL . 11.7 pt20 -58.94 -54.29 48.8 Favored 'General case' 0 CA--C 1.461 -2.469 0 CA-C-O 116.819 -1.562 . . . . 0.0 109.322 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -44.91 -38.41 4.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 128.572 2.749 . . . . 0.0 113.039 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -76.95 -35.78 57.0 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -75.83 -29.09 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 C-N-CA 126.224 1.809 . . . . 0.0 109.382 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -75.15 -35.97 36.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 C-N-CA 125.307 1.443 . . . . 0.0 110.043 175.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.04 -33.86 63.03 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.979 0.911 . . . . 0.0 111.31 165.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.14 -20.54 62.6 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 124.053 0.835 . . . . 0.0 112.709 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -82.12 -26.95 33.1 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.644 1.978 . . . . 0.0 109.502 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.4 -27.24 17.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 125.731 1.612 . . . . 0.0 108.621 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.9 t70 -74.84 -24.92 58.68 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.034 0.933 . . . . 0.0 110.461 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.56 31.83 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.844 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.348 0.3 OUTLIER -50.31 -58.97 8.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 171.992 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' HG22 ' A' ' 63' ' ' ILE . 74.4 Cg_endo -79.82 -13.29 13.12 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.915 2.41 . . . . 0.0 108.913 -169.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -59.44 3.2 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 127.353 2.261 . . . . 0.0 106.076 174.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -31.34 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.736 -164.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -28.77 47.76 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 118.984 0.811 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.37 -28.51 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.61 -15.4 79.67 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -39.94 62.21 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 126.712 2.005 . . . . 0.0 110.311 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.85 -35.06 46.4 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.75 -26.66 50.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.148 1.379 . . . . 0.0 112.17 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -80.31 -32.68 37.94 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 118.762 0.71 . . . . 0.0 110.17 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.51 -30.59 49.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 123.999 0.92 . . . . 0.0 109.667 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -37.21 66.54 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.546 0.739 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.31 -32.56 73.32 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 127.028 2.131 . . . . 0.0 110.314 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.871 0 C-N-CA 123.97 0.908 . . . . 0.0 111.781 -176.633 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.41 -31.2 71.25 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.847 1.259 . . . . 0.0 109.711 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -76.38 -50.52 13.99 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.326 1.45 . . . . 0.0 109.678 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.62 -20.48 21.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.039 2.535 . . . . 0.0 113.249 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.45 -40.46 50.48 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.626 1.17 . . . . 0.0 111.358 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -26.16 61.48 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 124.29 1.036 . . . . 0.0 109.351 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.94 -35.02 69.49 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.594 0.757 . . . . 0.0 110.166 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.99 -48.05 55.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.5 1.52 . . . . 0.0 109.271 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.18 -37.3 86.99 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.239 1.016 . . . . 0.0 113.083 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.62 44.02 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.283 1.033 . . . . 0.0 110.267 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.6 mtp -74.98 -14.38 60.62 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.753 0.821 . . . . 0.0 111.977 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.61 -51.74 57.32 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.965 1.306 . . . . 0.0 109.616 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.92 64.24 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.706 2.002 . . . . 0.0 113.385 170.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.73 -29.31 32.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 119.709 -1.87 . . . . 0.0 110.218 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -79.89 -40.17 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 C-N-CA 125.686 1.595 . . . . 0.0 108.662 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.5 ttm -84.53 -43.04 14.9 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.579 0.752 . . . . 0.0 111.431 -168.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.2 mtp -80.16 -28.59 38.81 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.28 -41.88 91.15 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.31 -44.12 92.56 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.673 1.189 . . . . 0.0 111.322 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.23 7.15 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.27 -28.54 58.99 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.68 -31.86 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.6 74.3 Favored Glycine 0 C--N 1.361 1.935 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -58.05 -74.01 0.07 Allowed 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.965 1.306 . . . . 0.0 109.312 164.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.55 69.79 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.762 1.625 . . . . 0.0 114.774 -161.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.7 mm -71.07 -45.43 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 124.869 1.267 . . . . 0.0 110.495 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.82 -41.18 29.1 Favored Glycine 0 CA--C 1.461 -3.314 0 CA-C-N 120.348 1.431 . . . . 0.0 114.494 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.02 -5.88 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 118.823 1.311 . . . . 0.0 110.323 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.95 -50.06 6.63 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -65.59 -71.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.042 0.937 . . . . 0.0 111.997 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.43 -30.96 71.82 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 129.425 3.09 . . . . 0.0 112.601 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.14 -19.13 47.68 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 119.113 0.87 . . . . 0.0 110.956 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.12 -36.29 9.09 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 118.329 1.064 . . . . 0.0 110.608 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.96 -20.42 45.63 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.208 1.403 . . . . 0.0 109.559 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -42.13 98.7 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.757 1.223 . . . . 0.0 111.188 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -10.81 59.7 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 123.353 0.661 . . . . 0.0 111.829 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -71.87 -36.8 70.2 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 120.185 -1.572 . . . . 0.0 109.268 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.22 -33.72 56.29 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.46 71.84 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.163 1.385 . . . . 0.0 113.066 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.76 -41.26 68.62 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.251 1.42 . . . . 0.0 112.636 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -75.92 -36.99 59.21 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.546 1.138 . . . . 0.0 111.453 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -84.44 176.42 3.74 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.97 155.41 52.96 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 CA-C-N 125.622 3.044 . . . . 0.0 109.542 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -87.09 54.3 3.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 169.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 tp -93.68 -75.8 0.49 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 125.498 1.519 . . . . 0.0 107.436 172.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.1 -54.26 2.08 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 115.567 -2.159 . . . . 0.0 108.885 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 43.76 1.02 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 CA-C-N 125.129 2.867 . . . . 0.0 110.498 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 tt -90.1 -46.55 8.4 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 152.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -34.75 65.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.999 1.719 . . . . 0.0 111.935 -175.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -42.96 64.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.922 0.868 . . . . 0.0 109.757 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -62.89 -37.61 87.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.236 2.214 . . . . 0.0 113.693 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 4.5 pt20 -66.42 -50.3 63.88 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.42 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -48.98 -28.93 4.25 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 126.704 2.002 . . . . 0.0 112.691 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.289 2.5 m-85 -77.09 -41.71 41.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 119.349 3.092 . . . . 0.0 119.349 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 pt -72.31 -23.24 21.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 CA-C-N 121.675 2.034 . . . . 0.0 110.357 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 52' ' ' GLN . 64.2 t -74.85 -35.42 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 C-N-CA 131.438 3.895 . . . . 0.0 111.607 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 38.1 ttp -55.36 -34.76 64.56 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.858 0.863 . . . . 0.0 111.257 162.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -12.87 80.65 Favored Glycine 0 C--N 1.353 1.486 0 C-N-CA 124.042 0.829 . . . . 0.0 112.701 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.82 -17.75 46.4 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.147 0.979 . . . . 0.0 110.433 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.6 -24.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 124.314 1.046 . . . . 0.0 108.628 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.1 t70 -77.97 -13.3 59.93 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.903 0.881 . . . . 0.0 111.305 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.22 -19.48 29.92 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.994 1.318 . . . . 0.0 111.834 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.321 0.3 OUTLIER -50.16 -58.77 8.6 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.22 -5.71 12.83 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.006 2.47 . . . . 0.0 108.828 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.63 -54.33 6.81 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -30.45 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.636 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.66 -29.38 40.87 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 119.124 0.874 . . . . 0.0 111.028 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.8 t -82.66 -29.78 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.26 80.03 Favored Glycine 0 C--N 1.359 1.83 0 CA-C-N 118.89 0.768 . . . . 0.0 111.432 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.84 68.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.34 1.856 . . . . 0.0 110.988 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.03 -42.66 28.96 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.21 -36.62 83.53 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 127.402 2.281 . . . . 0.0 112.616 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -79.91 -33.02 40.16 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.014 0.126 . . . . 0.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.25 -30.25 45.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.876 0 C-N-CA 124.095 0.958 . . . . 0.0 109.742 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.2 ttt -72.93 -31.69 64.79 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.71 -0.619 . . . . 0.0 110.397 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -71.75 -30.76 65.94 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 126.178 1.791 . . . . 0.0 110.124 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.661 -174.251 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.481 -1.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.16 -30.54 67.72 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.69 1.196 . . . . 0.0 108.348 164.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.03 -49.05 40.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.424 1.49 . . . . 0.0 110.501 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.35 -28.64 59.7 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.89 -44.11 50.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.524 1.13 . . . . 0.0 110.786 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -25.03 61.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.363 1.465 . . . . 0.0 109.947 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.06 -43.03 65.52 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.031 0.932 . . . . 0.0 110.201 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.29 -35.31 71.26 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.318 1.447 . . . . 0.0 109.879 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -67.79 -40.91 83.9 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.258 1.823 . . . . 0.0 112.684 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -48.73 60.3 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.221 1.409 . . . . 0.0 108.84 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.0 mtt -68.51 -16.43 63.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.425 1.09 . . . . 0.0 112.076 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.09 62.43 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.398 1.079 . . . . 0.0 109.929 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.44 70.49 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 125.113 1.365 . . . . 0.0 113.509 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.83 -20.5 35.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.719 1.145 . . . . 0.0 110.421 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.64 -26.54 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 125.408 1.483 . . . . 0.0 107.767 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 mmt -81.35 -68.76 0.66 Allowed 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.68 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -16.58 53.38 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.81 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.44 -51.79 40.11 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.46 -61.98 1.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.291 0.636 . . . . 0.0 110.925 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.577 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.43 -41.47 39.68 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -161.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.88 66.96 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.46 -31.3 9.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.66 -32.05 74.1 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.32 -63.89 1.11 Allowed 'General case' 0 CA--C 1.493 -1.222 0 C-N-CA 125.014 1.325 . . . . 0.0 110.169 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.41 -41.67 4.34 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 126.879 2.072 . . . . 0.0 115.258 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.75 -53.68 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 125.592 1.557 . . . . 0.0 111.487 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.67 67.4 Favored Glycine 0 CA--C 1.49 -1.508 0 CA-C-N 120.143 1.338 . . . . 0.0 114.988 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.445 HG12 ' HA3' ' A' ' 58' ' ' GLY . 8.4 mt -74.22 -27.89 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -48.56 10.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.74 -76.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 124.32 1.048 . . . . 0.0 112.484 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.17 -36.76 83.96 Favored 'General case' 0 CA--C 1.493 -1.236 0 C-N-CA 126.45 1.9 . . . . 0.0 113.385 -170.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -21.01 64.18 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.11 -34.92 31.89 Favored Glycine 0 C--N 1.362 2.003 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -73.33 -31.13 63.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 126.763 2.025 . . . . 0.0 109.654 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -38.17 84.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.729 1.211 . . . . 0.0 111.176 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.28 -13.97 60.14 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.923 -0.485 . . . . 0.0 111.946 175.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -67.12 -38.38 85.5 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 119.777 -1.827 . . . . 0.0 110.333 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.53 -36.4 58.88 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.21 62.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.241 1.417 . . . . 0.0 113.859 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.57 -53.69 12.94 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.679 1.591 . . . . 0.0 111.392 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -23.54 41.09 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.84 0.856 . . . . 0.0 111.16 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.23 167.33 31.22 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.97 153.35 63.39 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.342 2.028 . . . . 0.0 108.078 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.26 42.86 1.06 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.254 0.622 . . . . 0.0 109.951 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.1 tp -93.28 -79.42 0.4 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.096 0.958 . . . . 0.0 108.656 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.78 -53.53 2.43 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-O 115.783 -2.056 . . . . 0.0 111.223 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.15 3.68 7.63 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 125.262 2.915 . . . . 0.0 110.933 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.09 -28.6 48.72 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -36.92 66.17 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.19 0.996 . . . . 0.0 110.917 -177.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.67 66.74 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.326 -0.859 . . . . 0.0 112.201 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -62.91 -43.63 98.28 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.804 1.242 . . . . 0.0 112.809 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 9.3 pt20 -63.97 -49.07 73.94 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 124.179 0.992 . . . . 0.0 109.869 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -49.63 -31.97 11.99 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.928 1.691 . . . . 0.0 112.28 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 5.3 m-30 -77.76 -34.59 52.31 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 121.163 3.764 . . . . 0.0 121.163 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 pt -76.79 -23.79 15.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 CA-C-N 120.95 1.705 . . . . 0.0 109.197 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 52' ' ' GLN . 76.3 t -75.13 -40.37 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 1 C-N-CA 131.827 4.051 . . . . 0.0 112.114 174.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.8 ttt -55.17 -31.47 61.39 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.164 1.386 . . . . 0.0 110.597 165.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 28' ' ' ILE . . . -89.17 -22.54 37.73 Favored Glycine 0 N--CA 1.426 -2.003 0 C-N-CA 124.254 0.931 . . . . 0.0 114.041 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.15 -40.57 27.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.614 1.566 . . . . 0.0 107.678 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.85 -18.93 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 C-N-CA 126.901 2.081 . . . . 0.0 111.382 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.46 -41.59 69.22 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.718 1.207 . . . . 0.0 110.141 173.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.32 21.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.641 0.776 . . . . 0.0 112.351 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -48.7 72.85 Favored Pre-proline 0 CA--C 1.507 -0.709 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -85.21 0.28 8.82 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 124.33 2.582 . . . . 0.0 107.366 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -93.92 -39.52 10.63 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.718 1.207 . . . . 0.0 108.093 -177.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.64 -31.78 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -26.89 57.53 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 118.653 0.661 . . . . 0.0 111.297 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.84 -26.33 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.77 -18.44 79.64 Favored Glycine 0 C--N 1.357 1.741 0 CA-C-N 119.082 0.856 . . . . 0.0 111.156 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -35.56 30.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 128.537 2.735 . . . . 0.0 109.205 175.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.07 -28.72 63.86 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -79.09 -29.09 43.12 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.043 1.737 . . . . 0.0 109.878 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.17 -35.5 36.41 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 124.017 0.927 . . . . 0.0 111.772 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.36 -26.71 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 C-N-CA 125.405 1.482 . . . . 0.0 108.716 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.8 tpt -74.27 -28.8 61.37 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.43 -29.0 59.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.677 1.591 . . . . 0.0 109.576 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 123.569 0.748 . . . . 0.0 111.284 -177.852 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.48 -1.726 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.87 -36.76 85.39 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 125.282 1.433 . . . . 0.0 109.412 168.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.9 m-80 -74.63 -47.83 29.87 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.392 1.477 . . . . 0.0 110.51 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.0 mt -56.33 -25.91 50.61 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 126.811 2.044 . . . . 0.0 113.221 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.58 -43.76 46.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.563 1.145 . . . . 0.0 110.71 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -67.02 -30.41 70.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 124.666 1.186 . . . . 0.0 110.185 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.85 -36.6 70.19 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.058 0.943 . . . . 0.0 110.957 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.53 -50.57 51.07 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 126.487 1.915 . . . . 0.0 108.165 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 mt -71.05 -28.42 64.36 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.931 1.292 . . . . 0.0 112.613 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -54.12 16.22 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.482 0.713 . . . . 0.0 110.823 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -18.74 62.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.075 0.55 . . . . 0.0 111.255 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.52 42.02 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 125.299 1.44 . . . . 0.0 110.077 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.53 63.87 Favored 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.802 2.041 . . . . 0.0 113.993 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.65 -22.92 24.41 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 119.197 0.908 . . . . 0.0 109.909 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.16 -30.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.9 mmt -76.87 -77.11 0.15 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 124.183 0.993 . . . . 0.0 108.439 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.2 ptt? -81.29 -5.5 57.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.946 -172.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.69 -52.05 32.02 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 165.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.43 -58.09 7.43 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 111.788 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.57 -47.51 19.25 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -171.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 17' ' ' MET . . . -56.69 -24.81 51.6 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pp -81.89 -32.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 CA-C-N 119.086 0.857 . . . . 0.0 111.562 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.17 -35.44 88.51 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 125.081 1.324 . . . . 0.0 111.181 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.22 60.58 Favored 'General case' 0 CA--C 1.486 -1.497 0 C-N-CA 128.334 2.654 . . . . 0.0 109.992 166.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.04 90.65 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 123.712 0.805 . . . . 0.0 112.068 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.3 -21.97 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.41 -32.08 9.06 Favored Glycine 0 CA--C 1.472 -2.605 0 CA-C-N 119.922 1.237 . . . . 0.0 112.3 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' HA3' ' A' ' 58' ' ' GLY . 64.4 mt -58.9 -36.98 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.15 -51.19 7.0 Favored Glycine 0 N--CA 1.414 -2.818 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 96.0 mt -66.31 -66.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.211 0 C-N-CA 124.316 1.046 . . . . 0.0 112.515 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.69 -58.47 6.21 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 126.021 1.728 . . . . 0.0 109.404 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.19 -16.6 62.58 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 119.221 0.919 . . . . 0.0 113.963 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.74 -43.52 14.57 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 118.861 1.331 . . . . 0.0 110.491 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.14 -32.85 56.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 125.515 1.526 . . . . 0.0 111.082 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 124.971 1.309 . . . . 0.0 111.014 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 tp -76.46 -21.05 56.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.499 0.59 . . . . 0.0 111.814 172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -80.75 2.9 24.18 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.701 -1.25 . . . . 0.0 110.385 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.9 -31.9 7.11 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 108.064 -2.014 . . . . 0.0 108.064 164.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.93 -22.22 53.63 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.688 1.195 . . . . 0.0 112.705 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.14 63.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.873 1.669 . . . . 0.0 112.484 -170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.15 -25.37 47.3 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 124.364 1.065 . . . . 0.0 110.58 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -83.7 176.73 3.5 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 125.673 1.589 . . . . 0.0 106.993 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.32 153.49 50.74 Favored 'Trans proline' 0 CA--C 1.501 -1.153 0 CA-C-N 123.787 2.388 . . . . 0.0 107.274 165.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -87.38 38.65 0.83 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.237 0.615 . . . . 0.0 109.757 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.64 -73.06 0.58 Allowed 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.82 -55.74 1.88 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 115.603 -2.142 . . . . 0.0 110.778 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -85.3 9.45 4.12 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 125.637 3.049 . . . . 0.0 111.71 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -78.53 -30.68 47.16 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -33.63 58.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 124.332 1.053 . . . . 0.0 111.43 -176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.23 -31.7 66.07 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 121.115 -0.991 . . . . 0.0 110.316 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -62.68 -24.21 67.52 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.496 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 mm-40 -60.39 -55.52 32.57 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.992 -1.004 . . . . 0.0 108.947 169.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -44.74 -36.47 3.19 Favored 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.423 1.489 . . . . 0.0 112.678 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.357 52.7 m-85 -78.03 -37.5 46.79 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.8 pt -75.55 -25.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.752 -1.217 . . . . 0.0 109.089 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.3 t -74.9 -38.59 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 130.042 3.337 . . . . 0.0 111.494 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.4 ttm -53.43 -33.67 54.91 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 125.707 1.603 . . . . 0.0 111.198 167.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 28' ' ' ILE . . . -76.4 -41.44 25.51 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 116.349 -0.387 . . . . 0.0 113.821 173.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.1 mt -66.02 -32.12 73.41 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 118.233 1.016 . . . . 0.0 112.371 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -77.1 -24.93 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 125.652 1.581 . . . . 0.0 111.246 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.51 -39.96 85.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.373 0.669 . . . . 0.0 111.161 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.11 24.89 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 123.654 0.782 . . . . 0.0 112.812 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -48.36 73.96 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.03 -7.75 9.18 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 CA-C-N 124.234 2.548 . . . . 0.0 108.485 -170.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -96.08 -29.97 13.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.068 1.747 . . . . 0.0 108.606 -177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.21 -30.73 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 108.926 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.23 -28.76 38.5 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.537 1.135 . . . . 0.0 110.898 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.58 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.42 -18.69 77.6 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.23 -37.07 54.0 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 126.928 2.091 . . . . 0.0 110.111 172.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.63 58.49 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.9 -28.41 49.82 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.783 1.633 . . . . 0.0 110.596 176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.06 -35.28 37.29 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.177 0.591 . . . . 0.0 110.801 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.14 -32.14 46.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 124.124 0.969 . . . . 0.0 109.122 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.8 ttt -75.5 -28.46 59.16 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.422 0.689 . . . . 0.0 110.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.33 -35.92 82.45 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.437 1.895 . . . . 0.0 109.422 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.62 -22.24 60.98 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -83.42 -45.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.877 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.595 0 C-N-CA 124.143 0.977 . . . . 0.0 112.465 -176.525 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mtp . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -63.99 -44.44 92.66 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.682 1.193 . . . . 0.0 110.031 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -82.01 -31.2 31.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.438 1.095 . . . . 0.0 110.958 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.44 -34.01 66.42 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 126.327 1.851 . . . . 0.0 111.632 168.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.54 -38.21 59.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.655 1.182 . . . . 0.0 111.404 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.83 -25.87 63.96 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.353 1.061 . . . . 0.0 110.153 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.08 -41.41 67.35 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.234 0.614 . . . . 0.0 110.128 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.93 -22.87 45.16 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.79 -45.36 64.81 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 125.113 1.365 . . . . 0.0 110.228 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -45.38 70.15 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.906 1.683 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -60.54 -35.23 75.51 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 126.291 1.836 . . . . 0.0 111.361 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.58 -52.97 62.91 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.735 1.214 . . . . 0.0 111.544 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.99 -36.04 74.22 Favored 'General case' 0 CA--C 1.484 -1.595 0 C-N-CA 125.544 1.538 . . . . 0.0 114.189 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.1 -22.16 25.57 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 119.532 1.06 . . . . 0.0 109.819 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -83.96 -27.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 125.05 1.34 . . . . 0.0 107.524 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.8 ttm -82.13 -71.62 0.48 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.335 0.654 . . . . 0.0 109.931 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -5.62 58.02 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.445 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.6 -54.98 7.89 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.45 -53.25 51.21 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.669 1.188 . . . . 0.0 111.134 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.22 -48.97 16.16 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.91 64.89 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.79 -33.85 12.33 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 CA-C-N 118.651 0.66 . . . . 0.0 111.7 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.84 -38.34 95.99 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 124.65 1.119 . . . . 0.0 110.504 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.02 -68.84 0.16 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 127.845 2.458 . . . . 0.0 108.736 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.61 64.95 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -163.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -71.05 -45.23 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 125.275 1.43 . . . . 0.0 110.826 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.07 -33.94 43.56 Favored Glycine 0 CA--C 1.465 -3.037 0 CA-C-N 120.246 1.385 . . . . 0.0 115.026 -174.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.98 -10.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 118.423 1.111 . . . . 0.0 110.721 171.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.74 -51.15 7.33 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.49 -71.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.065 0 C-N-CA 123.915 0.886 . . . . 0.0 111.892 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -38.18 89.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.782 2.833 . . . . 0.0 111.775 -174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.64 -20.34 71.53 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.88 -38.08 20.7 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.98 -18.88 49.18 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 125.387 1.475 . . . . 0.0 110.801 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -67.72 -42.03 82.58 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.93 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.0 -8.44 56.96 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-N 119.572 1.078 . . . . 0.0 111.567 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.26 -39.35 68.48 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 119.771 -1.831 . . . . 0.0 108.655 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -42.73 80.07 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 125.048 1.309 . . . . 0.0 111.082 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.48 62.91 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.206 1.402 . . . . 0.0 112.966 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.27 -52.29 19.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.991 1.316 . . . . 0.0 111.246 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -19.06 36.94 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 122.831 0.452 . . . . 0.0 111.434 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.11 169.53 18.13 Favored Pre-proline 0 C--N 1.355 0.825 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.86 148.54 52.09 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 CA-C-N 123.989 2.46 . . . . 0.0 107.798 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -87.31 43.92 1.14 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.521 0.728 . . . . 0.0 109.203 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.56 -77.75 0.44 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 124.411 1.085 . . . . 0.0 108.33 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.03 -56.92 1.54 Allowed Pre-proline 0 N--CA 1.435 -1.192 0 CA-C-O 116.118 -1.896 . . . . 0.0 110.916 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -81.69 7.31 5.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-N 124.75 2.732 . . . . 0.0 111.721 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.68 -34.75 34.5 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 121.229 1.832 . . . . 0.0 107.821 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -37.73 73.19 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.737 1.215 . . . . 0.0 107.831 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -22.85 60.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 121.074 -1.016 . . . . 0.0 112.688 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -63.01 -46.67 86.52 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 120.369 -1.457 . . . . 0.0 111.411 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 56' ' ' VAL . 10.1 pt20 -66.17 -50.76 62.81 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -43.74 -31.33 0.78 Allowed 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 128.275 2.63 . . . . 0.0 112.724 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.72 -53.27 8.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.17 -24.48 35.33 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 121.097 1.771 . . . . 0.0 111.515 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 52' ' ' GLN . 84.9 t -74.73 -40.21 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 C-N-CA 130.808 3.643 . . . . 0.0 112.031 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.1 ttm -55.0 -28.26 50.63 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.058 1.343 . . . . 0.0 111.602 167.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -7.4 52.97 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 122.045 -0.409 . . . . 0.0 113.946 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -81.65 -35.72 29.64 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.62 1.21 . . . . 0.0 109.066 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -77.11 -20.3 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 C-N-CA 126.361 1.864 . . . . 0.0 111.338 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.99 -44.13 70.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.923 1.689 . . . . 0.0 110.41 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.55 -25.73 24.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 123.785 0.834 . . . . 0.0 112.662 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.268 0.3 OUTLIER -49.47 -52.7 47.52 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 117.853 2.538 . . . . 0.0 117.853 177.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.63 -9.6 8.96 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 CA-C-N 123.773 2.383 . . . . 0.0 108.332 -168.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -87.01 -45.61 10.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 127.009 2.124 . . . . 0.0 105.817 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.18 -32.54 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.82 1.248 . . . . 0.0 109.628 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.49 -27.77 51.98 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.794 0.838 . . . . 0.0 111.086 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.69 -28.84 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.03 -19.88 76.69 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 119.087 0.858 . . . . 0.0 111.611 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.29 -35.33 48.05 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 127.753 2.421 . . . . 0.0 109.892 172.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.17 -32.59 62.77 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 mt -78.48 -23.33 46.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.438 1.895 . . . . 0.0 110.796 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -43.81 21.39 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.506 1.122 . . . . 0.0 110.295 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.0 t -75.1 -25.99 18.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 125.761 1.624 . . . . 0.0 109.162 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.8 ttm -76.63 -31.02 57.12 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 109.66 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -33.95 73.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.132 1.373 . . . . 0.0 109.575 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.66 -22.1 57.06 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 123.766 0.826 . . . . 0.0 111.559 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.0 t -91.38 -49.31 13.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.686 0 CA-C-O 117.158 -1.401 . . . . 0.0 112.071 -177.018 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.03 -27.99 65.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.061 0.944 . . . . 0.0 110.135 170.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -90.49 -32.47 16.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.729 1.212 . . . . 0.0 109.829 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.53 -34.83 67.41 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.228 1.811 . . . . 0.0 111.498 165.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.91 -37.48 58.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.613 1.165 . . . . 0.0 110.709 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.9 mtt -65.95 -30.91 71.56 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.799 1.24 . . . . 0.0 110.295 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.02 -36.9 69.82 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.784 0.834 . . . . 0.0 110.835 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.81 -28.41 36.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.71 1.204 . . . . 0.0 110.487 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 mt -79.68 -27.11 40.81 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.927 0.891 . . . . 0.0 112.024 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.4 -43.11 74.11 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.829 0.852 . . . . 0.0 109.193 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.3 -23.7 66.42 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.476 1.511 . . . . 0.0 111.708 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 -55.59 17.1 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.732 1.213 . . . . 0.0 110.304 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.14 -17.37 26.28 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.247 1.819 . . . . 0.0 114.234 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.37 -29.94 24.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 120.174 -1.579 . . . . 0.0 109.533 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.5 t -80.51 -37.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 125.774 1.63 . . . . 0.0 108.642 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.2 mmt -80.45 -51.18 9.12 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 124.924 1.29 . . . . 0.0 111.247 -172.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 34.7 mtm -80.77 -24.96 38.27 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.5 -48.08 77.28 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.24 -45.07 89.78 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 125.264 1.426 . . . . 0.0 112.458 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.69 -61.22 2.04 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.55 -22.72 35.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pp -81.81 -33.82 12.29 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 CA-C-N 120.13 1.332 . . . . 0.0 111.589 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.45 -36.71 93.52 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.64 -67.48 0.28 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.611 1.964 . . . . 0.0 108.926 164.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.79 68.53 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.465 1.506 . . . . 0.0 114.554 -160.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.0 -51.97 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 C-N-CA 124.753 1.221 . . . . 0.0 109.122 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.97 -37.49 29.17 Favored Glycine 0 CA--C 1.465 -3.074 0 C-N-CA 119.186 -1.483 . . . . 0.0 115.542 -171.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.412 HG21 ' HA3' ' A' ' 58' ' ' GLY . 1.9 pt -76.4 -9.48 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 118.682 1.241 . . . . 0.0 110.885 173.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.4 -51.22 7.53 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 165.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.44 -71.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 123.882 0.873 . . . . 0.0 111.909 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -38.88 91.55 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 129.245 3.018 . . . . 0.0 111.792 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.33 -19.74 68.46 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -37.82 20.14 Favored Glycine 0 C--N 1.361 1.932 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -79.97 -17.31 53.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.485 1.514 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -34.22 71.57 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.66 0.784 . . . . 0.0 110.802 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.4 -19.45 58.1 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-O 121.141 0.496 . . . . 0.0 112.051 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -75.16 -20.37 59.4 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.343 -1.473 . . . . 0.0 109.0 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.38 -24.64 67.71 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 125.071 1.32 . . . . 0.0 110.844 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.02 -26.82 54.19 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 118.9 1.35 . . . . 0.0 111.604 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -57.16 4.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.707 1.603 . . . . 0.0 112.144 -167.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -28.06 39.6 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.128 0.571 . . . . 0.0 111.303 -172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 29.0 mm100 -84.13 173.46 7.27 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 125.586 1.554 . . . . 0.0 106.921 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 56.4 Cg_endo -71.61 150.74 57.49 Favored 'Trans proline' 0 CA--C 1.5 -1.215 0 CA-C-N 123.946 2.445 . . . . 0.0 107.437 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -87.27 35.88 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.608 0.763 . . . . 0.0 109.592 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.43 -70.96 0.68 Allowed 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.84 -59.47 1.17 Allowed Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-O 116.103 -1.903 . . . . 0.0 110.483 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.43 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 71.6 Cg_endo -82.3 1.86 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 124.796 2.749 . . . . 0.0 112.695 -167.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.02 -27.69 21.87 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-N 121.241 1.837 . . . . 0.0 107.819 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -37.47 69.95 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -72.2 -24.86 61.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.044 -1.035 . . . . 0.0 112.084 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.5 m -63.09 -46.17 88.66 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.761 1.224 . . . . 0.0 112.046 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.1 pt20 -64.47 -49.95 69.38 Favored 'General case' 0 CA--C 1.469 -2.151 0 C-N-CA 123.752 0.821 . . . . 0.0 109.542 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -45.86 -33.67 3.32 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 126.538 1.935 . . . . 0.0 112.604 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.314 4.0 m-85 -77.28 -39.09 49.34 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.0 pt -74.16 -24.3 19.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 CA-C-N 121.283 1.856 . . . . 0.0 109.98 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' GLN . 67.5 t -74.9 -37.26 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 C-N-CA 131.509 3.924 . . . . 0.0 111.441 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.13 -32.94 62.47 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.201 1.0 . . . . 0.0 111.563 162.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -86.86 -9.34 74.51 Favored Glycine 0 C--N 1.352 1.466 0 C-N-CA 123.447 0.546 . . . . 0.0 112.989 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.3 mt -81.79 -16.8 49.76 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.933 0.893 . . . . 0.0 109.655 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.5 -30.03 19.04 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.91 -16.15 58.45 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.908 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 65' ' ' MET . . . -86.09 -24.07 26.44 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 110.997 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -50.19 68.41 Favored Pre-proline 0 C--N 1.35 0.63 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.44 0.87 9.66 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.335 2.69 . . . . 0.0 108.913 -173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 62' ' ' ALA . 2.7 ttt -67.99 -59.08 3.54 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.05 -38.17 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.684 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.886 -164.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.24 63.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.376 0.535 . . . . 0.0 111.562 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.8 -27.76 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.3 -20.01 77.66 Favored Glycine 0 C--N 1.36 1.891 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.841 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.33 48.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 129.046 2.938 . . . . 0.0 110.869 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.68 -33.69 66.89 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.47 -22.24 51.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.36 1.464 . . . . 0.0 112.233 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -80.26 -36.59 34.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.619 0.645 . . . . 0.0 110.084 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.4 -30.38 48.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 124.881 1.272 . . . . 0.0 109.242 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.1 tpt -76.67 -34.68 58.23 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.235 0.614 . . . . 0.0 110.261 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.03 -36.69 82.33 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 126.746 2.018 . . . . 0.0 109.712 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.4 -22.7 61.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.007 0.923 . . . . 0.0 111.724 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -93.68 -77.18 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.645 0 CA-C-O 117.605 -1.188 . . . . 0.0 109.73 -175.29 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 CA--C 1.482 -1.656 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -70.59 -26.77 63.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.192 0.997 . . . . 0.0 109.721 167.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -88.91 -34.95 16.76 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.625 1.17 . . . . 0.0 109.602 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 tp -56.49 -30.88 63.5 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.562 1.945 . . . . 0.0 112.005 166.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -78.32 -35.26 47.95 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.834 1.253 . . . . 0.0 111.261 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -26.26 61.74 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.18 0.992 . . . . 0.0 109.573 172.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.1 -34.95 69.04 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 123.944 0.898 . . . . 0.0 110.058 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 tt -70.13 -46.95 63.69 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 125.987 1.715 . . . . 0.0 109.126 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.06 -39.67 95.42 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.791 1.636 . . . . 0.0 112.451 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -48.96 59.11 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.104 0.962 . . . . 0.0 110.432 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.3 mtp -71.37 -17.37 62.42 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.178 0.991 . . . . 0.0 111.997 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -51.7 57.32 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.606 1.163 . . . . 0.0 110.071 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -20.83 56.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.025 2.13 . . . . 0.0 114.372 168.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.35 -31.34 24.84 Favored 'General case' 0 CA--C 1.5 -0.959 0 O-C-N 120.062 -1.649 . . . . 0.0 110.0 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -80.84 -41.61 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 125.774 1.629 . . . . 0.0 108.526 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -77.51 -45.23 26.13 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.952 1.301 . . . . 0.0 110.788 -172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.2 mtp -81.01 -20.31 42.05 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.925 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.2 -38.17 54.45 Favored Glycine 0 C--N 1.356 1.639 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.68 -55.91 22.54 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.085 1.354 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.71 -46.75 24.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -164.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' SD ' ' A' ' 65' ' ' MET . . . -56.23 -27.45 54.96 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 172.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.18 -32.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 O-C-N 121.158 -0.964 . . . . 0.0 108.788 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -32.35 78.34 Favored Glycine 0 C--N 1.36 1.9 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.94 -66.67 0.44 Allowed 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.201 1.4 . . . . 0.0 109.645 168.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.68 -32.61 59.64 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.626 1.97 . . . . 0.0 115.017 -166.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 77.4 mt -70.02 -50.63 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 C-N-CA 124.424 1.089 . . . . 0.0 109.553 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.06 -41.28 32.57 Favored Glycine 0 CA--C 1.463 -3.181 0 C-N-CA 119.672 -1.252 . . . . 0.0 115.202 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 pt -75.82 -9.27 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 118.814 1.307 . . . . 0.0 109.727 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.66 -48.92 8.39 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 166.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.72 -75.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.059 0 CA-C-N 117.942 0.871 . . . . 0.0 112.162 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.55 -41.79 92.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 C-N-CA 129.556 3.142 . . . . 0.0 112.447 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.39 -16.79 70.45 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.12 -44.08 12.39 Favored Glycine 0 C--N 1.363 2.033 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -73.72 -27.26 61.1 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.288 1.435 . . . . 0.0 110.611 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.21 82.38 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.581 1.152 . . . . 0.0 111.553 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -76.25 -17.78 59.32 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 118.792 0.724 . . . . 0.0 112.102 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.51 -27.74 64.41 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.964 -1.71 . . . . 0.0 109.997 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.32 -37.28 36.99 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.36 -17.1 61.32 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.451 1.501 . . . . 0.0 113.831 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.58 -54.92 8.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.901 1.681 . . . . 0.0 111.254 -171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -82.79 -20.09 36.47 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.906 0.882 . . . . 0.0 111.116 -175.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.99 168.46 22.7 Favored Pre-proline 0 C--N 1.355 0.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.93 149.12 58.89 Favored 'Trans proline' 0 CA--C 1.496 -1.408 0 CA-C-N 122.476 1.92 . . . . 0.0 107.666 170.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.43 40.21 0.91 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.467 0.707 . . . . 0.0 109.575 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -93.67 -76.52 0.47 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 124.696 1.199 . . . . 0.0 109.101 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.84 -49.84 3.38 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 115.408 -2.234 . . . . 0.0 111.087 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -82.94 11.03 3.39 Favored 'Trans proline' 0 N--CA 1.443 -1.493 0 CA-C-N 125.932 3.154 . . . . 0.0 111.111 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.56 -29.29 41.29 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -30.34 56.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.611 0.765 . . . . 0.0 112.123 -177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.71 -40.98 65.72 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.2 -0.938 . . . . 0.0 111.765 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.8 m -63.1 -38.54 91.59 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 125.605 1.562 . . . . 0.0 113.603 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.506 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.3 pp0? -62.77 -54.35 40.43 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 124.355 1.062 . . . . 0.0 109.655 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -47.63 -31.25 4.37 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 126.908 2.083 . . . . 0.0 112.577 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.305 6.1 m-30 -77.19 -45.46 26.56 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 118.928 2.936 . . . . 0.0 118.928 172.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -71.76 -18.97 20.02 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 121.306 1.866 . . . . 0.0 110.836 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 52' ' ' GLN . 61.5 t -75.0 -42.88 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 C-N-CA 130.329 3.452 . . . . 0.0 110.732 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ttt -55.19 -27.14 43.82 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 124.784 1.234 . . . . 0.0 111.743 162.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.52 -24.25 65.78 Favored Glycine 0 C--N 1.356 1.67 0 C-N-CA 124.739 1.162 . . . . 0.0 112.337 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.0 -21.71 36.93 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.145 1.378 . . . . 0.0 110.426 174.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.62 -28.11 17.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 124.908 1.283 . . . . 0.0 108.319 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 3.0 t70 -77.78 -29.76 51.05 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.062 0.945 . . . . 0.0 110.089 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 -14.65 42.76 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.083 1.353 . . . . 0.0 112.31 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.277 0.3 OUTLIER -49.94 -52.21 54.41 Favored Pre-proline 0 C--N 1.354 0.782 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 172.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.33 -13.21 12.48 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 123.707 2.36 . . . . 0.0 108.33 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.57 -51.21 45.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.35 2.26 . . . . 0.0 107.281 175.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.91 -39.15 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.178 -164.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.51 -27.22 58.66 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 119.316 0.962 . . . . 0.0 111.588 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.94 -30.41 10.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.76 -18.27 75.66 Favored Glycine 0 C--N 1.359 1.82 0 CA-C-N 118.842 0.747 . . . . 0.0 111.425 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.9 -35.67 59.72 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 127.778 2.431 . . . . 0.0 110.66 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.66 -41.26 24.7 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.62 -39.23 84.69 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.772 1.629 . . . . 0.0 112.128 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -80.18 -30.71 38.81 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 117.935 0.334 . . . . 0.0 111.425 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.1 t -71.02 -33.05 50.26 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.306 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 60.4 mtt -75.33 -31.75 60.68 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 123.297 0.639 . . . . 0.0 110.364 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.391 1.876 . . . . 0.0 109.751 172.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.31 -17.61 60.23 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.512 1.125 . . . . 0.0 112.807 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.52 -75.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.613 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.658 -176.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 CA--C 1.483 -1.597 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.14 -27.21 65.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.323 1.049 . . . . 0.0 110.196 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -87.13 -41.31 13.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 124.293 1.037 . . . . 0.0 108.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.8 tp -56.11 -29.98 61.41 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 127.277 2.231 . . . . 0.0 112.608 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -72.66 -46.85 51.83 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 124.461 1.104 . . . . 0.0 110.877 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.12 -25.08 62.43 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 125.338 1.455 . . . . 0.0 109.739 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.05 -43.87 64.23 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.754 0.821 . . . . 0.0 110.418 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.7 tp -72.11 -48.57 42.9 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 110.585 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 mt -65.54 -41.89 92.56 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.241 1.016 . . . . 0.0 112.759 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -51.17 37.43 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.389 1.075 . . . . 0.0 110.328 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.71 -19.31 62.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.63 -53.27 43.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.35 1.06 . . . . 0.0 110.173 170.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.79 -15.31 11.7 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.624 2.369 . . . . 0.0 114.453 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.85 -26.45 18.49 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 120.783 -1.198 . . . . 0.0 109.756 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.62 -34.17 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.084 1.353 . . . . 0.0 108.362 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.8 mtt -76.73 -65.72 0.9 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.738 1.615 . . . . 0.0 108.779 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.0 mtm -80.75 -18.96 46.04 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.39 -43.28 97.02 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.23 -64.76 0.8 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.145 0.978 . . . . 0.0 110.588 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.64 -52.69 8.59 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -169.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.97 44.41 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.1 -38.29 16.58 Favored 'Isoleucine or valine' 0 C--N 1.37 1.485 0 CA-C-N 120.291 1.405 . . . . 0.0 111.81 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.19 -38.52 95.76 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -54.51 -70.28 0.1 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.947 2.499 . . . . 0.0 109.32 164.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.63 72.44 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 114.15 -158.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.11 -47.23 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 C-N-CA 124.96 1.304 . . . . 0.0 109.908 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 -37.8 27.18 Favored Glycine 0 CA--C 1.465 -3.072 0 CA-C-N 120.218 1.372 . . . . 0.0 115.508 -173.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.1 -9.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 118.583 1.192 . . . . 0.0 110.408 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.32 -51.01 7.75 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 166.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.6 -71.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.994 0.918 . . . . 0.0 112.212 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.47 -39.85 92.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 129.211 3.004 . . . . 0.0 112.622 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.85 -19.1 66.22 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.97 -33.44 26.76 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -71.5 -35.7 70.84 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.716 2.006 . . . . 0.0 109.042 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -39.65 94.45 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 125.77 1.628 . . . . 0.0 111.429 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.38 -16.46 59.72 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.73 -26.45 62.48 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 120.006 -1.684 . . . . 0.0 110.199 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.5 -28.9 46.13 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -31.03 56.13 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.82 -50.91 25.47 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 124.519 1.128 . . . . 0.0 113.915 -163.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.05 -38.43 66.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.231 1.012 . . . . 0.0 111.785 -170.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.79 172.27 9.28 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.73 157.89 57.23 Favored 'Trans proline' 0 CA--C 1.496 -1.375 0 CA-C-N 124.585 2.673 . . . . 0.0 109.891 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.12 38.19 0.8 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 124.407 1.083 . . . . 0.0 110.063 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.17 -74.06 0.54 Allowed 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 123.723 0.809 . . . . 0.0 109.002 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.4 mt -75.79 -54.15 2.27 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-O 115.834 -2.031 . . . . 0.0 110.967 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.31 -5.26 14.22 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 125.122 2.865 . . . . 0.0 111.676 -168.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.97 -33.59 70.6 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 119.914 1.234 . . . . 0.0 108.742 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.33 68.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.52 1.128 . . . . 0.0 110.729 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -72.39 -28.88 63.28 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 120.713 -1.242 . . . . 0.0 112.95 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.6 m -62.95 -45.52 92.07 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.291 1.436 . . . . 0.0 112.381 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 56' ' ' VAL . 8.2 pt20 -59.81 -55.12 38.2 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 123.698 0.799 . . . . 0.0 109.331 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -43.86 -35.56 2.0 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 127.566 2.346 . . . . 0.0 112.904 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.27 8.0 m-85 -76.95 -49.46 15.47 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.9 pt -67.75 -24.51 30.96 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 CA-C-N 121.023 1.738 . . . . 0.0 111.172 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 52' ' ' GLN . 94.5 t -74.78 -40.58 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 C-N-CA 130.058 3.343 . . . . 0.0 112.065 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 50.0 ttp -51.5 -35.86 42.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.95 0.9 . . . . 0.0 111.309 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -11.82 62.87 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.56 -22.44 37.8 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.394 1.097 . . . . 0.0 109.28 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.9 t -76.76 -30.35 18.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 126.82 2.048 . . . . 0.0 108.749 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 7.6 t70 -70.13 -41.3 74.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.849 1.259 . . . . 0.0 111.082 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.61 31.7 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.695 0.798 . . . . 0.0 111.917 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -49.23 71.74 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.67 -11.5 10.34 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 CA-C-N 124.418 2.614 . . . . 0.0 107.986 -168.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.528 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -91.15 -34.76 14.91 Favored 'General case' 0 N--CA 1.42 -1.935 0 C-N-CA 126.002 1.721 . . . . 0.0 108.021 -178.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.49 -23.46 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 C-N-CA 123.357 0.663 . . . . 0.0 111.219 -176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -31.68 24.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 124.552 1.141 . . . . 0.0 110.101 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.37 -26.37 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.04 -16.51 79.72 Favored Glycine 0 CA--C 1.489 -1.537 0 C-N-CA 124.855 1.217 . . . . 0.0 110.728 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.73 -32.66 31.48 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 125.942 1.697 . . . . 0.0 109.311 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.16 -46.64 15.32 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.64 -39.71 94.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 126.446 1.899 . . . . 0.0 112.83 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -79.89 -28.87 39.84 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.06 -32.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 CA-C-N 118.753 0.706 . . . . 0.0 109.216 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.2 mmt -78.04 -19.78 53.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.275 0.63 . . . . 0.0 111.441 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.13 -37.82 53.27 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.297 1.439 . . . . 0.0 108.537 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.63 -18.96 46.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.867 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 p -83.23 -53.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -169.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.624 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.483 -1.634 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.74 -36.61 82.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.735 1.214 . . . . 0.0 110.278 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -90.41 -28.01 18.93 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.276 1.031 . . . . 0.0 110.804 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.77 -35.84 69.13 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.608 1.563 . . . . 0.0 112.026 164.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.58 -36.19 44.77 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 124.661 1.184 . . . . 0.0 110.133 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttp -63.95 -33.19 75.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 125.704 1.602 . . . . 0.0 109.748 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.01 -35.44 69.42 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.349 1.06 . . . . 0.0 110.096 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.5 -49.4 33.19 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 125.432 1.493 . . . . 0.0 109.852 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.9 -34.17 71.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.843 0.857 . . . . 0.0 112.024 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.63 -50.48 62.85 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.511 0.596 . . . . 0.0 111.273 175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.6 mtp -72.73 -13.48 61.34 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.066 0.546 . . . . 0.0 112.215 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.65 -56.32 12.81 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.727 1.211 . . . . 0.0 110.035 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.61 54.78 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 126.735 2.014 . . . . 0.0 114.33 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 -22.72 20.26 Favored 'General case' 0 CA--C 1.499 -1.005 0 O-C-N 120.711 -1.243 . . . . 0.0 110.48 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.94 -33.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.7 tpp -79.61 -62.71 1.6 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 109.806 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mtm -81.31 -23.56 37.78 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.35 99.16 Favored Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.19 -67.98 0.39 Allowed 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.94 -57.05 4.0 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.01 -27.84 54.75 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.28 -31.73 10.24 Favored 'Isoleucine or valine' 0 C--N 1.369 1.42 0 CA-C-N 120.481 1.491 . . . . 0.0 111.638 172.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.05 76.23 Favored Glycine 0 C--N 1.363 2.044 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -73.2 0.08 Allowed 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 127.912 2.485 . . . . 0.0 108.65 167.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.59 30.89 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -167.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.6 mm -71.0 -50.31 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.187 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.28 -40.48 49.16 Favored Glycine 0 CA--C 1.46 -3.36 0 CA-C-N 120.087 1.312 . . . . 0.0 114.585 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 pt -75.87 -8.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 119.026 1.413 . . . . 0.0 110.703 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.92 -50.51 7.75 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 165.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -65.41 -70.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.144 0 CA-C-N 117.617 0.709 . . . . 0.0 112.278 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.81 -46.02 91.34 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 129.398 3.079 . . . . 0.0 111.506 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.09 -19.49 79.78 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 119.435 1.016 . . . . 0.0 111.996 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.57 14.64 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -74.23 -27.0 60.57 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.01 1.724 . . . . 0.0 110.693 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -43.73 91.17 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.45 1.5 . . . . 0.0 112.091 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -10.64 59.56 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -70.14 -34.53 73.17 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 120.035 -1.666 . . . . 0.0 110.434 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.43 -35.19 48.33 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.15 62.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.652 1.581 . . . . 0.0 113.729 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.71 -48.42 47.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.31 1.444 . . . . 0.0 113.594 -169.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -37.23 63.91 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.159 0.984 . . . . 0.0 111.324 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -84.47 174.67 5.51 Favored Pre-proline 0 C--N 1.353 0.757 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.98 153.5 57.95 Favored 'Trans proline' 0 CA--C 1.5 -1.2 0 CA-C-N 125.435 2.977 . . . . 0.0 109.158 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -87.25 44.43 1.18 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.095 0.958 . . . . 0.0 108.551 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -93.77 -75.47 0.5 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 124.713 1.205 . . . . 0.0 108.255 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -75.84 -54.04 2.27 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 115.777 -2.058 . . . . 0.0 111.116 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.05 -1.75 11.61 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 CA-C-N 125.24 2.907 . . . . 0.0 111.429 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 tp -77.98 -26.85 48.94 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 120.049 1.295 . . . . 0.0 108.86 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.16 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.87 0.868 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . 0.258 0.8 OUTLIER -72.41 -27.65 62.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 120.65 -1.281 . . . . 0.0 112.984 173.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -62.9 -44.52 95.88 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 112.962 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.4 pt20 -59.28 -51.11 71.35 Favored 'General case' 0 CA--C 1.474 -1.959 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.44 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -41.89 -37.66 1.35 Allowed 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.853 2.461 . . . . 0.0 113.566 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.12 -46.26 24.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.81 -21.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 120.889 1.677 . . . . 0.0 110.924 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 52' ' ' GLN . 73.9 t -75.02 -40.67 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 C-N-CA 130.9 3.68 . . . . 0.0 112.019 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.8 ttp -53.17 -31.83 44.73 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.387 1.075 . . . . 0.0 111.544 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.04 -3.92 51.33 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.186 0.435 . . . . 0.0 114.186 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.87 -38.05 25.98 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.5 -21.17 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 C-N-CA 127.264 2.226 . . . . 0.0 110.289 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.05 -42.36 72.99 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.963 1.705 . . . . 0.0 110.628 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.48 -20.67 27.74 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.408 1.083 . . . . 0.0 112.729 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.276 0.3 OUTLIER -49.62 -52.27 52.06 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 175.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -85.45 -5.37 9.23 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 CA-C-N 123.748 2.374 . . . . 0.0 107.82 -168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.4 mmt -92.48 -41.27 10.38 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 126.701 2.0 . . . . 0.0 106.184 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -29.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 C-N-CA 124.392 1.077 . . . . 0.0 109.848 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.87 -29.88 56.02 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 124.031 0.932 . . . . 0.0 111.584 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.04 -31.88 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.06 -18.71 80.14 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.324 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -36.88 38.47 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 127.964 2.506 . . . . 0.0 110.559 174.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.86 -38.84 85.62 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.16 -23.31 61.27 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.544 1.538 . . . . 0.0 111.716 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -79.99 -35.21 37.81 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.847 0.859 . . . . 0.0 110.68 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.64 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 124.293 1.037 . . . . 0.0 109.538 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.4 mtp -77.96 -25.48 48.24 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.627 0.771 . . . . 0.0 111.268 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.96 -36.99 78.54 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 125.95 1.7 . . . . 0.0 108.516 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.69 62.71 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.322 1.049 . . . . 0.0 111.556 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -87.56 -85.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.603 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.046 -178.271 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.34 -41.27 98.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.091 1.356 . . . . 0.0 110.074 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -78.26 -44.6 25.07 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 124.945 1.298 . . . . 0.0 110.631 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.63 -23.7 43.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.105 2.162 . . . . 0.0 113.029 173.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.97 -43.85 42.63 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.302 1.041 . . . . 0.0 110.945 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.2 mtm -69.57 -27.22 64.94 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.88 1.272 . . . . 0.0 110.219 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.86 -37.03 70.28 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.691 0.797 . . . . 0.0 110.131 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.9 tp -77.81 -31.72 51.9 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.233 1.413 . . . . 0.0 110.128 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.08 -45.08 82.52 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.219 1.408 . . . . 0.0 111.256 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -69.34 -41.7 76.29 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.467 0.707 . . . . 0.0 111.637 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.9 ttm -61.9 -32.79 73.2 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.099 1.36 . . . . 0.0 111.149 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.54 -60.17 3.91 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 125.194 1.397 . . . . 0.0 110.786 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.01 58.69 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.718 1.607 . . . . 0.0 114.416 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.34 -33.28 18.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 120.469 -1.394 . . . . 0.0 110.3 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.11 -33.76 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 125.312 1.445 . . . . 0.0 108.393 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 34.2 ttm -82.53 -53.23 6.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 124.576 1.15 . . . . 0.0 110.041 -170.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.1 mtm -80.65 -23.69 39.5 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.92 90.55 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.7 tt -64.36 -51.61 62.45 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.966 1.307 . . . . 0.0 112.29 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.04 -50.05 13.99 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -170.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.15 57.77 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.87 -32.77 11.46 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 CA-C-N 119.156 0.889 . . . . 0.0 111.928 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.84 91.49 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -57.45 -53.16 61.26 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 128.752 2.821 . . . . 0.0 110.831 165.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.62 82.07 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.906 0.882 . . . . 0.0 113.194 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.01 -37.61 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 C-N-CA 126.183 1.793 . . . . 0.0 110.052 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -33.71 32.54 Favored Glycine 0 CA--C 1.478 -2.227 0 CA-C-N 119.875 1.216 . . . . 0.0 113.682 -172.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.476 HD11 ' HA3' ' A' ' 58' ' ' GLY . 21.1 mt -62.6 -30.28 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.58 9.11 Favored Glycine 0 N--CA 1.421 -2.365 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.21 -73.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.139 0 C-N-CA 123.773 0.829 . . . . 0.0 112.543 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.68 -45.52 82.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.964 2.506 . . . . 0.0 111.335 -171.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.27 -17.03 80.27 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.29 -36.56 30.48 Favored Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -74.98 -35.47 62.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.528 1.931 . . . . 0.0 108.883 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -34.66 76.55 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.657 1.183 . . . . 0.0 111.218 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -76.3 -13.43 60.15 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 122.89 0.476 . . . . 0.0 112.149 175.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.53 -39.59 85.06 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 119.902 -1.748 . . . . 0.0 109.803 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.92 -26.77 66.01 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.9 59.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.924 1.289 . . . . 0.0 112.948 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.69 -55.23 8.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 125.521 1.528 . . . . 0.0 111.639 -171.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -29.55 51.4 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 111.205 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -84.04 167.44 27.78 Favored Pre-proline 0 N--CA 1.441 -0.894 0 C-N-CA 125.193 1.397 . . . . 0.0 107.277 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.06 155.01 62.32 Favored 'Trans proline' 0 CA--C 1.494 -1.505 0 CA-C-N 123.538 2.299 . . . . 0.0 108.275 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.11 42.03 1.01 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 123.33 0.652 . . . . 0.0 110.066 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -93.5 -79.16 0.41 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 123.992 0.917 . . . . 0.0 108.7 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.2 mm -75.79 -52.48 2.7 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-O 115.615 -2.136 . . . . 0.0 111.864 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.68 2.79 8.3 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 125.57 3.025 . . . . 0.0 110.858 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 -27.01 35.25 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 172.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -72.04 -36.48 69.64 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.798 0.839 . . . . 0.0 110.837 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -32.56 66.59 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.179 -0.951 . . . . 0.0 112.131 173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.7 m -62.79 -42.53 99.75 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.92 1.288 . . . . 0.0 113.109 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 11.6 pt20 -63.87 -45.05 91.14 Favored 'General case' 0 CA--C 1.464 -2.347 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -52.76 -30.8 34.78 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.889 1.276 . . . . 0.0 112.297 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 10.3 m-30 -78.15 -28.55 48.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 121.364 3.839 . . . . 0.0 121.364 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.79 -29.12 25.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 121.251 1.841 . . . . 0.0 108.597 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.81 -35.04 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 1 C-N-CA 132.645 4.378 . . . . 0.0 111.794 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.4 ttt -55.05 -33.21 62.51 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.724 1.21 . . . . 0.0 110.919 164.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -76.48 -38.26 33.53 Favored Glycine 0 N--CA 1.433 -1.526 0 O-C-N 121.888 -0.508 . . . . 0.0 114.045 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.5 -35.07 76.99 Favored 'General case' 0 CA--C 1.508 -0.673 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.08 -25.73 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 C-N-CA 126.267 1.827 . . . . 0.0 110.93 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 19.0 t70 -71.53 -37.04 71.19 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.631 0.772 . . . . 0.0 111.681 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.71 -20.81 27.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.484 1.113 . . . . 0.0 112.882 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.5 -45.9 78.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 118.32 2.711 . . . . 0.0 118.32 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.14 -7.49 8.05 Favored 'Trans proline' 0 CA--C 1.494 -1.479 0 CA-C-N 124.189 2.532 . . . . 0.0 107.318 -168.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -91.4 -40.43 11.44 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 125.54 1.536 . . . . 0.0 107.77 -176.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 tp -77.74 -30.58 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.64 -31.15 57.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.162 0.985 . . . . 0.0 111.313 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -77.96 -28.67 15.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 CA-C-N 118.298 0.499 . . . . 0.0 109.947 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.94 -21.92 70.08 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -34.9 62.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.604 2.362 . . . . 0.0 110.462 170.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.43 -35.61 63.19 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.2 mt -73.74 -25.86 60.39 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 110.876 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -39.88 29.11 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 124.671 1.188 . . . . 0.0 110.814 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 -26.15 20.01 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.891 1.277 . . . . 0.0 109.247 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -28.18 57.48 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.61 0.764 . . . . 0.0 109.344 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.57 -33.68 69.28 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.798 1.239 . . . . 0.0 109.425 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.59 -23.68 61.77 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.733 0.813 . . . . 0.0 111.96 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -93.86 -36.42 7.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.668 0 CA-C-O 117.133 -1.413 . . . . 0.0 111.91 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.478 -1.801 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -36.62 82.76 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.35 1.06 . . . . 0.0 108.345 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.04 -48.85 16.75 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 125.254 1.422 . . . . 0.0 111.672 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.264 1.8 pp -56.78 -27.95 60.52 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.973 1.309 . . . . 0.0 113.099 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.88 -45.22 44.36 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.96 1.304 . . . . 0.0 110.837 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 81.8 mtp -64.07 -31.58 72.83 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 125.36 1.464 . . . . 0.0 110.282 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.98 -38.71 69.67 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.097 0.959 . . . . 0.0 110.701 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.46 -36.14 58.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 125.136 1.375 . . . . 0.0 110.181 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.31 -27.29 42.16 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.87 0.868 . . . . 0.0 111.852 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.41 -44.76 70.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 123.14 0.576 . . . . 0.0 109.913 168.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm -63.72 -25.78 68.35 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 111.712 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.49 -59.14 4.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.061 1.345 . . . . 0.0 110.503 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.39 -9.61 2.5 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 126.428 1.891 . . . . 0.0 114.742 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.03 -28.26 14.71 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 120.865 -1.147 . . . . 0.0 109.153 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.24 -27.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.709 0.804 . . . . 0.0 109.334 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -59.99 2.56 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.638 1.575 . . . . 0.0 108.701 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.6 mtm -80.9 -22.81 39.44 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.921 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.8 -40.84 75.03 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.35 -51.03 65.37 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.105 0.962 . . . . 0.0 111.715 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.02 -51.86 10.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.25 -25.69 48.74 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.88 -33.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 119.828 1.195 . . . . 0.0 110.907 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.8 -38.27 95.68 Favored Glycine 0 C--N 1.355 1.619 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -56.95 -64.64 0.81 Allowed 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 126.266 1.826 . . . . 0.0 109.659 165.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.04 73.31 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.712 1.205 . . . . 0.0 113.964 -159.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.5 mm -70.81 -47.11 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 C-N-CA 124.908 1.283 . . . . 0.0 109.54 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.9 27.76 Favored Glycine 0 CA--C 1.462 -3.235 0 C-N-CA 119.235 -1.46 . . . . 0.0 115.455 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -73.68 -10.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 118.924 1.362 . . . . 0.0 109.842 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.6 -50.27 8.25 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 167.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.73 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.048 0 C-N-CA 123.493 0.717 . . . . 0.0 112.42 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.69 -44.29 86.64 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 129.417 3.087 . . . . 0.0 112.138 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.56 -18.33 68.73 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.7 -38.45 20.29 Favored Glycine 0 C--N 1.364 2.115 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 125.939 1.695 . . . . 0.0 109.925 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -39.3 85.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 124.456 1.102 . . . . 0.0 111.604 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -10.18 59.21 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.71 -43.04 80.97 Favored 'General case' 0 C--N 1.362 1.114 0 O-C-N 119.995 -1.691 . . . . 0.0 109.625 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.67 -27.11 65.76 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.95 -22.04 60.77 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.662 1.185 . . . . 0.0 112.914 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.63 -56.4 5.91 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 125.198 1.399 . . . . 0.0 111.559 -171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -28.32 40.25 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 111.467 -173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -84.02 164.78 42.47 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.94 155.2 62.48 Favored 'Trans proline' 0 CA--C 1.491 -1.642 0 CA-C-N 123.294 2.212 . . . . 0.0 108.38 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -87.21 45.02 1.22 Allowed 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 123.734 0.647 . . . . 0.0 109.455 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -79.19 0.41 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.058 0.943 . . . . 0.0 108.718 173.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.31 -54.26 2.5 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-O 115.766 -2.064 . . . . 0.0 111.587 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.66 0.19 10.21 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 CA-C-N 125.32 2.936 . . . . 0.0 111.001 -170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.6 -35.71 57.95 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -42.2 84.2 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.744 1.218 . . . . 0.0 110.956 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.01 -31.6 66.36 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.859 -1.15 . . . . 0.0 112.596 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -62.87 -45.09 94.2 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 124.735 1.214 . . . . 0.0 112.738 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.729 ' O ' HG23 ' A' ' 56' ' ' VAL . 11.7 pt20 -58.94 -54.29 48.8 Favored 'General case' 0 CA--C 1.461 -2.469 0 CA-C-O 116.819 -1.562 . . . . 0.0 109.322 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -44.91 -38.41 4.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 128.572 2.749 . . . . 0.0 113.039 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -76.95 -35.78 57.0 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -75.83 -29.09 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 C-N-CA 126.224 1.809 . . . . 0.0 109.382 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -75.15 -35.97 36.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 C-N-CA 125.307 1.443 . . . . 0.0 110.043 175.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.04 -33.86 63.03 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.979 0.911 . . . . 0.0 111.31 165.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.14 -20.54 62.6 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 124.053 0.835 . . . . 0.0 112.709 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -82.12 -26.95 33.1 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.644 1.978 . . . . 0.0 109.502 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.4 -27.24 17.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 C-N-CA 125.731 1.612 . . . . 0.0 108.621 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.9 t70 -74.84 -24.92 58.68 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.034 0.933 . . . . 0.0 110.461 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 -18.56 31.83 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.844 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.348 0.3 OUTLIER -50.31 -58.97 8.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 171.992 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' HG22 ' A' ' 63' ' ' ILE . 74.4 Cg_endo -79.82 -13.29 13.12 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.915 2.41 . . . . 0.0 108.913 -169.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -59.44 3.2 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 127.353 2.261 . . . . 0.0 106.076 174.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -31.34 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.736 -164.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.26 -28.77 47.76 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 118.984 0.811 . . . . 0.0 111.306 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -83.37 -28.51 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.61 -15.4 79.67 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -39.94 62.21 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 126.712 2.005 . . . . 0.0 110.311 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.85 -35.06 46.4 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.75 -26.66 50.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.148 1.379 . . . . 0.0 112.17 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -80.31 -32.68 37.94 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 118.762 0.71 . . . . 0.0 110.17 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.51 -30.59 49.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 123.999 0.92 . . . . 0.0 109.667 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -37.21 66.54 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.546 0.739 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.31 -32.56 73.32 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 127.028 2.131 . . . . 0.0 110.314 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.67 60.73 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.97 0.908 . . . . 0.0 111.781 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.44 -46.68 24.98 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.652 0 CA-C-O 117.14 -1.409 . . . . 0.0 111.948 -178.619 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 CA--C 1.48 -1.749 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.41 -31.2 71.25 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.847 1.259 . . . . 0.0 109.711 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -76.38 -50.52 13.99 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.326 1.45 . . . . 0.0 109.678 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.62 -20.48 21.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.039 2.535 . . . . 0.0 113.249 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.45 -40.46 50.48 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.626 1.17 . . . . 0.0 111.358 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -26.16 61.48 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 124.29 1.036 . . . . 0.0 109.351 174.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -71.94 -35.02 69.49 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.594 0.757 . . . . 0.0 110.166 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.99 -48.05 55.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.5 1.52 . . . . 0.0 109.271 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.18 -37.3 86.99 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.239 1.016 . . . . 0.0 113.083 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.43 -50.62 44.02 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 124.283 1.033 . . . . 0.0 110.267 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.6 mtp -74.98 -14.38 60.62 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.753 0.821 . . . . 0.0 111.977 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.61 -51.74 57.32 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 124.965 1.306 . . . . 0.0 109.616 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.92 64.24 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.706 2.002 . . . . 0.0 113.385 170.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.73 -29.31 32.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 119.709 -1.87 . . . . 0.0 110.218 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -79.89 -40.17 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 C-N-CA 125.686 1.595 . . . . 0.0 108.662 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 29.5 ttm -84.53 -43.04 14.9 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.579 0.752 . . . . 0.0 111.431 -168.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.2 mtp -80.16 -28.59 38.81 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.28 -41.88 91.15 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -64.31 -44.12 92.56 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.673 1.189 . . . . 0.0 111.322 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.23 7.15 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.27 -28.54 58.99 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.68 -31.86 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.6 74.3 Favored Glycine 0 C--N 1.361 1.935 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -58.05 -74.01 0.07 Allowed 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.965 1.306 . . . . 0.0 109.312 164.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.55 69.79 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.762 1.625 . . . . 0.0 114.774 -161.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.7 mm -71.07 -45.43 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 124.869 1.267 . . . . 0.0 110.495 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.82 -41.18 29.1 Favored Glycine 0 CA--C 1.461 -3.314 0 CA-C-N 120.348 1.431 . . . . 0.0 114.494 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 pt -76.02 -5.88 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 118.823 1.311 . . . . 0.0 110.323 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.95 -50.06 6.63 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -65.59 -71.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.042 0.937 . . . . 0.0 111.997 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.43 -30.96 71.82 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 129.425 3.09 . . . . 0.0 112.601 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.14 -19.13 47.68 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 119.113 0.87 . . . . 0.0 110.956 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.12 -36.29 9.09 Favored Glycine 0 C--N 1.36 1.915 0 CA-C-N 118.329 1.064 . . . . 0.0 110.608 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -79.96 -20.42 45.63 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.208 1.403 . . . . 0.0 109.559 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -42.13 98.7 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.757 1.223 . . . . 0.0 111.188 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -10.81 59.7 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 123.353 0.661 . . . . 0.0 111.829 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -71.87 -36.8 70.2 Favored 'General case' 0 CA--C 1.5 -0.945 0 O-C-N 120.185 -1.572 . . . . 0.0 109.268 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.22 -33.72 56.29 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.46 71.84 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.163 1.385 . . . . 0.0 113.066 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.76 -41.26 68.62 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.251 1.42 . . . . 0.0 112.636 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -75.92 -36.99 59.21 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.546 1.138 . . . . 0.0 111.453 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -84.44 176.42 3.74 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.97 155.41 52.96 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 CA-C-N 125.622 3.044 . . . . 0.0 109.542 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -87.09 54.3 3.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 169.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 tp -93.68 -75.8 0.49 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 125.498 1.519 . . . . 0.0 107.436 172.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.1 -54.26 2.08 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 115.567 -2.159 . . . . 0.0 108.885 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 43.76 1.02 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 CA-C-N 125.129 2.867 . . . . 0.0 110.498 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 tt -90.1 -46.55 8.4 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 152.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -34.75 65.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.999 1.719 . . . . 0.0 111.935 -175.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -42.96 64.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.922 0.868 . . . . 0.0 109.757 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -62.89 -37.61 87.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.236 2.214 . . . . 0.0 113.693 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 4.5 pt20 -66.42 -50.3 63.88 Favored 'General case' 0 CA--C 1.469 -2.151 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.42 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -48.98 -28.93 4.25 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 126.704 2.002 . . . . 0.0 112.691 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.289 2.5 m-85 -77.09 -41.71 41.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 119.349 3.092 . . . . 0.0 119.349 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 pt -72.31 -23.24 21.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 CA-C-N 121.675 2.034 . . . . 0.0 110.357 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 52' ' ' GLN . 64.2 t -74.85 -35.42 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 C-N-CA 131.438 3.895 . . . . 0.0 111.607 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 38.1 ttp -55.36 -34.76 64.56 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.858 0.863 . . . . 0.0 111.257 162.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.89 -12.87 80.65 Favored Glycine 0 C--N 1.353 1.486 0 C-N-CA 124.042 0.829 . . . . 0.0 112.701 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.82 -17.75 46.4 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.147 0.979 . . . . 0.0 110.433 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.6 -24.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 124.314 1.046 . . . . 0.0 108.628 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 1.1 t70 -77.97 -13.3 59.93 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.903 0.881 . . . . 0.0 111.305 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.22 -19.48 29.92 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.994 1.318 . . . . 0.0 111.834 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.321 0.3 OUTLIER -50.16 -58.77 8.6 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.22 -5.71 12.83 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.006 2.47 . . . . 0.0 108.828 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.63 -54.33 6.81 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -30.45 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.636 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.66 -29.38 40.87 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 119.124 0.874 . . . . 0.0 111.028 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.8 t -82.66 -29.78 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.26 80.03 Favored Glycine 0 C--N 1.359 1.83 0 CA-C-N 118.89 0.768 . . . . 0.0 111.432 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.84 68.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.34 1.856 . . . . 0.0 110.988 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.03 -42.66 28.96 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.21 -36.62 83.53 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 127.402 2.281 . . . . 0.0 112.616 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -79.91 -33.02 40.16 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 122.014 0.126 . . . . 0.0 110.771 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.25 -30.25 45.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.876 0 C-N-CA 124.095 0.958 . . . . 0.0 109.742 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.2 ttt -72.93 -31.69 64.79 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 121.71 -0.619 . . . . 0.0 110.397 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -71.75 -30.76 65.94 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 126.178 1.791 . . . . 0.0 110.124 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.57 -22.0 44.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.661 -174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.36 -64.06 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.631 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.111 -177.51 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.481 -1.687 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.16 -30.54 67.72 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.69 1.196 . . . . 0.0 108.348 164.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.03 -49.05 40.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.424 1.49 . . . . 0.0 110.501 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.2 mt -56.35 -28.64 59.7 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.89 -44.11 50.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 124.524 1.13 . . . . 0.0 110.786 -177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -25.03 61.95 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 125.363 1.465 . . . . 0.0 109.947 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.06 -43.03 65.52 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.031 0.932 . . . . 0.0 110.201 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp -71.29 -35.31 71.26 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.318 1.447 . . . . 0.0 109.879 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -67.79 -40.91 83.9 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.258 1.823 . . . . 0.0 112.684 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -48.73 60.3 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.221 1.409 . . . . 0.0 108.84 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.0 mtt -68.51 -16.43 63.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.425 1.09 . . . . 0.0 112.076 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.09 62.43 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 124.398 1.079 . . . . 0.0 109.929 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.44 70.49 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 125.113 1.365 . . . . 0.0 113.509 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.83 -20.5 35.55 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 119.719 1.145 . . . . 0.0 110.421 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -87.64 -26.54 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 125.408 1.483 . . . . 0.0 107.767 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.8 mmt -81.35 -68.76 0.66 Allowed 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.68 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -16.58 53.38 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.81 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.44 -51.79 40.11 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.46 -61.98 1.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.291 0.636 . . . . 0.0 110.925 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.577 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -77.43 -41.47 39.68 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -161.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.88 66.96 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.46 -31.3 9.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.66 -32.05 74.1 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.32 -63.89 1.11 Allowed 'General case' 0 CA--C 1.493 -1.222 0 C-N-CA 125.014 1.325 . . . . 0.0 110.169 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -43.41 -41.67 4.34 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 126.879 2.072 . . . . 0.0 115.258 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 71.8 mt -64.75 -53.68 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 125.592 1.557 . . . . 0.0 111.487 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.67 67.4 Favored Glycine 0 CA--C 1.49 -1.508 0 CA-C-N 120.143 1.338 . . . . 0.0 114.988 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.445 HG12 ' HA3' ' A' ' 58' ' ' GLY . 8.4 mt -74.22 -27.89 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 168.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -48.56 10.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.74 -76.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 124.32 1.048 . . . . 0.0 112.484 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.17 -36.76 83.96 Favored 'General case' 0 CA--C 1.493 -1.236 0 C-N-CA 126.45 1.9 . . . . 0.0 113.385 -170.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -21.01 64.18 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.11 -34.92 31.89 Favored Glycine 0 C--N 1.362 2.003 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -73.33 -31.13 63.81 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 126.763 2.025 . . . . 0.0 109.654 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -38.17 84.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.729 1.211 . . . . 0.0 111.176 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.28 -13.97 60.14 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.923 -0.485 . . . . 0.0 111.946 175.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -67.12 -38.38 85.5 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 119.777 -1.827 . . . . 0.0 110.333 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.53 -36.4 58.88 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.21 62.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.241 1.417 . . . . 0.0 113.859 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.57 -53.69 12.94 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.679 1.591 . . . . 0.0 111.392 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -23.54 41.09 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.84 0.856 . . . . 0.0 111.16 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.23 167.33 31.22 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.97 153.35 63.39 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.342 2.028 . . . . 0.0 108.078 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -87.26 42.86 1.06 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.254 0.622 . . . . 0.0 109.951 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.1 tp -93.28 -79.42 0.4 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.096 0.958 . . . . 0.0 108.656 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.9 mt -75.78 -53.53 2.43 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-O 115.783 -2.056 . . . . 0.0 111.223 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.15 3.68 7.63 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 125.262 2.915 . . . . 0.0 110.933 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.09 -28.6 48.72 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -73.37 -36.92 66.17 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.19 0.996 . . . . 0.0 110.917 -177.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.67 66.74 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.326 -0.859 . . . . 0.0 112.201 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -62.91 -43.63 98.28 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.804 1.242 . . . . 0.0 112.809 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 49' ' ' LEU . 9.3 pt20 -63.97 -49.07 73.94 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 124.179 0.992 . . . . 0.0 109.869 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -49.63 -31.97 11.99 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.928 1.691 . . . . 0.0 112.28 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 5.3 m-30 -77.76 -34.59 52.31 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 121.163 3.764 . . . . 0.0 121.163 172.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 pt -76.79 -23.79 15.28 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 CA-C-N 120.95 1.705 . . . . 0.0 109.197 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 52' ' ' GLN . 76.3 t -75.13 -40.37 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 1 C-N-CA 131.827 4.051 . . . . 0.0 112.114 174.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.8 ttt -55.17 -31.47 61.39 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.164 1.386 . . . . 0.0 110.597 165.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 28' ' ' ILE . . . -89.17 -22.54 37.73 Favored Glycine 0 N--CA 1.426 -2.003 0 C-N-CA 124.254 0.931 . . . . 0.0 114.041 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.15 -40.57 27.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.614 1.566 . . . . 0.0 107.678 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.85 -18.93 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 C-N-CA 126.901 2.081 . . . . 0.0 111.382 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.46 -41.59 69.22 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.718 1.207 . . . . 0.0 110.141 173.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.32 21.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.641 0.776 . . . . 0.0 112.351 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -48.7 72.85 Favored Pre-proline 0 CA--C 1.507 -0.709 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -85.21 0.28 8.82 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 124.33 2.582 . . . . 0.0 107.366 -170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -93.92 -39.52 10.63 Favored 'General case' 0 N--CA 1.421 -1.916 0 C-N-CA 124.718 1.207 . . . . 0.0 108.093 -177.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.64 -31.78 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -26.89 57.53 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 118.653 0.661 . . . . 0.0 111.297 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.84 -26.33 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.77 -18.44 79.64 Favored Glycine 0 C--N 1.357 1.741 0 CA-C-N 119.082 0.856 . . . . 0.0 111.156 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.54 -35.56 30.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 128.537 2.735 . . . . 0.0 109.205 175.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.07 -28.72 63.86 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -79.09 -29.09 43.12 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.043 1.737 . . . . 0.0 109.878 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.17 -35.5 36.41 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 124.017 0.927 . . . . 0.0 111.772 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.36 -26.71 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 C-N-CA 125.405 1.482 . . . . 0.0 108.716 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.8 tpt -74.27 -28.8 61.37 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.43 -29.0 59.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.677 1.591 . . . . 0.0 109.576 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.68 -23.9 49.44 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.569 0.748 . . . . 0.0 111.284 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.3 t -91.29 -71.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.61 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 0 0 . 1 stop_ save_